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Abstract
Anorexia nervosa (AN) is a life threatening and difficult-to-treat eating
disorder with a high relapse rate and an often chronic course of illness.
Despite various efforts, the etiopathogenesis of this disorder remains
enigmatic. This work sets out to investigate structural and functional
brain alterations in young women with AN and closely matched healthy
control participants, to help clarify the role of neural changes in this
challenging disorder. Its main aim is the temporal mapping of neural
and behavioural changes in a longitudinal design with three measurement
time points: from the acute phase of AN, with severe underweight, to a
weight-restored phase.
To examine brain alterations during acute underweight, as well as res-
torative mechanisms induced by weight gain treatment, two longitudinal
studies and a cross-sectional study were conducted. Study I provides
insight into structural brain alterations of AN patients during acute
underweight as well as longitudinal regenerative processes with weight
restoration. The findings demonstrate strong global reductions of cor-
tical and subcortical grey matter at the beginning of treatment and a
partial reversibility over the course of treatment. Notably, these brain
recovery processes were dependent on patients’ age, potentially indicating
decreases of brain plasticity across the lifespan.
Study II examines network changes of resting-state functional connectiv-
ity in patients with AN during acute underweight, as well as over the
course of weight restoration treatment. With the help of network-based
analyses a network of reduced functional connectivity was identified at
the beginning of treatment comprising fronto-basal ganglia/limbic regions
related to reward, learning, and cognitive-emotional integration. This
network of reduced connectivity recovered with weight normalisation. The
regeneration of functional connectivity within the network significantly
correlated with changes in patients’ psychopathology.
Study III is a cross-sectional investigation of structural connectivity at
the beginning of treatment with a focus on the fornix, a tract of the limbic
system connecting the mammillary bodies with the hippocampi. Findings
of reduced structural connectivity in previous studies had suggested the
fornix as a key structure in the pathomechanism of AN. By integrating
knowledge from Study I to investigate potential pitfalls in the investigation
of structural connectivity in AN, Study III shows that previous results
had been biased by enlarged ventricles of AN patients. The findings
reveal that differences of structural connectivity in the fornix disappear,
compared to healthy controls, when adequately controlling for effects of
the enlarged ventricles. This suggests that microstructural alterations
unlikely occurred in the fornix of AN patients.
Taken together, the findings of the present PhD thesis demonstrate a
tremendous plasticity of young AN patients’ brains and suggest that
drastic alterations in the structural and functional realm are largely
reversible with specific treatment and careful weight restoration. Remain-
ing residual alterations both on a structural and functional level by the
end of the weight normalisation treatment highlight the importance of
sufficiently long and well-structured treatment programmes, including
outpatient after-care, to further normalise and stabilise weight and eating
behaviour, as well as to improve psychopathology. The complex nature
of AN underscores the necessity in neuroimaging research to combine
and carefully evaluate different sources of information to avoid erratic or
premature conclusions about brain alterations.
Kurzfassung
Anorexia nervosa (AN) ist eine lebensbedrohliche und schwierig zu behan-
delnde Essstörung, mit einer hohen Rückfallrate und einem oft chronischen
Krankheitsverlauf. Trotz vielseitiger Forschungsbemühungen bleibt die
Äthiopathogenese dieser Krankheit bislang ein Rätsel. Die vorliegende
Arbeit hat zum Ziel, strukturelle und funktionelle Gehirnveränderungen
bei jungen Frauen mit AN, sowie gesunden Kontrollprobandinnen, zu
untersuchen, um so die Rolle neuronaler Veränderungen bei dieser heraus-
fordernden Krankheit zu beleuchten. Das Hauptziel der Arbeit ist die
zeitliche Abbildung neuronaler und verhaltensbezogener Veränderungen
in einem Länsschnittsdesign mit drei Messzeitpunkten: von der akuten
Phase der AN mit schwerem Untergewicht, zu einer Phase der Gewichts-
normalisierung.
Um Gehirnveränderungen während des akuten Untergewichts, sowie Mech-
anismen der Hirnregeneration im Verlaufe des Gewichtsaufbaus zu un-
tersuchen, wurden zwei Längsschnittstudien und eine Querschnittsstudie
durchgeführt. Studie I liefert Einblicke in strukturelle Gehirnveränder-
ungen bei Patientinnen mit AN, sowohl während akutem Untergewicht,
als auch während des Gewichtsaufbaus. Die Ergebnisse zeigen eine starke
globale Verminderung kortikaler und subkortikaler Grauer Substanz zu
Beginn der Therapie, sowie eine unvollständige Erholung im Verlauf
der Behandlung. Bemerkenswerterweise waren diese Erholungsprozesse
abhängig vom Alter der Patientinnen, was auf die über die Lebensspanne
hinweg abnehmende Hirnplastizität hinweisen könnte.
Studie II untersucht Netzwerkveränderungen funktioneller resting-state
Konnektivität in Patientinnen mit AN während akutem Untergewicht,
sowie über den Verlauf des Gewichtsaufbaus. Netzwerkanalysen identifiz-
ierten zu Beginn der Therapie ein Netzwerk mit reduzierter funktioneller
Konnektivität in frontalen, basal gangliären und limbischen Regionen,
die eine Rolle spielen bei Belohnung, Lernen und der Integration von
Kognitionen und Emotionen. Dieses Netzwerk mit reduzierter Konnekt-
ivität erholte sich im Verlaufe der Gewichtsnormalisierung. Die Erholung
der funktionellen Konnektivität innerhalb des Netzwerkes korrelierte
signifikant mit Veränderungen in der Psychopathologie der Patientinnen.
Studie III ist eine Querschnittsuntersuchung der strukturellen Konnekt-
ivität zu Beginn der Therapie, mit einem Fokus auf den Fornix, ein
Fasertrakt des limbischen Systems, welcher die Mammillarkörper mit
den Hippocampi verbindet. Ergebnisse vorheriger Studien zu reduzierter
struktureller Konnektivität hatten den Fornix als eine Schlüsselstruktur
im Pathomechanismus von AN suggeriert. Durch die Integration von
Wissen gewonnen aus Studie I, zur Aufdeckung potentielle Fallstricke
bei der Untersuchung struktureller Konnektivität in AN, konnte Studie
III zeigen, dass vorherige Resultate verzerrt waren durch den Einfluss
der vergrösserten Ventrikel der AN Patientinnen. Die Ergebnisse zeigen,
dass Unterschiede in struktureller Konnektivität, im Vergleich von AN
Patientinnen zu gesunden Kontrollprobanden, verschwinden, wenn für die
Effekte der vergrösserten Ventrikel adäquat kontrolliert wird. Das weisst
darauf hin, dass keine mikrostrukturellen Veränderungen im Fornix von
AN Patientinnen vorliegen.
Zusammengefasst zeigen die Ergebnisse der vorliegenden Doktorarbeit
eine enorme Plastizität der Gehirne junger AN Patientinnen und weissen
darauf hin, dass sich drastische strukturelle und funktionelle Gehirnverän-
derungen mit spezifischer Behandlung und sorgfältigem Gewichtsaufbau
weitgehend umkehren lassen. Die, nach der Gewichtsnormalisierung
zurückbleibenden, strukturellen und funktionellen Gehirnveränderungen
heben die Wichtigkeit eines ausreichend langen und gut strukturierten
Behandlungsprogramms, mit anschliessender Nachbehandlung zur weit-
eren Normalisierung und Stabilisierung des Essverhaltens, sowie zur
Verbesserung der Psychopathologie, hervor. Die komplexe Natur der AN
unterstreicht für die Neurowissenschaften die Notwendigkeit verschiedene
Informationsquellen zu kombinieren und sorgfältig auszuwerten, um keine
fehlerhaften oder voreiligen Schlüsse bezüglich Gehirnveränderungen zu
ziehen.
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CHAPTER 1
Introduction
Anorexia nervosa (AN) is a psychiatric disorder with initial mani-
festation often during puberty and adolescence (Zipfel, Giel, Bulik, Hay,
and Schmidt, 2015). Current treatment options comprise psychotherapy
along with nutritional counselling but treatment success is variable and
often does not last. Relapse probabilities are high and up to half of the
affected patients face a chronic course of illness (Herpertz-Dahlmann,
Seitz, & Konrad, 2011; Kaye, 2009; Steinhausen, 2002). This may in
part be attributable to our lack of a comprehensive understanding of
the pathomechanisms underlying the disorder (Compan, Walsh, Kaye, &
Geliebter, 2015; Herpertz-Dahlmann et al., 2011; Kaye, 2009). By means
of magnet resonance imaging, the present thesis thus aims at providing a
better understanding of the neural changes in AN during the phase of
acute underweight, as well as during two distinct phases over the course
of an inpatient weight restoration therapy.
The present thesis is structured into three parts: First, the theoretical
background gives an overview of the clinical picture of AN, its treatment
and its consequences. Epidemiological considerations and the current
knowledge about the aetiology of AN will then serve as a theoretical basis
for the present thesis. Second, in the empirical part, encompassing the
aims and hypotheses, the general methods, and three empirical studies
(Chapter 5-7), as well as an additional data exploration (Chapter 8),
structural and functional brain alterations in young women with AN
will be investigated. In the third and final part of the present thesis,
key findings of the three studies, as well as the additional exploratory
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data analyses, will be summarised briefly and integrated into a general
discussion with respect to relationships between results. Furthermore,
clinical and therapeutic implications of these findings, methodological
considerations, and suggestions for future research will be outlined.
This thesis was written within a project funded by the Swiss Anorexia
Nervosa Foundation (SANS; project no. 19-12), the Gottfried and Julia
Bangerter-Rhyner-Foundation, and the Parrotia Foundation, led by Prof.
Dr. Gabriella Milos of the Department of Psychotherapy and Psychiatry
at the University Hospital of Zurich, Switzerland. This work was written
under the supervision of Prof. Dr. C. Martin-Soelch, Chair of Clinical
Psychology at the University of Fribourg, Prof. Dr. L. Jäcke, Chair of
Neuropsychology at the University of Zurich, and Dr. J. Hänggi, senior
researcher at the Division of Neuropsychology at the University of Zurich,
Switzerland.
CHAPTER 2
Background
This chapter gives an overview of the clinical picture of AN, its
treatment, its consequences for the individual as well as for society. After
a summary of the most important cornerstones in the history of the
disease, current diagnostic criteria and treatment guidelines are outlined
and supplemented with a short depiction of the economic burden of
AN. Further, epidemiological aspects are highlighted and the current
knowledge of predisposing and maintaining factors is summarised and
assembled in an aetiological model of AN, which will serve as a theoretical
basis for the present thesis.
2.1 Anorexia nervosa
2.1.1 Historical evolution of the concept of Anorexia nervosa
Etymologically the term anorexia nervosa originates from Greek an-
("without") and órexis, ("appetite, desire"), and Latin nervosa ("nervous"),
thus translating to "nervous absence of appetite" (Stevenson, 2010).
However, the syndrome was described long before the medical term
anorexia nervosa had been coined. First reports that are now suspected
to be early cases of AN stem from cases of religious fasting (Bemporad,
1997; Fox, 1987). From the Hellenistic era (323 BC - 330 AD) until the
Middle Ages there have been numerous accounts of self-starvation, often
in the name of religion with the aim of spiritual purification (Pearce,
2004; Vandereycken & Van Deth, 1994b). The death of a young woman
following the precepts of Saint Jerome in 383 AD is probably the first
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record of such a case (Bemporad, 1997; Fox, 1987). Whether these
historical accounts of fasting women were cases of AN as we see them
today, or merely showed analogous symptoms cannot be determined
conclusively (Vandereycken & Van Deth, 1994a).
These early anecdotes were followed by a medical description of the
anorexic condition by the English physician Richard Morton in 1689
(Morton, 1720). He described two independent cases of a girl and a
boy, who both started fasting at the age of 16. Shortly after the girl
sought help from Dr Morton because of her frequent fainting fits, the
unsuccessful treatment resulted in her death at the age of 18. The male
patient, "Son of the Reverend Minister Steele", "recovered his Health in a
great Measure" when he adhered to the "Milk Diet" (Morton, 1720, p.10)
and abandoned his studies as Morton had prescribed (Morton, 1720).
With Morton’s work, AN was the first eating disorder to be recognised
as a clinical condition (American Psychiatric Association [APA], 1952;
Morton, 1720; Pearce, 2004). This marks the beginning of a change in
perception of the ascetic fasting in earlier centuries (Fox, 1987).
Two centuries later, Sir William Gull, a famous British physician,
furthered the medicalisation of self-starvation as he described the ema-
ciated condition in young women in his address to the British Medical
Association in Oxford (Gull, 1868). Independently, the French neuro-
psychiatrist Ernest Charles Lasègue published a similar description in
a paper in 1873 with the title "De l’anorexie hystérique [On hysterical
anorexia]" (Lasègue, 1873). While both men used the term "Anorexia",
Gull is generally credited with coining the term "Anorexia nervosa" (Gull,
1874, p.22) in his seminal work "Anorexia nervosa (Apepsia Hysterica,
Anorexia Hysterica)" (Gull, 1874; Pearce, 2004). He stated that the onset
of the condition is chiefly during adolescence and affects mostly females
(Gull, 1868, 1874), observations that hold true until today (Treasure,
Cardi, Leppanen, & Turton, 2015). Further, he notes that there is no
primary medical lesion to be observed, that the origin of the condition
seems to be "central" (brain) rather than "peripheral" (stomach) (Gull,
1874, , p.24) and that patients are often restless and in constant motion.
Additionally, he points out that the causes for the condition are unknown
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(Gull, 1874), a circumstance that sadly also still applies (Woerwag-Mehta
& Treasure, 2008). Comparing Gull’s (1868, 1874) description to today’s
diagnostic criteria in the Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-5) (American Psychiatric Association
[APA], 2013), demonstrates that presentation and concept of AN have
remained relatively stable over a long period of time. While Gull (1868)
defined many of the core features of AN we know today, there are aspects
he did not mention, like shape concerns and the fear of gaining weight.
Whether these symptoms were not mentioned or observed by Gull, or not
present in the patients he encountered, remains unclear (Moncrieff-Boyd,
2016). Notably though, his work laid the foundation for the understand-
ing and the research of AN conducted today (Gianini et al., 2016; Guarda,
Schreyer, Boersma, Tamashiro, & Moran, 2015).
2.1.2 Symptomatology and diagnostic criteria today
With the latest version of the DSM-5 (APA, 2013), AN is placed
in the "Feeding and Eating Disorders" chapter and characterised by the
following diagnostic criteria: (A) restricted nutritional "intake relative to
requirements, leading to a significantly lower body weight", (B) "fear of
gaining weight . . . , or persistent behaviour that interferes with weight
gain" despite significant underweight, (C) distorted body image, "undue
influence of body weight or shape on self-evaluation" (APA, 2013, pp.
338-9), or enduring denial of the severity of the low weight (APA, 2013).
The previously in the DSM-IV-TR included criterion (D) requiring amen-
orrhoea, or the absence of at least three menstrual cycles (APA, 2000),
was deleted from the DSM-5 (APA, 2013) as it inherently only applied to
post-menarcheal and pre-menopausal women. Furthermore, criterion (A)
was changed to no longer contain the word "refusal" in regard to weight
maintenance, as to avoid the inappropriate implication of intentional
behaviour (American Psychiatric Association Division of Research, 2014).
Two different subgroups of AN can be distinguished as reflected in
the diagnoses of the International Statistical Classification of Diseases
and Related Health Problems, 10th Revision (ICD-10) (World Health
Organization [WHO], 2009): a restrictive and a binge-purge subtype.
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While both subtypes are characterised by a highly restrictive eating
pattern, the binge-purge subtype also displays "episodes of binge-eating
or purging behaviour" (APA, 2013, pp. 338-9), such as vomiting or abuse
of laxatives (WHO, 2009). In addition to the specific diagnosis, the
DSM-5 (APA, 2013) offers an estimation of the current severity of the
disorder according to the Body Mass Index (BMI, calculated as kg/m2)
of a patient as mild (BMI ≥ 17), moderate (BMI 16-16.99), severe (BMI
15-15.99), and extreme (BMI < 15).
2.1.3 Somatic complications
AN is associated with several somatic problems due to the emaciation
of the body. Often times, patients are not immediately aware of the
severity of these issues but only become aware of them when the situation
is progressed and physical signs become more obvious and urgent (Katz
& Vollenhoven, 2000). While most of these symptoms are reversible with
weight restoration, some, e.g. osteoporosis, can cause permanent damage
even when remission is achieved, e.g. bone fractures or the need for
artificial joints (Fairburn & Harrison, 2003).
Nearly all organ systems are affected by the severe malnutrition (see
Figure 2.1 for a summary) (Zipfel et al., 2015). Physical signs include
heightened sensitivity to low temperatures (Wakeling & Russell, 1970),
low body temperature (Zipfel et al., 2015), sleep disturbances (Kim et al.,
2010; Lauer & Krieg, 2004), gastrointestinal problems (e.g. obstipation)
(McCallum et al., 1985), dizziness and fainting (Sharp & Freeman, 1993),
as well as reduced libido (Gold et al., 1986; Katz & Vollenhoven, 2000).
Furthermore, dermatological alterations such as dryness of the skin and
a gradual skin yellowing can be observed, along with loss of scalp hair,
the development of fine hair covering the body (i.e. lanugo hair), and
oedema (Strumia, 2005).
The malnutrition also causes disturbances of the neuroendocrine
system, such as decreased luteinising hormone, follicle stimulating hor-
mone, and oestrogen, leading to amenorrhoea and thus infertility in
post-menarcheal women (Katz & Vollenhoven, 2000). In men, reduced
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testosterone levels can be observed, which instigate hypogonadism (Katz
& Vollenhoven, 2000). In children with pre-pubertal onset of AN, pu-
berty onset may be significantly delayed (Pugliese, Lifshitz, Grad, Fort, &
Marks-Katz, 1983) and body growth reduced (Fairburn & Harrison, 2003).
Some of these alterations improve upon weight restoration others, how-
ever, persist (Katz & Vollenhoven, 2000; Meczekalski, Podfigurna-Stopa,
& Katulski, 2013). For example, while body growth in pre-pubertal AN
patients has been reported to accelerate upon re-nutrition, body height re-
mains stunted even after weight normalisation (Lantzouni, Frank, Golden,
& Shenker, 2002).
Additionally, AN can be accompanied by abnormal electrolyte levels
(Mitchell & Crow, 2006; Sharp & Freeman, 1993). Hypokalaemia, hy-
pomagnesaemia, and imbalances of the acid-base metabolism influence
bowel motility (Fairburn & Harrison, 2003), and cause renal dysfunction
(Stheneur, Bergeron, & Lapeyraque, 2014). Other severe consequences of
the electrolyte disturbances include impaired cardiovascular functioning
such as bradycardia, hypotension, and arrhythmia (Cooke et al., 1994;
Mont et al., 2003). These symptoms are potentially life threatening
(Sharp & Freeman, 1993), thus electrolyte levels need close monitoring
during therapy (Winston, 2012). Cardiovascular complications and in-
fections represent the most common medical cause of death among AN
patients (Papadopoulos, Ekbom, Brandt, & Ekselius, 2009). Particularly
the diagnosis of the latter is often critically delayed, due to the absence
of febrile temperatures and inflammatory markers in most AN patients
(Brown, Bartrop, Beumont, & Birmingham, 2005).
Among the irreversible or difficult to treat somatic problems, os-
teoporosis is one of the most important (Fairburn & Harrison, 2003).
Puberty is the critical phase for bone structure configuration, where
maximal bone mineral density is reached in healthy adolescents (Theintz
et al., 1992). Illness onset of AN typically happens around the same time,
causing insufficient bone density build up in affected individuals (Misra
& Klibanski, 2007). Almost half of adolescent AN patients are reported
to suffer from osteopenia, a reduction in mineral density, and 11% from
osteoporosis, where bone strength is severely reduced (Castro, Lázaro,
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Pons, Halperin, & Toro, 2000; Castro, Toro, Lázaro, Pons, & Halperin,
2002; Misra et al., 2004). In adults, the proportion of osteoporosis goes
up to 40% and normal bone mineral density is found in only 11% of
patients (Milos et al., 2005). These changes in bone metabolism become
irreversible with a proceeding malnutrition of the body (Milos et al.,
2007), causing an elevated risk for fractures already at a young age (Faje
et al., 2014; Lucas, Melton, Crowson, & O’Fallon, 1999).
2.1.4 Comorbid mental conditions
AN often comes with other comorbid diagnoses such as depressive and
anxiety disorders (Bühren et al., 2014; Hudson, Hiripi, Pope, & Kessler,
2007; O’Brien & Vincent, 2003). Furthermore, an increased occurrence
of personality disorders, especially cluster B (borderline, histrionic, and
narcissistic) and C (avoidant, dependent, and obsessive compulsive) per-
sonality disorders, have been reported (Cassin & von Ranson, 2005;
Spindler & Milos, 2007). Other psychological features present in pa-
tients with AN comprise perfectionism (Bastiani, Rao, Weltzin, & Kaye,
1995; Halmi et al., 2000; Lloyd, Yiend, Schmidt, & Tchanturia, 2014),
heightened impulsivity and impulse-control problems, alcohol and drug
abuse, the latter of which are mainly reported in individuals exhibit-
ing the binge-purge subtype of AN (DaCosta & Halmi, 1992; Garner,
Garner, & Rosen, 1993; Rosval et al., 2006). In the realm of affect,
recent studies suggest altered emotional processing in AN patients, such
as heightened harm avoidance (Cassin & von Ranson, 2005), anhedonia
(Davis & Woodside, 2002; Tchanturia et al., 2012), alexithymia (Bourke,
Taylor, Parker, & Bagby, 1992; Tchanturia et al., 2012), and impaired
emotion regulation skills (Lavender et al., 2015). The heritability of these
traits (Bevilacqua & Goldman, 2011; Jørgensen, Zachariae, Skytthe, &
Kyvik, 2007) suggests a potential genetic component contributing to a
heightened vulnerability for AN, similar to other mental disorders (Aldao,
Nolen-Hoeksema, & Schweizer, 2010; Schürhoff et al., 2003). Depend-
ing on the severity, these comorbid disorders and psychological features
may have a significant influence on therapy outcome and need to be
considered for treatment planning (Kask et al., 2016; Milos, Spindler,
2.1 Anorexia nervosa 9
O
rg
an
sy
st
em
s
or
or
ga
n
Pa
th
ol
og
ic
al
fin
di
ng
s
Le
ad
in
g
sy
st
em
s
C
en
tr
al
ne
rv
ou
s
sy
st
em
M
or
ph
ol
og
ic
al
an
d
fu
nc
tio
na
l
ce
re
br
al
ch
an
ge
s;
vo
lu
m
e
re
du
c-
tio
n
in
ve
rt
eb
ra
l
gr
ey
an
d
w
hi
te
m
at
te
r
C
og
ni
tiv
e
de
fic
its
D
en
ta
l
sy
st
em
an
d
pa
-
ro
tid
gl
an
ds
Im
pa
ire
d
de
nt
al
st
at
us
,
de
nt
al
ca
rie
s,
in
cr
ea
se
d
se
ru
m
am
yl
as
e
D
en
ta
lc
ar
ie
s,
en
la
rg
em
en
t
of
th
e
pa
ro
tid
gl
an
ds
E
nd
oc
rin
e
sy
st
em
an
d
re
pr
od
uc
tiv
e
fu
nc
tio
n
H
yp
ot
ha
la
m
us
-p
itu
ita
ry
-g
on
ad
al
-
ax
is,
lo
w
T
3
sy
nd
ro
m
e,
hy
pe
r-
co
rt
iso
l
A
m
en
or
rh
oe
a
in
w
om
en
,
sy
m
pt
om
s
of
hy
po
th
yr
oi
d-
ism
,
de
pr
es
sio
n,
el
ev
at
ed
st
re
ss
le
ve
ls
C
ar
di
ov
as
cu
la
r
sy
st
em
H
yp
ot
en
sio
n,
br
ad
yc
ar
di
a,
ar
-
rh
yt
hm
ia
Sy
nc
op
e
G
as
tr
oi
nt
es
tin
al
tr
ac
t
Im
pa
ire
d
ga
st
ric
em
pt
yi
ng
,g
as
tr
ic
di
la
tio
n,
ga
st
ro
du
od
en
al
ul
ce
rs
A
na
em
ia
,
(b
ac
te
ria
l)
in
-
fe
ct
io
ns
,
co
m
pr
om
ise
d
im
-
m
un
e
co
m
pe
te
nc
e
R
en
al
tr
ac
t
H
yp
ok
al
ae
m
ia
,
hy
po
ph
os
-
ph
at
em
ia
,h
yp
er
na
tr
em
ia
N
ep
hr
ol
ith
ia
sis
,
oe
de
m
a,
sy
nc
op
e
B
on
e
R
ed
uc
ed
bo
ne
de
ns
ity
(o
st
eo
pe
ni
a)
or
os
te
op
or
os
is
B
on
e
fra
ct
ur
es
an
d
co
nc
om
-
ita
nt
pa
in
,s
pi
na
lc
om
pr
es
-
sio
n
Fi
gu
re
2.
1.
O
rg
an
s
an
d
or
ga
n
sy
te
m
s
aff
ec
te
d
by
A
N
(a
da
pt
ed
af
te
r
Zi
pf
el
et
al
.,
20
15
).
Fi
gu
re
on
th
e
rig
ht
ad
ap
te
d
fr
om
"F
em
al
e
sh
ad
ow
w
it
h
or
ga
ns
",
by
M
.H
äg
gs
tr
öm
,2
01
1
(h
tt
ps
:/
/c
om
mo
ns
.w
ik
im
ed
ia
.o
rg
/
wi
ki
/F
il
e:
Fe
ma
le
_s
ha
do
w_
wi
th
_o
rg
an
s.
pn
g)
vi
a
W
ik
im
ed
ia
C
om
m
on
s.
U
se
d
un
de
r
C
re
at
iv
e
C
om
m
on
s
A
tt
ri
bu
tio
n
C
C
0
1.
0
U
ni
ve
rs
al
P
ub
lic
D
om
ai
n
D
ed
ic
at
io
n.
10 Chapter 2 Background
Buddeberg, & Crameri, 2003). Due to the complexity of the disorder
and the illness onset in late adolescence (see Section 2.3), AN can have
serious consequences for the education and later career of a patient. In
sum, this causes significant direct and indirect costs.
2.1.5 Economic burden
Considering the treatment costs and productivity losses, the annual ex-
penses for AN sum up to a substantial economic burden (Simon, Schmidt,
& Pilling, 2005). A recent cost-of-care study by Guarda et al. (2017)
has estimated the cost of weight restoration in an inpatient treatment for
a single patient in the Johns Hopkins Eating Disorder Program to vary
between approximately 75’000 and 300’000 Euro per stay, depending on
the speed of weight gain, with faster weight gain inducing lower costs.
The authors suggest that on top of reduced costs, faster weight gain
increases the likelihood of a full weight restoration (Guarda et al., 2017).
However, the situation is more complex as a higher weight gain target
per week not only seems to make it less likely for the patients to achieve
a healthy BMI during treatment but additionally might make patients
less likely to maintain the gained weight in the long-run (Herzog, Zeeck,
Hartmann, & Nickel, 2004).
Broadening the focus beyond purely treatment related costs, a cost-of-
illness study conducted in Germany suggests a total of direct and indirect
costs of 195 million Euro per year due to AN (Krauth, Buser, & Vogel,
2002), excluding outpatient treatment, medication, and secondary costs,
such as losses of productivity among caretakers of under-age patients.
The bulk of the costs (67% of the overall costs) does not stem from
immediate expenses due to necessary treatments but rather from indirect
costs such as inability to work or premature death (Krauth et al., 2002).
The significant indirect costs due to premature death (63% of the overall
costs) are related to the young age of the patient population, where a
fatal disease trajectory corresponds to several decades of potential gainful
employment (Krauth et al., 2002). These numbers underline the potential
gains of a successful treatment and the prevention of a chronic course of
AN, not only for the individual patient but also for society.
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2.2 Therapeutic treatment
Incorporating the available research results and suggestions, the Ger-
man Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesell-
schaften (AWMF) published evidence-based (S3) guidelines regarding the
diagnostic and treatment of eating disorders in 2011 (Zeeck et al., 2011).
These guidelines were the first German guidelines for eating disorders
and amended the evidence-based guidelines by the National Institute of
Clinical Excellence (NICE, 2004) and the APA (APA, 2006). Striving to
support practitioners with informed recommendations regarding treat-
ment strategies and diagnostics, these guidelines integrate findings from
basic research, systematically collected expert knowledge, and results
from randomized controlled trials.
The primary treatment targets for AN as recommended by the S3-
guidelines are restoration of a normal body weight, normalisation of
eating behaviour, and treatment of psychological and somatic issues.
The recommended approach to achieve these therapy aims comprises
specialised psychotherapy, accompanied by nutrition counselling, as well
as close monitoring and treatment of somatic issues (Zeeck et al., 2011). In
the following, the main psychotherapeutic approaches will be characterised
briefly.
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2.2.1 Cognitive behavioural therapy
In the A-B-C triad of psychology, cognitive behavioural therapy (CBT)
addresses the latter two elements behaviour (B) and cognition (C) to
influence the patients’ condition and affect (A) (Pike, Carter, & Olmsted,
2010). During therapy, individuals learn to identify dysfunctional beliefs,
attitudes, and behaviours and to replace them with more appropriate cog-
nitions and behaviour (Garner, Vitousek, & Pike, 1997). A core element
of CBT for AN is a tailored psychoeducation regarding the importance
of a healthy body weight, the association of hunger and eating disorder
symptoms like binge eating, the somatic consequences of the disorder, as
well as the identification and handling of sociocultural influences such
as media images of an ideal body (Garner et al., 1997). Additionally,
a problem analysis is typically conducted to identify predisposing and
maintaining conditions for disordered eating behaviours and to develop
response alternatives (Pike et al., 2010). Food and weight management
represent a central component throughout the treatment, with regular
meals to reach weight normalisation and stabilisation, and eventually a
reduction of the "forbidden foods list" that most patients have (Pike et al.,
2010). Finally, the identification and treatment of underlying problems,
as well as work on a potential body dysmorphic disorder are important
in CBT for AN (Pike et al., 2010). In sum, the underlying model of
AN in CBT is one of dysfunctional cognitions (over-valuation of weight
and shape) and behaviours (avoidance of high caloric food, excessive
physical activity), developed to cope with stressful life experiences, that
are targeted in therapy and aimed to be replace with more appropriate
ones (Vitousek, 2002). CBT for AN does not focus on aetiological factors,
however its theory recognises a multifactorial origin of the disorder (Pike
et al., 2010) and views the need for self-control (Fairburn, Cowen, & Har-
rison, 1999), low self-esteem, mood intolerance, interpersonal problems,
and high perfectionism as important aspects in the maintenance of AN
(Fairburn & Harrison, 2003).
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2.2.2 Psychodynamic therapy
In contrast to CBT, psychodynamic therapy for AN focusses predom-
inantly on the meaning of the eating disorder symptomatology within the
life on an individual and in the context of important relationships (Zeeck
et al., 2011). The constitution of self, self-image, and self-esteem form a
core process in the psychodynamic model of AN (Zerbe, 2010). Repetitive
neurotic, interpersonal behaviour patterns, the role of food and eating,
and the conflict of autonomy and dependence are viewed as central to
AN and are targeted by means of psychoeducative components as well as
genuine psychotherapeutic strategies such as conflict repetition within
the therapeutic relationship (Zerbe, 2010). In an effort to standardise
this otherwise rather broad and diverse therapy approach, a treatment
manual for focal psychodynamic therapy (FPT) has been developed, to
allow for comparisons with other treatments in an outpatient setting
(Wild et al., 2009). At the beginning of FPT, a diagnostic interview is
conducted to identify psychodynamic conflicts (Arbeitskreis OPD, 2006).
FPT then follows three phases, the first of which is dedicated to exploring
the disordered eating behaviour, related beliefs, and the self-esteem of an
individual. The second phase looks at interpersonal relationships in the
context of AN. The last phase is used to prepare the transfer to everyday
life and the end of therapy (Schauenburg, Friederich, Wild, Zipfel, &
Herzog, 2009). In the context of FPT, AN is interpreted as an attempt
to gain control over the body and to form an identity, as well as to avoid
anxiety. Main aetiological factors are seen in the interaction of biological,
sociocultural and family aspects (Schauenburg et al., 2009).
2.2.3 Family therapy
Due to the onset of AN during adolescence, different forms of therapy
have been developed that specifically consider the family system in the
treatment of the individual. Two main groups of approaches can be dis-
tinguished: (1) structural and (2) strategic family therapy (Dare, Gerald,
Szmukler, Grange, & Dodge, 2011). While structural family therapy
views the family as a causative factor of the disease and concentrates
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on improving the dysfunctional family dynamic, strategic family ther-
apy focuses on using the family as resource to improve the individual’s
behaviour (Dare et al., 2011). More recently, family-based therapy was
developed as a combination of the earlier variants of family-therapeutic
approaches and represents to most widely implemented family therapy
today (Dare et al., 2011). Its view is agnostic regarding the pathogenesis
of AN and treatment generally consists of three stages (Lock & le Grange,
2005). In the first stage, the focus is put on weight restoration and
parents are given authority over their child’s eating behaviour until a
healthy weight is reached and a normal eating pattern is established.
During family meals, the therapist helps to identify behaviours of family
members that may hinder refeeding. In the second stage, the patient
gradually takes back on responsibility for the eating behaviour. In the
last stage of family-based therapy, the focus is widened to general topics
such as challenges in the family dynamic during adolescence (Lock &
le Grange, 2005).
2.2.4 Therapy settings
Regarding the question whether treatment should be delivered in an
in- or outpatient setting, there is not enough empirical data available to
date to favour one setting over the other. However, weight gain seems
to be faster during inpatient treatment (Hartmann, Weber, Herpertz, &
Zeeck, 2011). Furthermore, due to the need for intensive interdisciplinary
treatment, inpatient therapy often becomes necessary with increasing
severity of the disorder (Zeeck et al., 2011).
2.2.5 Pharmacotherapy
Pharmacological agents have not proven to be effective in the treat-
ment of AN. The body of evidence for the efficacy of pharmacotherapy in
AN is unsatisfactory, and the quality of studies – often conducted in small
samples – is questionable (Claudino et al., 2006; Court, Mulder, Hetrick,
Purcell, & McGorry, 2008). In case of enduring rumination and anxiety
related to eating and body shape, or intense physical hyperactivity, off-
label use of low dosed neuroleptics might be justified (Brewerton, 2012).
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For the treatment of comorbid depressive symptoms antidepressants are
occasionally being used (Zeeck et al., 2011). However, no beneficial effects
for the treatment of AN have been reported (Brewerton, 2012).
2.2.6 Treatment conclusions
The evidence base for particular psychotherapeutic approaches is very
limited. While all sufficiently examined eating-disorder specific treatments
described above seem to be partly effective, findings suggest that none
of the available approaches is superior (Hay et al., 2003; Zeeck et al.,
2011; Zipfel et al., 2014). A recent randomised controlled trial comparing
outpatient CBT, FPT, and treatment as usual (outpatient psychotherapy
and care from a family doctor) for adult patients suggests that over the
course of treatment, as well as after a follow-up period of 3 and 10 months,
all three treatment approaches performed equally well regarding BMI
improvement (Zipfel et al., 2014). An exception to this equal effectiveness
may be the treatment of adolescents. A recent meta-analysis suggests
that while immediate treatment outcomes are the same, there may be
positive long-term effects of family-based therapy that exceeds the impact
of individual treatment for adolescents (Couturier, Kimber, & Szatmari,
2013). A possible explanation for this might be that younger patients are
not yet able to fully understand the implications of the disorder, thus the
involvement of parents or close relatives is important (Jäger, Herpertz,
Salbach-Andrae, Hagenah, & Tuschen-Caffier, 2011).
A common goal of the summarised psychotherapeutic approaches
represents the normalisation of eating behaviours, body weight, and the
treatment of problems associated with AN (Jäger et al., 2011). Further-
more, two approaches acknowledge a multifactorial aetiological model
of AN (CBT and FPT), while one is agnostic with regard to its causes
(family-based therapy). Independent of the specific psychotherapeutic
approach, there is evidence that treatment should be started as soon as
possible to reduce the risk for a chronic course of the disorder (Stein-
hausen, 2002; Zeeck et al., 2011). Additionally, as the somatic risks of the
disorder require intensive interdisciplinary collaboration of health care
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providers, treatment should take place in institutions and with therapists
that have expertise and training with eating disorders (Jäger et al., 2011).
2.3 Epidemiology
While eating disorders in general affect 5.3% of women and 1.3% of
men, AN affects 1.2–1.9% (DSM-IV vs. DSM-5) of women and 0.2%
of men in Switzerland (Mohler-Kuo, Schnyder, Dermota, Wei, & Milos,
2016). These lifetime prevalences of AN are comparable to those of other
European countries1, where the lifetime prevalence amounts to 0.9% in
females and 0% in males, (Preti et al., 2009) and the United States, where
0.9% of females and 0.3% of males are affected by AN (Hudson et al.,
2007). Although the prevalence of AN may appear low, the numbers are
very similar compared with the prevalence of other serious psychiatric
disorders affecting young adults, such as schizophrenia (prevalence rate
of 1%; McGrath, Saha, Chant, & Welham, 2008; Simeone, Ward, Rotella,
Collins, & Windisch, 2015).
To measure time trends, the incidence rate is a more suitable measure
than prevalence. The incidence describes the occurrence of new cases
within a defined time frame, in the following the incidence per year will
be reported. Several studies have suggested that the incidence of AN
in industrialised countries may have risen over the last decades (Hoek,
2006; Hoek & Van Hoeken, 2003; Milos et al., 2004). However, recent
reviews have concluded that the overall incidence of AN in these countries
has remained stable at 4.7 to 7 per 100,000 person-years after a rise
of incidence up to the 1970s (Fombonne, 1995; Pike, Hoek, & Dunne,
2014; Smink, Van Hoeken, & Hoek, 2012). It might be that increases
between the 1930s and 1970s reflect a true rise of incidence of AN, it
is also possible that raising numbers are attributable to a heightened
awareness and improvements in diagnostics during that time (Fombonne,
1995).
AN is the eating disorder with the lowest age of onset (Smink et
1 Belgium, France, Germany, Italy, the Netherlands and Spain
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al., 2012). The incidence peak of AN lies in late adolescence, between
16-18 years of age, although early-onsets have been reported from age
10 (Hudson et al., 2007; Mohler-Kuo et al., 2016). As underweight
and emaciation affect the whole body (see Section 2.1.3), AN holds the
unedifying record of the highest mortality rate amongst mental disorders
with a crude mortality rate of 5-10% (Chesney, Goodwin, & Fazel, 2014;
Steinhausen, 2002). Of the surviving patients, less than 50% achieve a
full recovery after a follow-up time of more than four years, while 30%
show some improvement in clinical symptoms, and roughly 20% of AN
patients face a chronic course of illness (Steinhausen, 2002). A more
positive outcome has been associated with younger age at illness onset,
a shorter duration of symptoms before treatment, as well as features of
a histrionic personality (Steinhausen, 2002). Negative prognoses have
been linked to binge-purging behaviour, a longer duration or chronic
course of illness, and symptoms of an obsessive-compulsive personality
(Steinhausen, 2002). Thus, although there are specialised guidelines and
treatments available (see Section 2.2), the long-term prognosis of AN is
not yet satisfactory.
2.4 Aetiology
The long history of AN has been accompanied by assumptions and
speculations about the causes and contributing factors that lead to the
disorder. Early research saw the family environment, namely conflict-
avoiding interactions between patients and their parents and an overpro-
tective parenting style, as a key influence (Katz, Mazer, & Litt, 1985;
Kog & Vandereycken, 1985). These assumptions quickly formed the basis
for stigmatisation of the parents and patients (Herpertz-Dahlmann et al.,
2011). Continued investigation of the disorder however challenged this
perception. Today, numerous predisposing and maintaining factors are
considered to be relevant for the aetiology of AN. After a short clarifica-
tion of terminology, the main aetiological factors will be described and
summarised in a neuropsychiatric model of the disease.
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2.4.1 Aetiological terminology
When talking about aetiological factors of a disorder, it is useful to
distinguish predisposing and maintaining factors. The main difference
between the two is the temporal precedence of occurrence. A predisposing
factor, also called risk factor, occurs first and prospectively predicts the
subsequent symptomatic. A maintaining factor on the other hand predicts
the symptom persistence or remission in affected individuals over time
(Kraemer, 1997). Risk factors are commonly targeted with preventive
programmes, maintaining factors on the other hand are targeted with
treatment intervention designs.
It is evident that the temporal succession of risk factors, disorder, and
maintaining factors gives a causal attribute to the former. To establish
causality, randomized controlled trials are a useful instrument. However,
due to the nature of the risk factors, randomised experiments often cannot
be performed to establish causality (Kraemer, Stice, Kazdin, Offord, &
Kupfer, 2001). In that case, it is not possible to separate causal and
proxy risk factors, the latter of which show a prospective correlation
with the disorder due to a concealed correlation with a causal risk factor
(Kraemer et al., 2001). Due to a lack of randomised prospective studies,
this important differentiation is difficult to make when it comes to the
aetiology of AN. Thus, in the following the term risk factor will be used
to describe factors which may contribute causally to the disorder, as well
as factors which may be associated with AN in a more indirect way.
2.4.2 Sociocultural and developmental factors
Regarding cultural factors, looking at reports of lower prevalence rates
of AN in Africa and Latin-America the question arose whether increased
exposure to Western lifestyle with its eating habits and thin body ideal
leads to increasing prevalence rates (Smink et al., 2012). This fits with
findings of body dissatisfaction as a risk factor for eating disorders in
general (Stice, Marti, & Durant, 2011). However, to date there is no
solid empirical evidence of sociocultural pressure for women to be slim as
a risk factor for AN (Zipfel et al., 2015). Furthermore, AN can also be
2.4 Aetiology 19
found in countries where the culture does not promote a thin body ideal,
such as Iran (Nobakht & Dezhkam, 2000) or Kenya (Njenga & Kangethe,
2004) and there are reports of AN cases with confirmed non-exposure to
Western influences from India (Chandra et al., 1995; Gandhi, Appaya, &
Machado, 1991), Pakistan (Yager & Smith, 1993), and the United Arab
Emirates (Abou-Saleh, Younis, & Karim, 1998). Recognising the possible
impact of this factor, it is possible that Western influences facilitate the
onset of eating disorders in vulnerable individuals by promoting strict
dieting or extreme exercising behaviour.
Common developmental factors that may promote such vulnerability
include adverse experiences in infancy such as prematurity, dysmaturity,
as well as feeding and sleeping difficulties (Jacobi, Hayward, de Zwaan,
Kraemer, & Agras, 2004; Tenconi, Santonastaso, Monaco, & Favaro,
2015). Furthermore, developmental disorders from the autism spectrum
as well as the development of personality traits related to obsessionality,
anxiety, depression, and perfectionism have been frequently reported in
AN (Jacobi et al., 2004).
2.4.3 Genetic factors
Female sex has been consistently reported to be a risk factor for AN as
it is unchangeable for the affected patients. It is unclear, how much of this
correlation can be ascribed to biological factors rather than sociocultural
factors. However, genetic factors have become increasingly important
in the quest for the etiopathology of this challenging disorder. While
family studies have reported heterogeneous findings regarding the familial
element of AN (Steinhausen, Jakobsen, Helenius, Munk-Jørgensen, &
Strober, 2015; Strober, 2000), twin-studies have repeatedly pointed to a
strong heritable component in AN, with explained phenotypic variance
ranging from 48–74% (Yilmaz, Hardaway, & Bulik, 2015). To further
explore the heritable biological features, several genetic studies have been
conducted. Progress in genotyping technologies has made it possible
to genotype genetic markers on a much larger scale than before and
most recent efforts focus on genome-wide association studies (GWAS).
Three of these studies have been published on AN (Boraska et al., 2014;
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Nakabayashi et al., 2009; Wang et al., 2011), all of which were unable
to reach enough power to detect genome-wide significant loci. However,
a very recent unpublished study by Duncan et al. (2016), comparing
3’495 cases with AN to 10’982 controls, was able to identify a first robust
genome-wide locus in a region including six genes. The authors note that
functional data will be necessary to draw more specific conclusions about
the role of these variants in the aetiology of AN. However, they state that
the identified genes have been suspected to play a role in growth regulation,
in calcium signalling, postsynaptic density of patients with schizophrenia,
as well as in diabetes type 1 and rheumatoid arthritis. Further analyses of
the study revealed positive genetic correlations between AN and a range
of other phenotypes, including neuroticism and schizophrenia. Significant
negative correlations were found with regard to weight-related phenotypes
such as BMI and obesity (Duncan et al., 2016). These promising results
support a biopsychosocial model of AN as well as they underline the
complexity of the disorder.
2.4.4 Neurobiological factors
Together with genetic research, neurobiological studies may help elu-
cidate mechanisms associated with brain pathophysiology that drive and
maintain disordered eating habits. Impaired brain development due to
complications during pregnancy and delivery, as well as neonatal complic-
ations have been suggested to play an important role in the development
of AN (Favaro, Tenconi, & Santonastaso, 2006; Tenconi et al., 2015).
The brain uses approximately 20% of the body’s metabolic energy at rest
(Attwell & Laughlin, 2001), which makes it the main energy consumer
and renders it particularly vulnerable to effects of malnourishment. As
brain functioning depends on glucose metabolism, poor nutrition affects
brain development as well as general brain functioning (Mergenthaler,
Lindauer, Dienel, & Meisel, 2013). This is of particular importance in
the case of AN, as the disorder emerges during a crucial period for brain
maturation and reorganisation (Giedd et al., 1999).
A variety of neuroimaging techniques are available to study the human
brain in vivo. T1-weighted magnet resonance imaging (MRI) is used to
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examine brain structure, diffusion tensor imaging (DTI) allows studying
water diffusion in white matter tracts and thus inspect fibre integrity
(Mori & Zhang, 2006), functional MRI (fMRI) maps blood flow and is
used as a proxy for brain activity, and positron emission tomography
(PET) assesses the distribution of neurotransmitter receptors (Raichle &
Mintun, 2006). The main findings of these approaches with regard to the
understanding of AN will be summarised below.
2.4.4.1 Findings from structural neuroimaging
In AN with severe underweight, MRI studies have largely demon-
strated reduced grey matter volumes of a distributed set of brain regions,
most consistently of limbic/paralimbic areas and the cortex (Seitz et al.,
2016; Eynde et al., 2012). Findings of reduced white matter volume
have been less consistent. While some studies reported decreased white
matter volume (e.g., Seitz et al., 2015; Via et al., 2014), others report
no significant differences (Fonville, Giampietro, Williams, Simmons, &
Tchanturia, 2014; Roberto et al., 2011). In cross-sectional studies with
long-term recovered AN patients, the broad impact of starvation-induced
shrinkage was found to be no longer present (Favaro, Tenconi, Degortes,
Manara, & Santonastaso, 2015; Frank, Shott, Hagman, & Yang, 2013;
Friederich et al., 2012; Joos et al., 2011; Wagner et al., 2006). A recent
meta-analysis supports these results (Seitz et al., 2016). However, per-
sisting local grey matter decreases in the precuneus were reported in a
study with a small sample of AN patients after a remission period of
more than 5 years (Joos et al., 2011). Longitudinal studies in adolescent
AN patients report normalisation of grey matter loss after a brief period
of weight restoration (Bernardoni et al., 2016; Bomba et al., 2015; Mainz,
Schulte-Rüther, Fink, Herpertz-Dahlmann, & Konrad, 2012). For adult
AN patients there is a lack of longitudinal studies. The two existing
studies examined only global volumes of grey and white matter before and
after treatment without performing a detailed regional analyses (Roberto
et al., 2011; Swayze et al., 2003), thus a thorough understanding of
mechanisms of grey matter reduction and recovery in AN is still lacking.
To date, five studies have used DTI in a cross-sectional design to
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more specifically measure structural connectivity in adults with acute AN
(Frieling et al., 2012; Hayes et al., 2015; Kazlouski et al., 2011; Nagahara
et al., 2014; Via et al., 2014). The main results of these studies point
to reduced fractional anisotropy (FA, a measure of fibre directedness),
which is commonly interpreted as white matter integrity (Mori & Zhang,
2006). Only three studies were conducted on adolescents with acute
AN, reporting decreased (Frank, Shott, Hagman, & Yang, 2013; Travis
et al., 2015), as well as increased FA measures (Travis et al., 2015;
Vogel et al., 2016). Possible explanations for these mixed findings might
be developmental factors, interacting with the nutritional challenges of
starvation (Vogel et al., 2016), in addition to longer duration of illness
and higher chronicity in adult patients (Steinhausen, 2002).
2.4.4.2 Findings from functional neuroimaging
Examining brain function, fMRI studies in AN have investigated
activation patterns at rest, as well as during a variety of tasks. Given
the reduced grey matter volume in the limbic/paralimbic system (Seitz
et al., 2016), structures of the "salience" resting-state network such
as the anterior insula and the anterior cingulate cortex, along with
subcortical structures are of particular interest in AN research (Seeley
et al., 2007). Indeed, the majority of resting-state studies conducted
in acute AN have reported brain regions with impaired hemodynamic
activation located in cortico-limbic circuits (Gaudio, Wiemerslage, Brooks,
& Schiöth, 2016). However, the heterogeneity in analysis approaches with
varying a priori assumptions makes the comparison of results difficult
and studies investigating the same networks (i.e. default mode and visual
networks) show diverging results (Boehm et al., 2014; Favaro et al., 2012;
Phillipou et al., 2016). Hence to date no consensus regarding alterations
in the acute stage of AN has been reached. Furthermore, the reversibility
of these diverging alterations over the course of treatment has yet to be
examined. First evidence of a cross-sectional study on weight-recovered
AN patients suggests that reduced resting-state functional connectivity
(rsFC) in visual and auditory resting-state networks (Scaife, Godier,
Filippini, Harmer, & Park, 2017) and increased rsFC in the default mode
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network (Cowdrey, Filippini, Park, Smith, & McCabe, 2014) remain even
after weight recovery. As a recent review on resting-state fMRI (rsfMRI)
in AN points out, there is a need for longitudinal investigation of rsFC
in AN employing whole-brain analysis, to elucidate potential causative
neurobiological mechanisms and possible subsequent damage due to the
disorder (Gaudio et al., 2016).
Task-based fMRI research has used a number of different paradigms
to examine the effect of disease related conditions on brain activation,
such as exposure to body, food, and emotional stimuli (Zhu et al., 2012).
Overall, the results of the fMRI studies point to increased activation in
reaction to food and body stimuli in regions associated with emotions
(caudate nucleus, insula, uncus, frontal cortex, temporal cortex) and
a decreased hemodynamic response in parietal regions. Results with
regard to emotional stimuli have been inconclusive (Zhu et al., 2012). In
this context, the anticipation of stimuli seems to play a role as well, as
decreased response sensitivity to expected salient stimuli was reported in
limbic/paralimbic regions and heightened sensitivity during the occurrence
of unexpected, although salient, stimuli (Treasure et al., 2015).
Assessing the functional availability of neurotransmitter receptors in
the brain, PET studies have mainly focused on the dopaminergic and
serotonergic system of the brain (Kaye, Wierenga, Bailer, Simmons, &
Bischoff-Grethe, 2013; Treasure et al., 2015). Playing an important role
in learning, motivation and reward processes, the dopamine D2 receptors
of recovered AN patients have been found to demonstrate increased
binding, while no differences were found in acutely ill patients (Broft
et al., 2015; Gérard, Pieters, Goffin, Bormans, & Van Laere, 2011).
Serotonin receptors (5-HT1A and 5-HT2A), involved in anxiety and
eating regulation, have been found to exhibit increased binding properties
in acute as well as in recovered patients (Bailer et al., 2005; Bailer et al.,
2007; Galusca et al., 2008). The interpretation of these altered binding
properties is not straight forward, as increased binding may reflect either a
neuroadaptation to increased transmission of dopamine or serotonin, or a
genuine hypofunction of the neurotransmitter signalling (Broft et al., 2015;
Laruelle, Slifstein, & Huang, 2003). It remains to be determined whether
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these alterations are apparent before illness onset (thus represent a risk
factor), or whether they are influenced by malnutrition and represent a
consequence of the illness (Treasure et al., 2015).
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2.4.4.3 Neuroendocrinology
Besides the brain alterations summarised above, another neurobiolo-
gical factor is of importance: The underweight in AN leads to significant
endocrine alterations. Altered levels of hormones involved in appetite
regulation, such as leptin and ghrelin, altered thyroid function, as well
as decreased gonadal hormone levels have most frequently been reported
(Lawson & Klibanski, 2008; Misra & Klibanski, 2014). Most of these
hormone alterations can be seen as physiological adaptations to starvation
and seem to normalise with weight recovery, however, some persist even
after recovery and may pose a risk factor for future relapse (Lawson &
Klibanski, 2008; Misra & Klibanski, 2014; Schorr & Miller, 2016).
2.4.5 An aetiological model of Anorexia nervosa and its challenges
In conclusion, there are multiple risk and maintaining factors associ-
ated with AN, which have led to a multifactorial model of the disorder.
Integrating the interaction of risk and maintaining factors with respect
to their occurrence during human development, Fig. 2.2 illustrates the
neuropsychiatric aetiological model of AN (Herpertz-Dahlmann et al.,
2011; Kaye, 2009). This model represents a diathesis-stress model of the
disorder and will serve as a theoretical framework of the present thesis. It
is based on the available empirical evidence summarised above and con-
siders the interplay of psychosocial processes and biological mechanisms,
as well as stressful life events as prompting the illness onset (Herpertz-
Dahlmann et al., 2011; Kaye, 2009): Based on factors that originated
prenatal or emerged during childhood (such as genetic predispositions,
developmental characteristics and personality traits), cultural factors and
developmental influences (puberty) facilitate initial dieting behaviour
and elicit weight loss. In combination with neurobiological alterations,
vulnerable individuals may find themselves in a vicious cycle that rein-
forces restrictive eating to counter negative emotionality, thus leading
to further weight loss and neurobiological alterations, which worsen the
dysphoric mood. In 20-50% of cases this leads to a chronic course of AN
(Steinhausen, 2002). To what extend individual factors, such as endocrine
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or brain circuit alterations, interact and influence behaviour of patients
with AN has yet to be explored (Treasure et al., 2015). However, the
contribution of brain alterations observed in AN are likely to facilitate the
abnormal food intake and high anxiety, and in interaction with endocrine
alterations, traits and environmental factors, determine the course of the
illness (Herpertz-Dahlmann et al., 2011; Kaye, 2009).
A main challenge in AN research poses the differentiation between
primary and secondary effects of starvation (e.g. effects of acute un-
derweight vs. irreversible neural alterations due to malnourishment),
affecting neurobiological factors and behaviour, and primary mechanisms
driving the disorder (Frank, Shott, Hagman, & Yang, 2013). Regarding
neuroimaging studies, this issue has yet to be resolved. The clear majority
of studies summarised above has either been conducted on currently ill
or already recovered patients. Longitudinal assessments are needed to
enhance the understanding of the restorative neural mechanisms in AN.
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Figure 2.2. Aetiological model of Anorexia nervosa (adapted after
Herpertz-Dahlmann et al., 2011; Kaye et al., 2009; Steinhausen, 2002).

CHAPTER 3
Aims and hypotheses
In the previous chapter, current knowledge about AN was summarised
and an aetiological model presented. The relationship between neural
alterations and AN are of particular importance to this thesis. The
differentiation between premorbid, potentially causative, neurobiological
alterations and post-morbid consequences of AN, as well as the effect
of starvation on neurobiological systems represents a key challenge in
AN research due to the lack of prospective longitudinal studies (see Sec-
tion 2.4.4). Furthermore, the majority of neurobiological studies has been
conducted cross-sectionally with either currently ill or already recovered
patients, thus processes of recovery are poorly understood. Given the
young age of potential subjects and the rarity of the disorder, prospective
longitudinal studies on the neurobiology of AN are difficult to conduct.
However, reorganisation processes during weight recovery are feasible to
investigate in a longitudinal design with acutely ill patients. The current
thesis therefore focusses on brain alterations in the acute phase of AN
and mechanisms of plasticity and gradual reorganisation during weight
recovery. Its main aim is the temporal mapping of neural and behavioural
changes induced by weight gain, to help elucidate restorative mechanisms
and identify potential residual brain alterations. In the following, the
aims and hypotheses of the empirical part of this thesis project will be
outlined.
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3.1 Empirical work I – Structural brain morphometry over the course
of treatment
As outlined above, the majority of brain imaging studies in AN have
been conducted with currently ill or recovered patients, capturing either
state-related consequences of malnourishment or so-called “scarring”
(Herpertz-Dahlmann et al., 2011; Joos et al., 2011; Uher et al., 2003).
The aim of the first empirical work thus was to examine structural brain
changes in the cerebrum and subcortical regions by using a novel surface-
based analysis approach. Morphometric alterations in AN patients were
investigated at three time points in AN patients: (TP1) at the beginning
of treatment with severe underweight, (TP2) during therapy after initial
weight gain, (TP3) at the end of therapy with a close to healthy BMI.
In accordance with previous studies, it was hypothesised that cortical
thickness and subcortical brain volumes of AN patients would be decreased
at the beginning of treatment compared to healthy control women (HC).
The AN group was predicted to show at least a partial recovery with
weight restoration, while no changes in the HC group were expected.
Furthermore, correlations between structural brain alterations in AN
patients and parameters of illness history, changes in eating disorder
severity, and age were explored.
3.2 Empirical work II – Resting-state functional connectivity over the
course of treatment
Investigation of resting-state functional connectivity (rsFC) networks
offers a task-independent tool to gain insight into biased information
processing underlying AN (Fox & Greicius, 2010; Gaudio et al., 2016).
There is a lack of longitudinal examination of rsFC in AN patients and as
a recent review points out, longitudinal whole-brain studies are required
to identify neurobiological mechanisms (Gaudio et al., 2016). Thus, the
second study aims at investigating rsFC in AN in a longitudinal design,
to elucidate potential network alterations and recovery processes. We
used resting-state fMRI to examine global network deviations and local
differences in neural synchrony at three time points in AN patients: (TP1)
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at the beginning of treatment with severe underweight, (TP2) during
therapy after initial weight gain, (TP3) at the end of therapy with a close
to healthy BMI. Based on the existing literature, it was hypothesized
that functional connectivity in AN patients is reduced at TP1, compared
to HC. With weight restoration, processes of recovery were expected in
the AN group. Additionally, correlations with clinical parameters were
explored.
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3.3 Empirical work III – Cross-sectional investigation of biased
diffusion indices in the fornix due to structural alterations in
Anorexia nervosa
Acute AN is characterized by reduced brain mass and increased
cerebrospinal fluid (CSF) in the ventricles and the subarachnoid space
(Seitz et al., 2014; Titova, Hjorth, Schiöth, & Brooks, 2013). Although the
underlying pathophysiology of AN is little understood, recent diffusion
imaging studies have repeatedly suggested the fornix as a key structure
with impaired fibre integrity in AN (Frank, 2015; Frank, Shott, Hagman,
& Yang, 2013; Hayes et al., 2015; Kazlouski et al., 2011; Nagahara et al.,
2014; Via et al., 2014). The aim of the third study thus was to combine
insights from structural MRI and DTI to investigate the identified altera-
tions of diffusion indices in the fornix with advanced analysis techniques,
considering CSF as potential confounder of diffusion imaging. It was
hypothesised that impaired forniceal fibre integrity in AN, as measured by
aberrant fractional anisotropy (FA), is dependent on ventricular volumes
and biased by partial volume effects (PVE). Previously found differences
in the fornix of AN patients were expected to diminish when appropriately
controlling for the PVE.
CHAPTER 4
Methods
This chapter will give an overview of the process and criteria of
participant recruitment, the design of the project, as well as utilised
measurements pertaining all three empirical studies of the present work.
4.1 Participants
4.1.1 Recruitment
Women diagnosed with current AN were recruited at the inpatient
unit, Centre for Eating Disorders, Department of Psychiatry and Psy-
chotherapy, University Hospital Zurich, Zurich, Switzerland. At the
Centre, all patients participated in an interdisciplinary, multimodal inpa-
tient program that offers structured and specific treatment for severely
eating-disordered patients (Department of Psychiatry and Psychother-
apy, 2016). For the duration of data acquisition of the current project,
patients were either presently participating in the inpatient programme
or had completed their inpatient treatment within four weeks prior to
data acquisition. A group of healthy control women was recruited us-
ing flyers and email advertisements. Both groups were closely matched
with respect to age, handedness, intelligence, and education. Participant
characteristics are summarised in Table 4.1.
4.1.2 Inclusion and exclusion criteria
General inclusion criteria comprised being female, aged between 18
and 35 years, and having good command of standard or Swiss German.
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Furthermore, AN patients were deemed eligible when diagnosed with
current AN (as assessed by the Structured Clinical Interview for DSM-IV
Axis I, SCID-I; Wittchen, Zaudig, and Fydrich, 1997), with a BMI ≤
15.5 (severe AN), and a duration of illness of at least 1 year. Healthy
controls were required to have a BMI between 18 and 23, no current
or past eating disorders or other psychiatric disorders (screened with
the SCID-I; Wittchen et al., 1997), no current diet, and no life-time
medication affecting the central nervous system.
General exclusion criteria included current or past neurological dis-
orders, current or past diagnosis of a psychotic disorder or psychoactive
substance dependence, abuse of alcohol/nicotine/caffeine, current preg-
nancy, high debility of sight (wearing glasses with no possibility of wearing
contact lenses), professional knowledge about nutrition (e.g., cook or di-
etician), and general contraindications against MRI procedures.
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4.2 Design
4.2.1 Project design
The project for the present thesis had a prospective longitudinal and
cross-sectional comparative design, with two groups. A group of AN
patients was assessed at three time points (TP1, TP2, TP3) to closely
capture potential weight-related brain changes over the course of an
in-patient programme at the University Hospital of Zurich, Switzerland
(Klinik für Psychiatrie und Psychotherapie, 2016). Measurements of the
AN group were scheduled according to patient’s BMI and were taken at
the beginning (TP1: BMI ≤ 15.5), in the middle (TP2: 15.5 < BMI <
17.5), and at the end of treatment with a (close to) healthy BMI ≥ 17.5
(TP3). A group of HC was assessed at two time points (TP1 and TP3).
The interval between TP1 and TP3 for both groups was 4-6 months
after TP1 (Table 4.2). Data acquisition started in April 2014 and is
ongoing to this date, the last datasets considered for the present work
were acquired in February 2017. Total counts of participants per time
point are summarised in Fig. 4.1.
4.2.2 Study design
Of the three empirical studies included into this work, two were
longitudinal and cross-sectional comparative in design and included all
three time points (Study I and II, see Chapter 5 and 6). Study III was
designed in a comparative cross-sectional design and focused on data
from TP1 (see Chapter 7). Participant counts per study are summarised
in Fig. 4.1.
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Table 4.2
Project design and procedures for each time point
Group Measures TP1 TP2 TP3
AN BMI ≤15.5 15.5 < BMI < 17.5 ≥ 17.5
Time after TP1 1-3 months 4-6 months
Inclusion/ exclusion criteria × × ×
Diagnostic interview (SCID-I ) ×
Informed consent ×
Neuropsychological tests ×
MRI × × ×
Questionnaires × × ×
HC BMI 18.0 – 23.0 18.0 – 23.0
Time after TP1 4-6 months
Inclusion / exclusion criteria × ×
Diagnostic interview (SCID-I ) ×
Informed consent ×
Neuropsychological tests ×
MRI × ×
Questionnaires × ×
Note. AN=Anorexia nervosa; BMI=Body mass index (kg/m2); HC=Healthy
controls; MRI=Magnetic resonance imaging; SCID-I=Structured Clinical Inter-
view for DSM-IV, Axis I; TP=Time point.
TP1
AN = 41
HC = 28
TP3
AN = 20
HC = 22
TP2
AN = 30
AN = 20
HC = 20
AN = 26
HC = 25
AN = 16
HC = 20
AN = 1
HC = 0
Time point
Subjects total
Excluded
Available at 
time of study
AN = 25
HC = 25
AN = 20
HC = 20
AN = 16
HC = 20
Included 
subjects
AN = 0
HC = 0
AN = 0
HC = 0
Study III Study IIStudy I
Figure 4.1. Overview of participant recruitment over time, with separate
participant counts per study.
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4.3 Procedures
For the AN group, data for the first measurement time-points (TP1)
were collected after a minimum hospitalisation time of 2 weeks with
a fixed meal plan and extensive somatic checks, to exclude biases due
to acute malnutrition and dehydration. To avoid effects of short-term
hormone dependent effects on functional or structural brain measures in
HC (Hagemann et al., 2011; Petersen, Kilpatrick, Goharzad, & Cahill,
2014), both scans were scheduled in the folicular phase of the women,
within the first 10 days of their cycle. Inpatients with AN had their meals
at 7.30 a.m., 11.45 a.m., and 5.45 p.m. each day. MRI measurements
took place between 3 p.m. and 4.30 p.m., corresponding to a fasting time
of about 3-4 hours and an intermediate hunger-satiety state during MRI
(Uher et al., 2003; Uher et al., 2004). Healthy subjects were instructed to
have a proper meal at noon.
4.4 Measures
In this section, the specific properties of the collected measures will
be summarised. The first subsection describes the interview and question-
naires assessed throughout the project, the second subsection describes
neuropsychological tests administered at TP1. A broad overview of the
time line of the measures assessed within this project is displayed in Table
4.2.
4.4.1 Interview and questionnaires
Apart from establishing BMI, socio-demographic data, and medical
history by semi-structured interviews, validated German versions of
psychometric instruments were used to assess the following constructs.
4.4.1.1 Diagnostic interview
The Structured Clinical Interview for DSM-IV Axis I (SCID-I; Wittchen
et al., 1997) was used to validate patients’ diagnosis, to assess any comor-
bid psychiatric disorders, and to confirm the absence of any diagnosis
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in the HC group. The SCID-I is a well-established diagnostic interview
for the assessment of Axis I mental disorders according to DSM-IV-TR
(APA, 2000) with fair to excellent inter-rater reliability (Lobbestael, Le-
urgans, & Arntz, 2011; Zanarini & Frankenburg, 2001). The SCID-I
was administered at TP1 of the present thesis project. Comprehensive
interviews with patients were conducted face-to-face, screening for dia-
gnosis with HC were conducted via telephone by well-trained interviewers.
Telephone-based screenings are comparable to diagnostic information
from face-to-face assessments (Rohde, Lewinsohn, & Seeley, 1997).
4.4.1.2 Eating disorder symptoms
The severity of eating disorder symptoms was measured with the
Eating Disorder Examination Questionnaire (EDE-Q; Hilbert & Tuschen-
Caffier, 2006) and the Eating Disorder Inventory (EDI; Garner, Olmstead,
& Polivy, 1983; Paul & Thiel, 2005).
The EDE-Q is a standardised self-report questionnaire, based on the
Eating Disorder Examination interview (Cooper & Fairburn, 1987), to
assess the eating disorder pathology within the past 28 days. Twenty-two
items are rated from 0 to 6 and form the four subscales eating concern,
restraint eating, shape concern, and weight concern. Additionally, a
global score can be calculated with a maximum value of 6, higher scores
indicating greater eating disorder severity. The optimal cut-off score to
discriminate between patients and controls on the global score is 2.5 (Rø,
Reas, & Stedal, 2015). Six additional items capture the frequency of
eating disorder-related behaviours, such as binging or purging, within the
same time frame of 28 days. Cronbach’s alpha (𝛼) of the German version
ranges between .85 and .97 and the test-test reliability of the total score
is .88 (Hilbert, Tuschen-Caffier, Karwautz, Niederhofer, & Munsch, 2007).
Within the present thesis project the EDE-Q was administered at all
three time points. In the sample of the present thesis, Cronbach’s alpha
of the AN group was .64 at TP1, .88 at TP2, .86 at TP3, and of the HC
group .88 at TP1, .91 at TP3, indicating overall good to excellent internal
reliability. The low internal reliability of the AN group at TP1 needs to
be understood within the context of a low variance of response scores
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of the patients, which directly influences the calculation of Cronbach’s
alpha (𝛼; Cronbach, 1951).
The EDI (Garner et al., 1983; Paul & Thiel, 2005) is a multidimen-
sional self-report questionnaire to assess pathological eating behaviours
with a 6-point Likert scale format ranging from 1 to 6. It consists of 64
items, which constitute the following 8 subscales: drive for thinness, in-
teroceptive awareness, body dissatisfaction, maturity fears, perfectionism,
interpersonal distrust, as well as a total score. Scale scores are the sum
of all relevant items, thus the maximum possible total score is 384. The
EDI has good (𝛼 > .80) to excellent (𝛼 > .90) internal consistency scores
for AN patients (Garner et al., 1983; Paul & Thiel, 2005) and shows good
test-retest reliability (Thiel & Paul, 2006). The EDI was administered
at TP1 and TP3 of the present thesis project. In the sample of present
thesis, Cronbach’s alpha of the AN group was .95 at TP1, .96 at TP3,
and of the HC group .94 at TP1, .93 at TP3, indicating excellent internal
reliability.
4.4.1.3 Depression
The Beck Depression Inventory (BDI; Beck & Steer, 1984; Hautzinger,
Bailer, Worall, & Keller, 1994) is a widely used 21-item self-rating ques-
tionnaire to assess depression severity. Participants are being asked to
rate how they felt during the past week on a Likert-scale ranging from 0
to 3, with a maximum possible sum score of 63. The clinically meaningful
cut-off score is 18, higher values indicating a higher depression severity.
The BDI has an internal consistency between .74 and .92 for psychiatric
and non-clinical samples respectively and shows good test-retest reliability
(Hautzinger et al., 1994). The BDI was administered at all three time
points of this thesis project. For this thesis, Cronbach’s alpha of the AN
group was .90 at TP1, .88 at TP2, .86 at TP3, and of the HC group .82 at
TP1, .64 at TP3, indicating overall good to excellent internal reliability.
As mentioned above, low variance of response scores directly influences
the calculation of Cronbach’s alpha (Cronbach, 1951), the low internal
reliability for the HC group at TP3 falls in this category.
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4.4.1.4 Hedonic capacity / anhedonia
The Snaith-Hamilton-Pleasure Scale (SHAPS; Franz et al., 1998;
Snaith et al., 1995) is a self-report questionnaire capturing the ability
to experience pleasure (hedonic capacity) with 14 items. Answers range
from 1 to 4 to indicate agreement, and are dichotomised for the total
score to 0 and 1, with 1 indicating disagreement (response value 1 or 2).
The total score is calculated as sum of the dichotomised answers, leading
to a maximum score of 14, with greater values indicating higher levels
of anhedonia. A cut-off score of 2 discriminates between normal and
abnormal levels of hedonic tone (Snaith et al., 1995). The SHAPS has
demonstrated good to excellent internal consistency in clinical (Franken,
Rassin, & Muris, 2007; Franz et al., 1998) as well as healthy samples
(Franken et al., 2007). The SHAPS was administered at all three time
points of the present thesis project. In the sample of present thesis,
Cronbach’s alpha of the AN group was .90 at TP1, .89 at TP2, .87 at
TP3, and of the HC group .86 at TP1, .84 at TP3, indicating good to
excellent internal reliability.
4.4.1.5 Handedness
To match patients and healthy controls for handedness, all parti-
cipants filled out a short form of the Edinburgh Handedness Inventory
(Veale, 2014). This scale comprises 4-items and captures lateralised beha-
viour along a continuum (from left-handed -100 to +100 right-handed).
Participants with a laterality score between -60 and +60 are classified as
mixed-handers. The scale shows very good internal consistency (𝛼=.93)
and correlates highly with the long form of this questionnaire (r=.94)
(Oldfield, 1971). In the sample of the present thesis, Cronbach’s alpha
was .90 at TP1 for both groups.
4.4.2 Neuropsychological tests
To assess the cognitive abilities of the participants, a number of
neuropsychological tests were used at TP1. All computer-based tests
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were administered within the Hogrefe Test System (Hänsgen & Merten,
2001).
4.4.2.1 Spatial neglect
To exclude brain lesions, laterality in spatial perception was assessed
using the well-established number location test from the validated Visual
Object and Space Perception Battery (Rapport, Millis, & Bonello, 1998;
Warrington & James, 1991). Cards with two squares each are presented to
the participant; the upper square presents a random selection of numbers
and the bottom square contains a single black dot. During 10 trials,
participants identify the number in the upper square that corresponds
to the position of the dot in the bottom square (Warrington & James,
1991). The test has been reported to have good specificity and an internal
consistency of .84 (Bonello, Rapport, & Millis, 1997), indicating a good
internal reliability. For the present sample, answers to individual items
were recorded as a sum score, thus individual item values could not be
analysed for internal consistency.
4.4.2.2 Intelligence
In addition, two scales were used to assess intelligence. Results of
these intelligence measures can be found in the sample descriptions of the
respective empirical work (see Table 5.1, 6.1, and 7.1). Fluid intelligence
was captured with the Wiener Matrizen-Test (WMT), a Rasch-scaled
language-free inventory (Formann & Piswanger, 1979). The original test
consists of 24 items, each presenting an array of abstract geometric figures
in a specific order. The participant is asked to choose for each item one
of eight possible answers to continue the array with the same logical rule.
For the present project, the updated shorter version with 18 items was
used (Formann, Waldherr, & Piswanger, 2011). The internal consistency
of the computer version lies between .76 and .81 (Formann et al., 2011).
To estimate verbal intelligence, a digital version of the Wortschatztest
(WST) was chosen (Schmidt & Metzler, 1992). The test presents six
words, only one of which actually exists. The participants are requested
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to identify the existing word. Besides verbal intelligence and language
understanding, this test allows for an estimation of the premorbid intelli-
gence level in case of mild to moderate brain impairments. The internal
consistency of the test is .94 (Schmidt & Metzler, 1992), indicating ex-
cellent internal reliability. For the present sample, answers to individual
items of both performance tests (WMT and WST) were recorded as a
sum score, thus individual item values were not analysed for internal
reliability.
4.5 Magnetic resonance imaging
For MRI data acquisition of the present thesis, a 3.0 Tesla whole-body
MRI system (Ingenia, Philips, Best, The Netherlands) was used, equipped
with a 32-channel head coil. The scans were conducted at the Division
of Neuroradiology, University Hospital Zurich. For all participants, T1-
weighted structural images were inspected by a trained neuroradiologist
for any relevant pathology. All scans comprised the following sequences:
4.5.1 T1-weighted images (structural MRI)
3D T1-weighted structural images were acquired using a three-dimen-
sional turbo field echo (TFE) sequence with echo time (TE)=3.8 ms,
repetition time (TR)=8.3 ms, field of view (FOV)=240×240 mm2, acquis-
ition matrix=240× 240, 160 sagittal slices, isotropic voxel size=1×1×1
mm3, flip angle=8°, and TFE factor=240.
4.5.2 Resting-state functional MRI
Resting-state functional images (rsfMRI) were acquired with eyes
closed using a gradient-echo T2*-weighted echo planar imaging (EPI)
sequence with TE=30 ms, TR=2.3s, flip angle=78°, FOV=220 × 220
mm2, isotropic voxel size=3×3×3 mm3, 40 axial slices, and 210 volumes
with a scan duration of ∼8 min. Subjects were instructed to close their
eyes, to lie quietly in the scanner, to relax, and to let their mind wander.
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4.5.3 Diffusion weighted images
Structural diffusion weighted images were acquired for 64 non-colinear
diffusion gradient directions and one non-diffusion-weighted b0 reference
volume, with a b-value of 1000 s/mm2, TE=90 ms, TR=9.8 s, flip
angle=90°, FOV=224 × 224 mm2, SENSE factor 2 (Pruessmann, Wei-
ger, Scheidegger, & Boesiger, 1999), EPI factor 55 (Mansfield, 1977)),
isotropic voxel size=2×2×2 mm3, 75 slices and a scan duration of 14 min.
Additionally, a T1-weighted fast-field echo sequence was acquired to map
the B0 field in order to correct the DTI data for echo planar imaging
related geometrical distortions (Jones & Cercignani, 2010) with TE=4.4
ms, TR=4.0 s, flip angle=45°, FOV=256 × 256 mm2, isotropic voxel
size=2×2×2 mm3, 77 slices and a scan duration of ∼ 2 min. During DTI
acquisition, subjects were instructed to lie still and had the option to
either watch a video or to close their eyes and relax.
4.5.4 Cardiopulmonary data
For each MRI sequence, the heart rate was concurrently recorded at
500 Hz using an MRI compatible electrocardiograph (InVivo International,
Best, The Netherlands). The scanner software automatically detected the
maximum of the cardiac signal (R-peak) and registered their occurrences
in a logfile.
4.6 Ethics
Permission to conduct this research was granted by the Ethics Com-
mittee of Zurich, Switzerland (see Appendix C). The study protocol
complied with the Declaration of Helsinki and all participants provided
written informed consent prior to participation (see Appendix C).
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5.1 Abstract
Background: Neuroimaging studies on anorexia nervosa (AN) have
consistently reported globally reduced grey matter in AN patients with
acute underweight. While some studies on recovered patients provide
evidence for the reversibility of these impairments, longitudinal studies
investigating temporal patterns of recovery processes are scarce and
factors associated with brain restitution are poorly understood.
Methods: We report a structural magnetic resonance imaging study
using surface-based morphometry to analyse high resolution T1-weighted
images from a sample of 20 adult patients with severe AN and 20 closely
matched healthy controls (HC). The longitudinal design comprised three
time points, capturing the course of weight restoration therapy in AN
patients at distinct stages of weight gain.
Results: Linear-mixed effect models revealed reversibility of globally
reduced cortical thickness and reduced subcortical volumes observed
in AN patients at the beginning of treatment, with significant residual
differences remaining in parietal and frontal brain regions even after weight
restoration. Interestingly, the broad restoration of cortical thickness in
AN patients showed a strong negative association with age.
Conclusions: Temporal patterns of structural brain recovery in adult
AN patients suggest partial restoration of cortical thickness with patients’
age as a strong predictor of brain restitution, potentially indicating
decreases of brain plasticity across the lifespan. These results may be of
value to provide evidence for treatment decisions towards early weight
restoration therapy and a sufficient period of weight stabilisation at the
end of treatment.
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5.2 Introduction
Anorexia nervosa (AN) is a severe and enduring psychiatric disorder,
characterised by significantly reduced body weight (APA, 2013) and
associated reduced brain volume (Seitz et al., 2016; Titova et al., 2013).
Results from early computed tomographic (CT) studies provided first
evidence for enlarged ventricles and sulci in AN patients with acute
underweight (Artmann, Grau, Adelmann, & Schleiffer, 1985; Dolan,
Mitchell, & Wakeling, 1988; Krieg, Backmund, & Pirke, 1986). Later
magnetic resonance imaging (MRI) studies supported these findings and
further suggested grey and white matter reductions (Golden et al., 1996;
Katzman et al., 1996; Kingston, Szmukler, Andrewes, Tress, & Desmond,
1996).
Recent studies have largely demonstrated reduced grey matter volume
in AN with severe underweight, in a globally distributed set of brain
regions, affecting almost the whole cortex (for reviews see Seitz et al.,
2016; Eynde et al., 2012). Reports on reduced white matter volumes have
been less consistent, with some studies reporting decreased volume (e.g.,
Seitz et al., 2015; Via et al., 2014), while others did not find significant
changes (Fonville et al., 2014; Roberto et al., 2011). These reductions are
generally interpreted as consequences of patients’ malnutrition and have
been largely found to be absent in long-term recovered adult AN patients
(Favaro et al., 2015; Frank, Shott, Hagman, & Yang, 2013; Friederich
et al., 2012; Joos et al., 2011; Wagner et al., 2006). In a voxel-based
morphometric study, an adult sample of long-term recovered AN patients
displayed grey and white matter values similar to HC after a remission
period of more than one year (Wagner et al., 2006). However, a more
recent study on five AN patients with a remission period of more than 5
years found some indication of persevering grey matter decreases (Joos
et al., 2011).
In adolescent AN patients, three longitudinal studies exist reporting
complete normalisation of grey matter loss after a brief period of weight
restoration (Bernardoni et al., 2016; Bomba et al., 2015; Mainz et al.,
2012). For adult AN patients there is a lack of longitudinal studies. The
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two existing studies only examined overall volumes of grey and white
matter before and after treatment and failed to perform detailed regional
analyses (Roberto et al., 2011; Swayze et al., 2003).
In the present longitudinal study, we used a well-validated surface-
based approach to analyse structural MRI scans from female patients with
AN, acquired at three time points: (1) at the beginning of treatment with
acute underweight, (2) during therapy after initial weight gain, and (3) at
the end of therapy with a close to healthy BMI. The aim was to identify
brain structural alterations in the phase of acute underweight and monitor
their development over the course of treatment to better understand
regional processes of disease-specific brain changes with weight restoration.
Specifically, we hypothesised in accordance with previous studies (Seitz et
al., 2016; Eynde et al., 2012) that cortical and subcortical brain structures
of AN patients would show decreases in thickness or volume, respectively,
at the beginning of treatment compared to healthy control women (HC).
With respect to the temporal development of these impairments we
predicted at least a partial recovery with weight restoration. Additionally,
we examined whether structural brain alterations in AN patients were
related to parameters of eating disorder severity and patients’ age at the
time of the study. We hypothesised that patients’ initial cortical thickness
would be associated with lower BMI, longer illness history, and greater
eating disorder pathology. As patients with an early onset of AN have
been reported to have a more favourable outcome (Steinhausen, 2002),
increasing cortical thickness over the course of treatment was expected
to be more pronounced in younger patients.
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5.3 Methods and materials
5.3.1 Participants
Women diagnosed with severe AN (BMI ≤ 15.5) according to DSM-
IV criteria (APA, 2000) and a group of HC were assessed with the
Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I,
First, Spitzer, Gibbon, & Williams, 2002). Groups were matched for sex,
age, handedness, intelligence and education. All women were strongly
right-handed, except for one left-handed woman in each group, as assessed
with the Edinburgh inventory (Oldfield, 1971).
Patients with AN participated in an eating disorder-specific inpatient
programme at the University Hospital of Zurich, Switzerland (Department
of Psychiatry and Psychotherapy, 2016), with a target BMI ≥ 18.5.
Thirty-five patients completed the baseline time point (TP1) of this
study, 20 of which were eligible for participation in all three time points
(see study design). Two patients’ data was not available at TP1 due to
technical difficulties. Nine patients were given comorbid diagnoses besides
AN: major depressive disorder (n=7) and depression and social phobia
(n=2). Seven patients (38.9%) were medicated: SSRI (n=4) and SSRI
and atypical antipsychotics/anxiolytics (n=3). Medication was stable for
3 weeks prior to TP1 and patients were instructed to continue taking it
as normal.
Inclusion criteria for HC were a BMI of 18.5-23.0, not having a
history of any mental illness, not having first-degree relatives with a
lifetime diagnosis of an eating disorder, and not be taking any medication,
including hormonal contraceptives. Twenty-two controls participated in
TP1, two of whom had to be excluded from the second time point due to
somatic complaints. Thus, the final sample for the statistical analyses
consisted of 20 AN patients and 20 HC. The study was approved by
the local ethics committee and the study protocol complied with the
Declaration of Helsinki. All participants gave their written informed
consent prior to study enrolment.
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5.3.2 Study design
Over the course of the inpatient programme (Department of Psy-
chiatry and Psychotherapy, 2016), measurements of the AN group were
taken at three time points: at the beginning (TP1, BMI ≤ 15.5), in the
middle (TP2: 15.5 < BMI < 17.5), and at the end of treatment with a
close to healthy BMI of ≥ 17.5 (TP3). To calculate the BMI, patients’
height was measured at the beginning of treatment, weight measures were
obtained twice per week before breakfast, within the regular treatment
scheme by trained hospital nurses. The HC group participated in the
same procedure at two time points (TP1 and TP3). The interval between
TP1 and TP3 for both groups was 4-6 months after TP1. The first time
point of AN patients was scheduled after a hospitalization time of 2 weeks
with a fixed meal plan and extensive somatic checks, to exclude biases
due to acute malnutrition and dehydration. To avoid effects of short-term
hormone dependent structural changes in HC (Hagemann et al., 2011),
both scans were scheduled in the folicular phase of the women, within
the first 10 days of their cycle. Scans for all participants were performed
between 3 p.m. and 4.30 p.m.
5.3.3 Behavioural and psychometric assessment
Validated German versions of the following psychometric tests were
used in this study: The Viennese Matrices Test (WMT) for non-verbal
intelligence (Formann & Piswanger, 1979) and the Vocabulary test (WST)
for verbal intelligence (Schmidt & Metzler, 1992). Eating disorder severity
was assessed with the Eating Disorder Examination Questionnaire (EDE-
Q) (Hilbert & Tuschen-Caffier, 2006), depression severity was captured
with the Beck Depression Inventory (BDI, Hautzinger et al., 1994), and
anhedonia was assessed with the Snaith-Hamilton Pleasure Scale (Snaith
et al., 1995).
5.3.4 MRI data acquisition
Brain images were acquired with a 3.0 Tesla whole-body magnetic res-
onance imaging (MRI) system (Ingenia, Philips, Best, The Netherlands),
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equipped with a 32-channel head coil. Whole-brain 3D T1-weighted struc-
tural images were acquired using a three-dimensional turbo field echo
(TFE) sequence with echo time (TE)=3.8 ms, repetition time (TR)=8.3
ms, field of view (FOV)=240 × 240 mm2, acquisition matrix=240 × 240,
160 sagittal slices, isotropic voxel size=1×1×1 mm3, flip angle=8°, and
TFE factor=240. For all subjects, T1-weighted images were checked for
relevant clinical pathology or anomalies by a trained neuroradiologist.
5.3.5 MRI data pre-processing
Structural T1-weighted images were processed with the FreeSurfer
software suite version 6.0 (surfer.nmr.mgh.harvard.edu). This automated
analysis procedure has been widely used and its processing steps have
been described in detail elsewhere (Dale, Fischl, & Sereno, 1999). In brief,
T1-weighted images in stereotactic space are segmented into different
tissue types, considering a priori anatomical information and each voxel’s
intensity value. To reliably estimate cortical thickness and subcortical
volumes, images were processed with FreeSurfer’s longitudinal stream (Re-
uter, Schmansky, Rosas, & Fischl, 2012). For each subject, an unbiased
median template image was created (Reuter & Fischl, 2011) using robust,
inverse consistent registration between each time point of a subject (Reu-
ter, Rosas, & Fischl, 2010). Data for each subject were then resampled to
the respective template and pre-processed by (1) registration to Talairach
space, (2) construction of brain mask and skull stripping, (3) normal-
isation and registration to the probabilistic atlas (Fischl et al., 2002;
Fischl et al., 2004), (4) segmentation of subcortical regions, (5) creation
of spherical surface maps, registration to cortical atlas, and parcellation,
initialised with common information from the within-subject template
to improve statistical power and reliability (Reuter et al., 2012). For
each time point, cortical thickness maps for both hemispheres were then
extracted and smoothed with a 15 mm full-width at half-maximum Gaus-
sian kernel. Additionally, the following subcortical structures provided
by the FreeSurfer stream were segmented and extracted for both hemi-
spheres: nucleus accumbens, amygdala, caudate nucleus, hippocampus,
globus pallidus, putamen, and thalamus. To assure data quality, all pre-
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processed images were visually inspected and checked with the FreeSurfer
QA tools 1.1 (surfer.nmr.mgh.harvard.edu/fswiki/QATools). All subjects
had sufficient data quality.
5.3.6 MRI data analyses
Cross-sectional whole-brain differences of cortical thickness between
groups at TP1 and TP3 were analysed using vertex-wise general linear
models with group as independent and cortical thickness as dependent
variable. Subcortical volumes and global brain measures (cortical grey
matter, cortical white matter, cerebellar grey matter, cerebellar white
matter, cortico-spinal fluid [CSF], intracranial volume) were compared
using t-test for independent samples, corrected for multiple comparisons
using false discovery rate (FDR) correction (Benjamini & Hochberg, 1995;
Yekutieli & Benjamini, 1999).
The longitudinal analyses of the data were performed with linear-
mixed effects (LME) models, more specifically with the spatiotemporal
extension for mass-univariate data as implemented in FreeSurfer (Bernal-
Rusiel, Greve, Reuter, Fischl, & Sabuncu, 2013; Bernal-Rusiel, Reuter,
Greve, Fischl, & Sabuncu, 2013). LME models offer a powerful and
versatile approach for the analysis of longitudinal data, with the advantage
of differentiating between-subject and within-subject sources of variance
and handling unequal numbers of time points (Bernal-Rusiel, Greve, et al.,
2013). Visual inspection of mean trajectories revealed a linear trend over
time, thus the spatio-temporal model was fitted with the intercept as
random effect. For each tested contrast (main effect group, main effect
time, interaction effect group × time), significance maps were created and
FDR corrected at level 0.05 within FreeSurfer using an adaptive linear
two-stage procedure (Benjamini, Krieger, & Yekutieli, 2006) to control
for multiple comparisons.
5.3.7 Additional statistical analyses
Within- and between-group comparisons of demographic and psycho-
metric measures were performed using t-tests for paired and independent
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samples, respectively. Associations between brain measures and eating
disorder symptoms were calculated with Pearson’s correlations. These
tests were performed using IBM SPSS Statistics 23.0 (SPSS Inc, an IBM
company, Armonk, NY) and subsequently corrected for multiple com-
parisons with FDR correction (Benjamini & Hochberg, 1995; Yekutieli
& Benjamini, 1999). If not otherwise stated, two-tailed p-values are
reported.
5.4 Results
5.4.1 Demographic and psychometric measures
Group comparisons of demographic data at baseline (TP1) revealed
no significant differences between AN patients an HC with respect to age,
intelligence and education (ps > .17, see Table 5.1). As expected, AN
patients had significantly lower BMIs and higher eating disorder severity
(EDE-Q), depression (BDI), and anhedonia (SHAPS) scores compared
to HC. These scores improved significantly over the course of therapy
within the AN group, but stayed significantly elevated even at the end of
treatment (Table 5.1).
5.4.2 Brain alterations during severe underweight
Global brain volumes at TP1 showed significantly reduced cortical and
subcortical grey matter, reduced cerebellar white matter, and heightened
CSF in AN patients compared to HC (Table 5.2). No differences were
observed with respect to intracranial volume, excluding overall smaller
skulls in AN patients as explanation for the observed differences (p >.95).
Furthermore, volumes of cerebral white matter did not differ between
groups (p >.56, Table 5.2).
Cross-sectional group comparisons of cortical thickness at TP1 demon-
strated that global volumetric grey matter differences reported above
were largely driven by differences in cortical thickness. Compared to HC,
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Table 5.2
Comparison of global brain measures between groups at TP1
Group
AN (n = 18) HC (n = 20)
Measure M SD M SD t p
Grey matter (cortex) 453.6 31.1 483.2 32.9 −2.8 .018
Grey matter (subcortical) 56.9 3.9 60.4 3.7 −2.8 .011
White matter 432.9 33.6 440.6 53.5 −0.5 .605
CSF 1.5 0.5 1.2 0.2 3.1 .020
Intracranial volume 1554.1 139.6 1517.2 176.6 0.7 .604
Notes. Mean volumes represent absolute values (cm3). Comparisons were
corrected for false positives with FDR (Benjamini & Hochberg, 1995; Yekutieli
& Benjamini, 1999). CSF = cortico-spinal fluid.
AN patients showed considerable bilateral atrophy in clusters covering
large parts of both hemispheres (Fig. 5.1), sparing only parts of the
sensorimotor cortex.
In accordance with the overall reduced subcortical volume, separate
analyses of the individual subcortical structures yielded significant group
differences at TP1 with reduced bilateral volumes in AN patients of nuc-
leus accumbens, caudate nucleus, hippocampus, putamen, and thalamus,
as well as the amygdala of the right hemisphere and the left hemispheric
pallidum (Table 5.3).
5.4.3 Recovery processes with weight restoration
LME analyses yielded a significant interaction of group × time, re-
vealing patterns of cortical thickness restoration in AN patients over the
course of treatment (Fig. 5.3A), controlled for multiple comparisons at
p < 0.05 with FDR correction across both hemispheres. Within-group
analysis demonstrated significant improvements of cortical thickness dur-
ing both treatment phases (Fig. 5.2). Restoration processes took place
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Figure 5.1. Cross-sectional comparisons of cortical thickness between
groups at TP1. Significant clusters (blue) were projected onto inflated
brain surfaces (grey), after correcting for multiple comparisons using
Monte-Carlo simulations (5’000 permutations).
globally in both hemispheres during the first (TP1-TP2: mean increase
left=0.09mm ± 0.06, t(17)=-6.6, p < .001; mean increase right=0.08mm
± 0.06, t(17)=-6.1, p < .001) and second treatment phase (TP2-TP3:
mean increase left=0.03mm ± 0.06, t(19)=-2.1, p=.051; mean increase
right=0.03mm ± 0.06, t(19)=-2.1, p=.045), with a notably stronger
regeneration during the first phase.
Despite the significant global restoration of cortical thickness over the
course of treatment (Fig. 5.3A), whole-brain group comparisons at TP3
yielded clusters of significant residual cortical thinning in AN patients
compared to HC in frontal and parietal regions (Fig. 5.3B).
With regard to subcortical structures, mean volumes of the amyg-
dala, caudate nucleus, hippocampus, and thalamus of both hemispheres
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Figure 5.2. Mean cortical thickness per time point. Top: Global cortical
thickness (mm) per group, left hemisphere displayed (similar trajectory
for right hemisphere, not displayed). Error bars represent 95 % within-
subject confidence intervals (Morey, 2008). Bottom: Local differences
in cortical thickness [mm] between groups (HC-AN) per time point,
projected onto inflated brain surfaces. HC values were averaged over
time before differences to AN patients were calculated.
significantly increased in AN patients over the course of treatment (see
Table 5.3). Although mean values of the bilateral amygdala, pallidum,
and putamen did not increase significantly, group comparisons no longer
yielded significant differences at TP3 (Table 5.3). Interestingly, volumes
of the nucleus accumbens and the pallidum of both hemispheres did not
increase between TP1 and TP3, although the difference to HC was no
longer significant at TP3 (Table 5.3).
5.4.4 Correlations with clinical and demographic parameters
Within the group of AN patients, hemispheric mean cortical thickness
at TP1 was positively correlated with lower body weight, as measured
5.4 Results 59
Figure 5.3. Cortical thickness. (A) Interaction of group × time, signi-
ficant increase with weight restoration in AN patients. Red, p < .05;
yellow, p < .01, controlled for multiple comparisons with FDR correc-
tion. (B) Cross-sectional comparisons of cortical thickness AN vs. HC,
significant cluster at the end of treatment (TP3), corrected for multiple
comparisons using Monte-Carlo simulation (5’000 permutations).
by BMI (left hemisphere, r=.41, p=.046, one-tailed; right hemisphere,
r=.40, p=.048, one-tailed). Similarly, reduced subcortical tissue of the
left caudate nucleus (r=.42, p=.041) and the right amygdala (r=.41,
p=.047) were associated with poorer BMI values. Considering the high
homogeneity of BMI within the AN patient group, resulting in low
intra-individual variance and making it less likely to find significant
correlations, these associations underline the strong influence of BMI on
brain structural measures. The observed cortical thickness differences
were independent of age at AN onset and duration of illness (ps > .15).
To explore potential influence variables on recovery of cortical thick-
ness, correlations between change in cortical thickness and eating disorder
severity (EDE-Q), as well as the individuals’ age were computed. Due to
the massive global reductions of cortical thickness in both hemispheres,
mean cortical thickness per hemisphere was used for analyses. While
changes in cortical thickness did not predict improved eating disorder
severity (as measured with the EDE-Q; ps > .16), they were negatively
associated with age of AN patients. More specifically, recovery of cortical
thickness proceeded independently of age during initial weight restora-
60 Chapter 5 Empirical Work - Study I
tion, however, changes over the second half of treatment were strongly
associated with patients’ age, suggesting that younger patients’ cortical
thickness recovered to a larger degree than older patients’ (Fig. 5.4).
Of note, this relationship persisted even when controlling for the BMI
level at TP3 (left hemisphere, r=-.64, p=.004; right hemisphere, r=-.65,
p=.003). Similarly, the individual values of cortical thickness within
the residual clusters remaining at TP3 were significantly correlated with
the patients’ age (left hemisphere, r=-.552, p=.012; right hemisphere,
r=-.584, p=.007).
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Figure 5.4. Correlation between age and recovery of cortical thickness
in AN patients. Left: No significant correlation between age and
changes in cortical thickness between TP1 and TP2. Right: Significant
correlations between age and changes in cortical thickness of both
hemispheres between TP2 and TP3; left hemisphere R2=0.43, right
hemisphere R2=0.42.
5.4.5 Medication effects
Structural brain measures are susceptible to psychotropic medication,
with atypical antipsychotics being associated with significant shrinkage
of brain volume (Dorph-Petersen et al., 2005; Lieberman, 2005). To
assess whether morphology of AN patients with medication differed
from patients without medication with regard to cortical thickness and
subcortical volumes, AN patients were divided into two subgroups. Mean
values of cortical thickness (ps ≥ .68) and subcortical volumes (ps >
.19) did not differ between these subgroups, suggesting our findings of
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differences between AN patients and HC at TP1 and TP3 were not driven
by current medication at the time of scanning.
5.5 Discussion
This study investigated temporal patterns of cortical and subcortical
recovery during weight restoration therapy in adult patients with severe
AN. To the best of our knowledge, this is the first longitudinal study on
AN patients using three distinct time points to assess brain restorative
processes during multiple stages of weight recovery. Our longitudinal
analyses revealed reduced cortical thickness as well as diminished sub-
cortical volumes which regenerated (partially) with weight restoration.
Specifically, during the early phase of treatment (TP1-2, BMI increase of
19% compared to baseline), patients’ mean cortical thickness increased
markedly by 0.08-0.09mm. During the later phase of treatment (TP2-3,
BMI increase of 33% compared to baseline), further restitution of mean
cortical thickness by 0.03mm was observed. However, significant residual
differences remained in a left hemispheric frontal and a right hemispheric
parietal cluster. Closer examination of associated factors revealed a
strong negative association between restoration of cortical thickness and
age, suggesting that younger patients were more likely to restore cortical
thickness and potentially indicating decreases of brain plasticity across
the lifespan (Pascual-Leone et al., 2011).
The reversibility of cortical and subcortical reductions is in agreement
with overall findings of longitudinal studies in adolescent AN patients after
a brief period of weight restoration in an inpatient setting (Bernardoni
et al., 2016; Bomba et al., 2015). In adolescents, BMI increases of at least
10% were accompanied by an average restitution of cortical thickness
of 0.16 mm after a mean treatment duration of 12 weeks (Bernardoni
et al., 2016). In contrast, the mean increases of cortical thickness in our
sample ranged from 0.11–0.12 mm (right and left hemisphere, respectively)
after a total treatment duration of 20 weeks. At TP2, 10 weeks after
baseline and approximately 12 weeks after the beginning of treatment, our
adult sample had regained only 0.09 mm of cortical thickness. Recovery
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processes in adolescent AN patients thus might happen at a faster rate
compared to adult patients.
Additionally, cross-sectional comparisons at TP3 demonstrated re-
maining decreases of cortical thickness in frontal and parietal regions.
These residual reductions where strongly negatively correlated with age,
further supporting our hypothesis of a slower or incomplete recovery in
“older” AN patients. The residual grey matter reductions are in line
with another study on weight restored adult AN patients who reported
persisting reductions after recovering 90% of their ideal body weight
(Roberto et al., 2011). However, the authors of the study did not separ-
ately analyse the influence of patients’ age (Roberto et al., 2011). A study
on long-term (1.6 years) recovered AN patients (18 to 42 years) with a
similar age range as our study (18 to 32 years) reported no significant
association between age and residual alterations in the cingulate cortex
(Mühlau et al., 2007). Similarly, Wagner et al. (2006) found grey matter
volume to be independent of patients’ age after mean recovery length
of 3 years. This could indicate that recovery in older patients is slower,
rather than incomplete compared to younger patients. However, further
research including a wider age range beyond young adults is needed to
clarify the long-term influence of age in this context.
At baseline, volumes of the subcortical structures (nucleus accumbens,
amygdala, caudate nucleus, hippocampus, pallidum, putamen, and thal-
amus) were significantly reduced compared to HC, even after controlling
for multiple comparisons. After weight restoration at TP3, most of these
impairments had improved and were no longer significantly different form
HC, indicating a substantial restoration of subcortical structures. Average
volumes of nucleus accumbens and pallidum in both hemispheres stayed
largely unchanged, although differences compared to HC were no longer
significant at TP3. These results are in accordance with longitudinal
results from a study on adolescents, where volumes of subcortical regions
also increased with weight restoration, except for the pallidum where a
decrease was observed (Bernardoni et al., 2016).
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5.5.1 Underlying biology
Several biological mechanisms have been discussed but did not prevail
as possible explanations for the observed grey matter reduction and
recovery in AN patients, such as dehydration (Frank, 2015; Frank, Shott,
Hagman, & Mittal, 2013; Via et al., 2014), or programmed cell death
(apoptosis) of neurons or glia cells (Ehrlich, Burghardt, et al., 2008;
Ehrlich, Salbach-Andrae, et al., 2008). A recent study investigating an
animal model of activity-based anorexia (ABA) strongly supports the
hypothesis of glia cells playing a key role in AN. In a chronic model of
ABA, the study on female rats by Frintrop et al. (2017) observed massive
decreases of astrocyte counts in the cerebrum and corpus callosum of up to
39%, using glial fibrillary acid protein as marker, and reductions of total
cortical surface area covered by astrocytes of up to 83%. No alterations
in neuron or oligodendrocyte count were detected (Frintrop et al., 2017),
suggesting that severe sub-/cortical alterations in AN are selectively linked
to processes of astroglia. Astrocytes come in different forms and exist both
in the white and in the grey matter of the brain, closely connected with
surrounding neurons (Nedergaard, Ransom, & Goldman, 2003; Oberheim,
Wang, Goldman, & Nedergaard, 2006). The authors presume these strong
effects may be owed to reduced glia cell proliferation, as demonstrated
in an acute model of activity-based AN (Barbarich-Marsteller et al.,
2013). Reduced astrocyte density has previously been implicated in a
study on dehydration-induced anorexia and forced food restriction in rats
(Reyes-Haro, Labrada-Moncada, Miledi, & Martínez-Torres, 2015).
5.5.2 Brain plasticity and age
While the number of glia cells seems to stay relatively stable dur-
ing healthy ageing (Weissleder et al., 2016), the notion of diminished
astrocyte proliferation (Barbarich-Marsteller et al., 2013) could offer an
intriguing explanation for the slower recovery of cortical thickness as
marked by the strong correlation of age and recovery during the second
treatment phase of our study. Importantly, the observed influence of
age persisted even after controlling for the BMI level at TP3, suggesting
64 Chapter 5 Empirical Work - Study I
that individual BMI levels were not mediating this association. Altered
astrocyte function has been implicated in the pathological processes re-
lated to both neurodegenerative diseases as well as normal brain ageing
(for a review see Chen & Swanson, 2003). Recent evidence suggests
that particularly the senescence of astrocytic cells, a protective response
which permanently prevents cell proliferation (Campisi, 2001; Collado &
Serrano, 2010), increases with age (Chinta et al., 2015). The correlation
between patients’ age and the reduced recovery of cortical thickness thus
might be influenced by ageing processes of glia cells, in particular reduced
astrocyte proliferation (Chinta et al., 2015; Frintrop et al., 2017). Younger
AN patients potentially have a capacity for full restoration of cortical
thickness. This is in line with research on prognostic factors in AN,
reporting better outcome with illness onset at younger age (Steinhausen,
2002). In that respect, age may pose a risk factor for persisting brain
impairments and a chronic illness trajectory.
5.5.3 Cortical regions unaffected by starvation
The broad reductions of cortical thickness in both hemispheres raises
the question why some regions, namely the sensorimotor cortices (Fig.
5.1), were spared from weight-related shrinkage processes. Two distinct-
ive features of these regions stand out. First, the affected regions are
known to be myelinated very late in brain maturation, partly adolescence,
whereas the unaffected regions are myelinated early on in brain matura-
tion (Lenroot & Giedd, 2006). There may be protective mechanisms in
place, shielding primary brain regions essential to survival (Lenroot &
Giedd, 2006). Second, the unaffected regions, namely the motor cortex,
might be protected by high activation due to excessive physical activity
(hyperactivity) in AN patients (Gümmer et al., 2015).
Apart from the unaffected grey matter regions, cortical white matter
volume was another region unchanged by the severe underweight of AN
patients at baseline, compared to healthy controls (Table 5.2). While this
is well in line with previous morphometric studies on adult AN patients
(Fonville et al., 2014; Friederich et al., 2012; Joos et al., 2011; Roberto et
al., 2011), two voxel-based morphometry studies reported reduced cortical
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white matter volumes (Boghi et al., 2011; Via et al., 2014). Furthermore,
preliminary findings of diffusion tensor imaging studies in adolescent AN
patients indicate potential alterations in a number of white matter tracts
(Travis et al., 2015; Vogel et al., 2016), thus warrant further exploration
of potentially undetected white matter alterations employing other MRI
modalities.
5.5.4 Clinical implications
Overall, the findings of the present study provide encouraging evidence
for weight restoration as an effective intervention to ameliorate damages of
cortical and subcortical brain structures. Reductions of brain measures in
AN patients at baseline were independent parameters of patients’ illness
history, such as duration of illness and age at illness onset. However,
the strong correlation of age and recovery of cortical thickness in the
later treatment phase may indicate that younger patients have a better
chance for complete cortical restitution. Age-dependent decreases in brain
plasticity potentially aggravate the detrimental effects of malnutrition on
the brain. This has important clinical implications. Regarding therapy
start, these findings point out the benefit of weight restoration treatment
at an early stage of the disease when patients are younger. Moreover, with
regard to treatment planning and the question of treatment duration, a
phase of continued (guided) stabilisation of a healthy BMI (≥18.5) seems
vital to give all patients enough time to adjust and recover internally,
on a psychological as well as on a neural level. In fact, longer weight
maintenance before hospital discharge has previously been found to be
predictive of a longer time period before rehospitalisation (Lay, Jennen-
Steinmetz, Reinhard, & Schmidt, 2002).
5.5.5 Limitations
The strict weight criteria of the current study posed a challenge for
patient recruitment and thus resulted in a medium sample size. Neverthe-
less, our results are based on modern and powerful analyses approaches
and are in line with previous structural studies of adult AN patients (Seitz
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et al., 2016). Furthermore, the longitudinal measurement of both AN
patients and age-matched HC allowed to account for potential age-related
decreases of brain structures in HC (Lemaitre et al., 2012; Salat et al.,
2004; Tamnes et al., 2010) and supports the reliability of the findings.
Dehydration may lead to reduced measures of brain morphology by
affecting astrocyte density as findings in rats have demonstrated (Reyes-
Haro et al., 2015). Hydration status of the current AN sample was
not assessed separately, thus effects of dehydration cannot be ruled out
completely. However, the baseline scans of AN patients were acquired
after a minimum hospitalisation of 2 weeks to facilitate rehydration and
to avoid effects of acute starvation in patients. Furthermore, a recent
study (Bernardoni et al., 2016) gauging hydration status in AN patients
by specific gravity of urine samples suggests dehydration is unlikely to
be the main cause of the observed reductions in brain measures.
At the end of treatment, scanning took place after a restoration of
at least 85% of the ideal body weight (BMI > 17.5). Although at TP3
the mean BMI of our sample was close to the recommended minimal
BMI of 18.5 (18.2 ± 1.0), the question whether the residual clusters of
altered cortical thickness will completely be reversible with full weight
restoration cannot be answered with the current data set. Future studies
should address this question by implementing an additional follow-up
time point after a period of weight stabilisation at BMI > 18.5.
5.5.6 Conclusion
Temporal patterns of structural brain recovery in adult AN patients
suggest (partial) reversibility of cortical thickness and volumes of subcor-
tical structures. Patients’ age seems to have a notable influence on brain
restitution, potentially indicating decreases of brain plasticity across the
lifespan. Further longitudinal studies including an additional follow-up
time point after a period of weight stabilisation will allow us to advance
our understanding of the pathophysiological mechanism and elucidate
potential mediating factors of successful brain recovery in AN patients.
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6.1 Abstract
Background: While treatment of anorexia nervosa (AN) is often fo-
cused on reducing the strong fear of gaining weight, the neuropathological
underpinnings of such changes remain unclear. AN patients with acute
underweight were repeatedly reported to have altered functional con-
nectivity. The aim of this study was to elucidate alterations of functional
connectivity in AN patients over the course of a standardised multimodal
inpatient treatment and to investigate potential associations with changes
in eating disorder pathology such as excessive weight concerns.
Methods: In a longitudinal study with three time points, each re-
flecting a distinct stage of the treatment process, we performed resting
state functional magnetic resonance imaging and conducted a whole-brain
analysis in 16 women with AN and 20 closely matched healthy controls.
Using network-based statistics, we analysed functional connectivity on
the whole-brain level. Correlations between functional connectivity and
clinical variables were assessed.
Results: Compared to healthy controls, AN patients showed reduced
functional connectivity in a fronto-basal ganglia/limbic network in the
stage of severe underweight. This network of reduced connectivity re-
covered with weight normalisation. Network changes significantly correl-
ated with changes in patients’ weight concerns.
Conclusions: Weight restoration therapy has the potential to elicit
normalisation processes in a network related to reward, learning, and
cognitive-emotional integration, associated with improvements of eat-
ing disorder symptoms. Potential residual alterations need additional
investigation.
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6.2 Introduction
Anorexia nervosa (AN) is a severe and enduring psychiatric disorder,
characterised by a fear of gaining weight despite low body weight (APA,
2013). The main goals in treatment of AN is to restore and maintain a
healthy body weight (NICE, 2004; Watson & Bulik, 2013), though long-
term treatment results are often not satisfactory (Steinhausen, 2002). This
may be in part due to an incomplete understanding of the mechanisms
underlying and driving the etiopathology of AN (Zipfel et al., 2015).
Neuroimaging techniques have increasingly been employed to further
elucidate the neurobiology of AN and resting-state functional magnetic
resonance imaging (rsfMRI) studies have revealed a number of alterations
in functional connectivity in the acute phase of AN, with partially con-
verging findings of reduced resting-state functional connectivity (rsFC) in
cortico-limbic circuits (Gaudio et al., 2016; Phillipou, Rossell, & Castle,
2014). However, varying a priori assumptions and heterogeneous analysis
approaches impede comparisons and even studies investigating the same
networks (i.e. default mode and visual networks) show diverging results
(Boehm et al., 2014; Favaro et al., 2012; Phillipou et al., 2016). Thus,
no definite consensus regarding alterations in the acute stage of AN has
been reached. Whether these diverging alterations remain stable over
the course of treatment or whether recovery processes on a functional
level take place is yet unclear. First evidence in weight recovered AN
patients suggests that reduced rsFC in visual and auditory resting-state
networks (Scaife et al., 2017) and increased rsFC in the default mode
network (Cowdrey et al., 2014) persist after a recovery time of one year.
Resting-state functional connectivity is thought to reflect the intrinsic
connectivity of the brain(van den Heuvel & Hulshoff Pol, 2010). It is
based on the degree of inter-regional coherence of the spontaneous rsfMRI
signal changes (Biswal, Van Kylen, & Hyde, 1997). Investigation of rsFC
has great potential to elucidate dysfunctional network-related mechanisms
in psychiatric disorders (Greicius, 2008). Its minimal requirements of
lying quietly in the scanner without any particular cognitive performance
can be easily achieved by participants and thus it is not affected by po-
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tential attentional biases that task-based measurements might experience
in patients with AN due to impaired cognitive performance (Weider,
Indredavik, Lydersen, & Hestad, 2015) or avoidance of stimuli (Giel et al.,
2011).
Studies so far have predominantly used a region-specific approach
to examine rsFC in AN, employing seed-based analysis or independent
component analysis in networks of interest. Identified alterations in AN
comprised increased as well as decreased rsFC in a number of different
regions (Amianto et al., 2013; Biezonski, Cha, Steinglass, & Posner, 2016;
Boehm et al., 2014; Collantoni et al., 2016; Favaro et al., 2012; Favaro et
al., 2013; Lee et al., 2014; Phillipou et al., 2016), including the prefrontal
cortex (Biezonski et al., 2016; Boehm et al., 2014; Collantoni et al., 2016)
and the insula (Amianto et al., 2013; Boehm et al., 2014). One study
reported decreased rsFC between the executive control network and the
anterior cingulate cortex after a whole-brain independent component
analysis (Gaudio et al., 2015). More recently, the available analysis
approaches have been complemented with a network-based approach
on the whole-brain level (Zalesky, Fornito, & Bullmore, 2010), allowing
data-driven investigations of connections between multiple brain regions.
Network-based statistic (NBS) offers the advantage of representing the
underlying neural architecture of the brain on a global connectivity level
by conceptualising the brain as a complex network (Fornito, Zalesky,
& Breakspear, 2015; Zalesky, Fornito, & Bullmore, 2010). Two cross-
sectional studies have used this approach so far in AN research and
reported decreased connectivity of a thalamo-insular network in mixed
samples of adolescent and adult patients with AN compared to controls
(Ehrlich et al., 2015; Lord et al., 2016).
To date, there is no agreement regarding dysfunctional networks
impaired in acute underweight in AN patients and a lack of longitudinal
examinations of functional connectivity. As a recent review on rsfMRI
in AN points out, there is a need for longitudinal investigation of rsFC
in AN employing whole-brain analysis, to elucidate potential causative
neurobiological mechanisms and possible subsequent damage due to the
disorder (Gaudio et al., 2016). Thus, the present study investigated rsFC
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in AN in a longitudinal design, aiming at elucidating potential network
alterations and recovery processes in a sample of adult AN patients
and closely matched healthy controls (HC). In addition, associations
of rsFC and symptom improvements were explored. We used rsfMRI
to examine global network deviations and local differences in neural
synchrony at three time points in AN patients: (TP1) at the beginning
of treatment with severe underweight, (TP2) during therapy after initial
weight gain of approximately 2 BMI points, and (TP3) at the end of
therapy with a close to healthy body mass index (BMI, kg/m2). Based
on the existing literature, we hypothesized that rsFC between regions
related to reward, learning, and cognitive-emotional integration, such as
the prefrontal/orbitofrontal cortex and basal ganglia is reduced in AN
patients at TP1, compared to HC, and recovers with weight restoration.
6.3 Methods and materials
6.3.1 Participants
Thirty-two women with severe AN (BMI ≤ 15.5) and 22 HC par-
ticipated in the baseline assessment (TP1). Patients were enrolled in
an interdisciplinary multimodal inpatient programme at the University
Hospital of Zurich, Switzerland, (Department of Psychiatry and Psy-
chotherapy, 2016), with a target BMI ≥ 18.5. The nutritional program
consist in balanced structured fixed meals adequate to the severe under-
weight situation of the patients, in order to avoid refeeding problems.
Sixteen patients did not sufficiently gain weight to participate in the
second and third measurement (see study design), two HC were not able
to participate in the second measurement due to somatic complaints and
were excluded from the analysis. Thus, the final sample completing all
required measurements consisted of 16 patients with AN and 20 HC.
Healthy controls were required to have no history of any mental illness,
no first-degree relatives with a lifetime diagnosis of an eating disorder,
and not be taking any medications, including hormonal contraceptives.
Patients with AN who received medication were instructed to continue
with these as prescribed. Six patients (37.5%) were taking psychotropic
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medications: selective serotonin reuptake inhibitors (SSRI; 3), SSRI
and atypical antipsychotics/anxiolytics (3). The Structured Clinical
Interview for DSM-IV-TR (First et al., 2002, SCID-I) was used to assess
axis I psychiatric disorders according to the DSM-IV-TR (APA, 2000).
Comorbid diagnoses included major depressive disorder (6) and depression
plus social phobia (1).
Groups were matched for age, handedness, and intelligence. All parti-
cipants were female and strongly right handed, except for one patient and
one matched HC, as assessed with the Edinburgh handedness inventory
(Oldfield, 1971). The study protocol complied with the Declaration of Hel-
sinki and was approved by the local ethics review board. All participants
provided written informed consent prior to participation.
6.3.2 Study design
Brain images and psychometric parameters of the patients were ac-
quired at the beginning of treatment when severely underweight (TP1),
after an initial weight gain (TP2: 15.5 < BMI < 17.5), and at the end
of treatment with a (close to) healthy BMI ≥ 17.5 (TP3) 4-6 months
after TP1. To avoid effects of acute malnutrition and dehydration, the
patients’ first visit (TP1) was scheduled after a minimal hospitalization
time of 2 weeks with a fixed meal plan and extensive somatic checks. At
the beginning of treatment, all patients were amenorrhoic.
Healthy controls underwent the same procedure at two time points
(TP1 and TP3) with an interval of 4-6 months. As rsFC is influenced by
alterations of sex hormones across the menstrual cycle (Petersen et al.,
2014), all HC women were scanned in the follicular phase within the first
10 days of their cycle, to exclude modulation of rsFC. All participants
were asked to refrain from caffeine or alcohol consumption 24 hours prior
to scanning. Scanning took place between 3 p.m. and 4.30 p.m.
6.3.3 MRI data acquisition
A 3.0 Tesla whole-body magnetic resonance imaging (MRI) system
(Ingenia, Philips Healthcare, Best, The Netherlands) equipped with a 32-
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channels receive phased array head coil was used for data acquisition. 3D
T1-weighted structural images were acquired using a three-dimensional
turbo field echo (TFE) sequence with echo time (TE)=3.8 ms, repetition
time (TR)=8.3 ms, field of view (FOV)=240 x 240 mm2, acquisition
matrix=240 x 240, 160 sagittal slices, isotropic voxel size=1×1×1 mm3,
flip angle=8°, and TFE factor=240.
Resting-state functional images were acquired with eyes closed using
a gradient-echo T2*-weighted echo planar imaging (EPI) sequence with
TE=30 ms, TR=2.3 s, flip angle=78°, FOV=220 x 220 mm2, isotropic
voxel size=3×3×3 mm3, 40 axial slices, EPI factor=41, and 210 volumes
with a scan duration of 8 min. For all subjects, T1-weighted and resting-
state images were acquired and inspected by a trained neuroradiologist
for any relevant pathology.
6.3.4 MRI data preprocessing
Functional MRI data were preprocessed with the DPARSFA tool-
box (version 4.1) as part of DPABI (version 2.1, http://rfmri.org/dpabi
Yan, Wang, Zuo, & Zang, 2016) with functions of SPM 12
(www.fil.ion.ucl.ac.uk/spm/software/spm12), comprising the following
steps: 1) slice timing correction, 2) realignment and extraction of mean
frame-wise displacement values (Vinet & Zhedanov, 2010), 3) coregis-
tering the mean rsfMRI with the T1-weighted image, segmenting and
normalizing the T1-weighted image to MNI152 structural (T1-weighted)
space using linear and non-linear transformation, and storing the trans-
formations, 4) applying the transformations from step 3 to the rsfMRI
data and voxel re-sampling to 2 x 2 x 2 mm3, 5) smoothing with an
isotropic Gaussian kernel of 4 mm full width at half maximum, 6) de-
trending, 7) band-pass filtering between 0.01-0.08 Hz, and 8) regressing
out the variance of the six parameters from head motion correction (three
translation and three rotation parameters), their first temporal derivatives
and the 12 corresponding squared items (24-parameter model; Friston,
Williams, Howard, Frackowiak, & Turner, 1996), as well as the mean
signals of cerebrospinal fluid and white matter. To prevent spurious
correlations due to head motion (Power et al., 2014; Power, Schlaggar, &
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Petersen, 2015), group-level correction for mean frame-wise displacement
(FD; Vinet & Zhedanov, 2010) was used as recommended by Yan et al.
(2013). Global signal was not regressed out, as this step has been shown
to lower test-retest reliability (Yan et al., 2013) and is known to increase
anti-correlations and distance-dependent artefacts (Jo et al., 2013), which
are problematic for network-based analyses. To ensure the robustness of
our findings, all analysis steps were repeated with motion correction at
individual-level instead of group-level, using spike regression to identify
time points with FD > 0.2 mm and modelling each time point and their 1
back and 2 forward neighbours as separate regressors (Vinet & Zhedanov,
2010; Power et al., 2014, see Fig. A.2, Appendix A). Functional scans
were checked for excessive head motion (FD >3 mm Power, Barnes,
Snyder, Schlaggar, & Petersen, 2012); no participants had to be excluded
(mean FD=0.12 mm; max FD=0.31 mm; no significant group difference,
p=.73).
An adapted version of the automated anatomical labelling (AAL)
atlas with 94 ROIs was used to define the network nodes (Tzourio-Mazoyer
et al., 2002). The nucleus accumbens (derived from the Harvard-Oxford
subcortical atlas; Desikan et al., 2006) was added for both hemispheres,
as this structure is of interest in AN research due to its involvement in
reward processes (Sesack & Grace, 2010). Further, the insular cortex was
divided into anterior and posterior parts, as it has been shown that the
two regions are associated with distinct brain functions and are involved
in dissociable resting-state networks (Cauda et al., 2011). Functional
segmentation of the insula in its anterior and posterior parts based on
rsfMRI data of an independent sample was performed in a previous study
of our group and is described in detail elsewhere (Baur, Hänggi, Langer,
& Jäncke, 2013).
The connectivity matrices calculated with DPARSFA captured the
strength of functional connectivity as Pearson correlation coefficients
between the time series of two nodes, standardised with Fisher’s r-to-Z-
transformation. To test whether the network of disrupted rsFC in AN
patients could be explained by local reductions in neuronal synchrony,
intra-nodal (regional) homogeneity within nodes was extracted for group
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comparisons. Regional homogeneity of intrinsic brain activity was calcu-
lated as Kendall’s coefficient of concordance of the time series of a given
voxel with those of its 26 nearest neighbouring voxels (Zang, Jiang, Lu,
He, & Tian, 2004).
6.3.5 Network-based analyses
The network-based statistic (NBS) tool (Zalesky, Fornito, & Bullmore,
2010) and MATLAB (version R2016a, http://www.mathworks.com/) were
used for the network analyses to test for altered connections. With the
AAL parcellation scheme of 94 ROIs, our network consisted of 4371 (94
× 93 / 2; as connections are undirected) possible connections (edges).
When testing each of these edges, NBS offers a non-parametric method
to control the family-wise error rate of the large number of comparisons.
Network-based statistics translates the basic principles of conventional
cluster-based thresholding of statistical parametric maps (Hayasaka &
Nichols, 2004; Nichols & Holmes, 2002) to a graph. In brief, it applies
a chosen sensitivity threshold to the test statistic calculated for each
edge. Existing interconnected structures above that threshold are thus
identified, before assigning a family-wise error corrected p-value to each of
these so-called components through permutation testing (Zalesky, Fornito,
& Bullmore, 2010).
Functional connectomes were compared cross-sectionally between
groups at TP1, as well as with a longitudinal interaction analysis, calcu-
lated for the factor group (AN / HC) and time point (TP1 / TP3; TP2
was not included into the interaction analysis as it was not assessed for
HC). To examine possible recovery processes within networks, the longit-
udinal analysis was first performed focusing on the component identified
at TP1. Second, to investigate potential differences emerging during
therapy, a whole-brain interaction analysis was performed independent
of the initial alterations at TP1. To elucidate differences between groups
at the end of treatment, we conducted group comparisons at TP3 for the
network initially altered (at TP1) as well as for the whole-brain.
Group comparisons were performed for both contrasts (AN < HC and
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AN > HC) and all analyses were done with the total number of connections
as measure of component size, controlled for multiple comparisons using
5’000 permutations at p < .05, as implemented in NBS. The primary
sensitivity threshold for the cross-sectional analysis at TP1 and TP3
was set to t=3.5, the threshold for the longitudinal interaction analysis
was set to F=0.5. As the sensitivity threshold for the analyses must be
determined in an explorative way, these thresholds were chosen striving
for a network of interpretable edge count. To demonstrate the robustness
of the network over a broader range of thresholds, additional results are
reported in the supplementary. For further analysis, the mean correlation
(functional connectivity) of the network was extracted and examined for
significant within-group changes over time, using t-tests for dependent
samples.
6.3.6 Psychometric assessment
Eating disorder psychopathology was assessed at all time points
with the validated German version of the Eating Disorder Examination
Questionnaire (EDE-Q; Hilbert & Tuschen-Caffier, 2006), comprising
four subscales to restrained eating, concerns regarding eating, shape,
and weight. Becks Depression Inventory (BDI; Hautzinger et al., 1994)
was used to quantify depressive symptoms and the Snaith-Hamilton
Pleasure Scale (SHAPS) was employed to measure anhedonia (Franz et al.,
1998). Intelligence was estimated using the following two scales: Viennese
Matrices Test (WMT) for fluid intelligence (Formann & Piswanger, 1979);
Vocabulary test (WST) for verbal intelligence (Schmidt & Metzler, 1992).
6.3.7 Additional statistical analyses
Demographic and psychometric measures were compared between
groups using t-tests for independent samples. Pearson correlations were
calculated to test associations between mean functional connectivity and
demographic or psychometric parameters, as well as between functional
connectivity and regional homogeneity measures. These tests were per-
formed using R (R Core Team, 2016) and IBM SPSS Statistics 23.0 (SPSS
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Inc, an IBM company, Armonk, NY). If not otherwise stated, two-tailed
p-values are reported.
6.4 Results
6.4.1 Demographic and psychometric measures
We observed no significant differences between patients and HC in
age, education, and intelligence (Table 6.1). In AN patients, the psycho-
pathology scores for eating disorder severity, anhedonia and depression
were significantly higher at baseline compared to HC. These differences
decreased over the course of therapy, but remained significant even at
the end of treatment (Table 6.1).
6.4.2 Functional connectivity in the phase of severe underweight
Whole-brain analyses of rsFC yielded a significant network of de-
creased functional connectivity in patients with AN compared to HC
(p=.018, corrected for multiple comparisons). The network comprised
20 edges distributed over 14 nodes in mainly fronto-basal ganglia/limbic
regions, including the anterior insula, fusiform gyrus, hippocampus, nuc-
leus caudatus, nucleus accumbens, putamen, as well as frontal areas
(Fig. 6.1 and Table A.1, Appendix A). Decreased rsFC of this network
was independent of age and education within the groups (ps > .18) and
independent of age of illness onset and duration of illness within the
patient group (ps > .31).
6.4.3 Weight dependent changes in rsFC over the course of treatment
The interaction analysis (group x time) of the network identified at
baseline showed a significant change of rsFC in 18 of the 20 edges over
time (p=.006, corrected). Follow-up analysis of the direction of change
revealed an increase in mean rsFC in the patient group, most notably
between TP1 and TP2 (mean difference=0.08, SD=0.11, t(16)=2.803,
p=.013, d=.95), indicating that the network identified to be altered in the
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Figure 6.1. Network of hypoconnectivity in AN compared to HC at
TP1. Network-based statistics were applied to compare whole-brain
functional connectivity between the groups. The network consists of 14
nodes (blue spheres, 7 per hemishpere) and 20 edges (dark grey lines)
that survived a statistical threshold (p=.05), corrected for multiple
comparisons using family-wise error correction. Left column (top to
bottom): Lateral and medial view of left hemisphere, anterior view.
Middle: Top and bottom view. Right column: Lateral and medial view
of right hemisphere, posterior view. AC=Accumbens; CAU=Caudate
nucleus; F1MO=Superior frontal gyrus, medial orbital; F2=Middle
frontal gyrus; F3T=Inferior frontal gyrus, triangular; FUSI=Fusiform
gyrus; HIP=Hippocampus; INA=Insula anterior; PUT=Putamen. Net-
work visualised using BrainNet Viewer (Xia, Wang, & He, 2013).
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acute phase at TP1 recovered at least partially with weight restoration.
Between TP2 and TP3, mean rsFC in AN remained largely unchanged
(mean difference=0.004, SD=0.11, t(16)=0.158, p=.88). Within the HC
group, a medium decrease in mean connectivity was significant (mean
difference=-0.05, SD=0.08, t(19)=-2.793, p=.012, d=-0.53).
Group comparison of the network affected at TP1 no longer reach
significance at TP3. Furthermore, a whole-brain comparison of groups
at TP3 did not reveal additional networks with altered connectivity.
However, a residual reduction of functional connectivity in AN patients
seems to remain even after weight restoration (BMI ≥ 17.5), as not
all edges significantly changed between TP1 and TP3 in the specific
interaction analysis and the mean level of rsFC did not reach the same
level as in HC (compare Fig. 6.2). Comparing both groups in a whole-
brain interaction analysis (group x time) yielded no significant network
components, suggesting that no significant additional group differences
occurred over the course of therapy.
6.4.4 Correlations with clinical and demographic parameters
To explore whether individual differences in eating disorder sympto-
matology would explain additional variance in connectivity, correlations
between the mean rsFC of the network and the EDE-Q (total score and
subscale for weight concerns) were calculated within groups for values at
TP1 and change scores between TP1 and TP2, as well as between TP2
and TP3. There were no significant relationships in either group with
respect to the total score. Within the patient group, increases in rsFC
were correlated with a significant reduction in weight concerns between
TP1 and TP2 (EDE-Q; Fig. 6.3A), this negative association did not
reach statistical significance in the second half of therapy between TP2
and TP3 (Fig. 6.3B).
6.4.5 Intra-nodal homogeneity
Groups comparisons of intra-nodal homogeneity showed no signi-
ficant differences between groups at TP1. Furthermore, exploratory
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Figure 6.2. Trajectory of functional connectivity (standardised with
Fisher’s r-to-Z-transformation) per group within the network identified
at TP1. Error bars represent 95 % within-subject confidence intervals
(Morey, 2008).
group comparisons of correlations between intra-nodal homogeneity and
inter-regional connectivity yielded no significant differences in correla-
tions, except for the left putamen (for further details see Table A.2,
Appendix A).
6.4.6 Medication effects
Six patients of the AN group were on psychotropic medication at
the time of scanning. As this might alter functional brain connectivity
(McCabe & Mishor, 2011; van Wingen et al., 2014), we compared mean
connectivity within the network at TP1 of patients with and without
medication. There were no differences between patients receiving medica-
tion (M=0.079, SD=0.080) and patients without medication (M=0.083,
SD=0.052; t(14)=0.13, p=.90), suggesting that group differences between
AN and HC were not driven by extreme values of medicated patients (see
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Figure 6.3. Correlations between changes in connectivity within the
network and changes in weight concern scores in patients with Anorexia
nervosa. A: time point 2 – time point 1; one-tailed comparison. B: time
point 3 – time point 2; one-tailed comparison. Confidence intervals of
the mean at 95 % are displayed in grey.
also Fig. A.4, Appendix A).
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6.5 Discussion
Using a longitudinal design with three time points, this is the first
study to examine rsFC in women with AN over the course of weight-
recovery therapy, compared to closely matched HC. At the initial phase
of treatment, rsFC was disrupted in a fronto-basal ganglia/limbic network
in patients with AN. More specifically, using network-based analysis we
observed reductions of rsFC, which were (partially) reversible with weight
normalisation during a multimodal inpatient treatment. Critically, the
extent of normalization of rsFC at the first half of the therapy correlated
with the extent of clinical amelioration.
Alterations of rsFC in AN have been previously reported in a num-
ber of cross-sectional resting-state studies using whole-brain approaches,
spanning samples in the acute stage (Ehrlich et al., 2015; Gaudio et al.,
2015; Geisler et al., 2016; Scaife et al., 2017) as well as samples recovered
from AN (Cowdrey et al., 2014; Scaife et al., 2017). The present longit-
udinal investigation of functional connectivity during weight gain for the
first time extends these findings by examining their evolution over the
course of treatment. Measurements of a homogeneous sample of adult AN
patients with similar age, undergoing the same standardised treatment,
were obtained at three time points to capture their dynamic over the
different stages of weight gain. With the design of our study it is for the
first time possible to examine trajectories of early vs. late normalisation
of rsFC during therapy.
rsfMRI is an established and reliable method to investigate brain
activation at rest (Shehzad et al., 2009). To take account for its known
sensitivity to natural fluctuations of anxiety during MRI scans (Dennis,
Gotlib, Thompson, & Thomason, 2011), measurements of the HC group
were collected at two time points. This allowed for a robust assessment of
rsFC over time in both groups, as state anxiety between first-time scans
and follow-up sessions has been found to decrease substantially due to
habituation (Chapman, Bernier, & Rusak, 2010). Another strength of
the present study is the use of a reliable data-driven analysis method
(Zalesky, Fornito, & Bullmore, 2010) examining the whole brain without
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a priori restrictions to specific brain regions.
6.5.1 Stage of severe underweight (TP1)
In the stage of severe underweight, our results suggest a distinctive
network of functional hypoconnectivity in AN. The almost symmetric
network comprised bilateral nodes of the basal ganglia (caudate nuc-
leus; putamen), the limbic system (hippocampus; nucleus accumbens),
the anterior insular cortex, unilateral frontal areas (left middle frontal
gyrus; left medial orbitofrontal cortex; right inferior frontal gyrus, pars
triangularis), and the right fusiform gyrus. Except for the left putamen,
the inter-regional network of disrupted connectivity was not explained
by reductions in intra-nodal signal homogeneity. This result is in line
with a previous study in which alterations in functional connectivity were
unrelated to local neuronal synchrony of AN patients (Ehrlich et al.,
2015).
The basal ganglia are not only highly interconnected but also project
to frontal regions and are chiefly involved in reward processes of the brain
(Sesack & Grace, 2010). Decreased connectivity among these regions in
AN may be in line with findings of altered dopaminergic neurotransmission
observed in the reward system of recovered AN patients (Bailer et al.,
2012; Frank et al., 2005). The basal ganglia are closely connected to the
identified limbic regions (Sesack & Grace, 2010), which play an important
role in reward-dependent decision making, as well as in higher mental
functions such as memory formation and habit-learning (Rolls, 2015).
Alterations in these regions are in accordance with a number of different
task-based studies in AN patients, implicating the mesolimbic reward
system as central to AN. A study on the perception of female bodies of
varying weight categories observed strong differences in brain activation
between AN patients and HC in the ventral striatum (Fladung et al.,
2010). Food-related tasks, using pictures (Cowdrey, Park, Harmer, &
McCabe, 2011) or sugar solution as stimuli (Frank & Kaye, 2012), have
reported markedly elevated activation in the nucleus accumbens as well as
the orbitofrontal cortex. Tasks with monetary reward observed aberrant
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striatal activation in acute (Decker, Figner, & Steinglass, 2015) and
recovered AN patients (Wagner et al., 2007).
Further nodes of the affected network were the anterior insular cor-
tex, critical for interoception (Adolfi et al., 2017), the fusiform gyrus,
associated with body recognition (Peelen & Downing, 2007), as well
as frontal regions, related to divers cognitive, affective, and volitional
brain functions. These results extend prior findings of cross-sectional
NBS studies, reporting networks of reduced connectivity in a sample of
adolescents and young adults affected by AN (Ehrlich et al., 2015; Lord
et al., 2016). Of note, using a similar parcellation scheme, there was
an overlap in nodes with our network in the left and right putamen as
well as the right fusiform gyrus. Contrasting our findings, Ehrlich et al.
(2015) found reduced connectivity of the left amygdala and thalamus,
and the posterior insula. These deviations are possibly due to the dif-
ferences in sample composition (e.g. a mixed sample of adolescents and
adults vs. adults only in our study), as processes of brain development
continue throughout adolescence and lead to substantial alterations in
brain measures (Semple, Blomgren, Gimlin, Ferriero, & Noble-Haeusslein,
2013). There are two other cross-sectional whole-brain rsFC studies with
adult samples, the most recently published used independent component
analysis and found decreased insular connectivity (anterior and posterior
parts were not differentiated) in AN patients (Scaife et al., 2017). The
other study by Kullmann et al. (2014), used degree centrality and ef-
fective connectivity as measures in a graph-theoretical analysis approach.
Their results suggested increased connectivity of the insula (anterior and
posterior parts were not differentiated) to the inferior frontal gyrus and
decreased connectivity from the orbitofrontal gyrus to the inferior frontal
gyrus, as well as decreased connectivity from the inferior frontal gyrus to
the midcingulate cortex (Kullmann et al., 2014), underlining the potential
importance of the connectivity between these regions in the pathomechan-
isms of AN. Given the known involvements of the nodes identified in our
study, these regions form a network of reduced connectivity in AN that
might underlie symptoms central to AN, such as a dissatisfaction with
body and body weight, a desire to fast, and avoidance of food despite
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low body weight (APA, 2013).
6.5.2 Stages of weight restoration (TP2 and TP3)
Over the course of weight restoration, connectivity within the weakened
network of AN patients normalised at least partially. Notably, this in-
crease happened mainly within the first half of treatment (1-10 weeks
after TP1) during an improvement of eating disorder severity from severe
to moderate (estimated by BMI: APA, 2013). Furthermore, recovery
of connectivity during this period was predictive of ameliorated eating
disorder symptomatology, as expressed by a reduction of weight concerns
(EDE-Q). Weight restoration during the second half of treatment (11-20
weeks after TP1) seemed to have a lesser influence on connectivity as there
was no substantial increase in mean connectivity of the network. The lack
of connectivity changes was paralleled by a diminished improvement of
weight concerns, suggesting that the initial phase of therapy might be of
particular importance to successful recovery processes. Group comparis-
ons at the end of treatment no longer revealed any differences, indicating
an effective treatment and reversibility of the initial brain alterations.
However, as the mean connectivity was still slightly weaker in the AN
group, subthreshold alterations cannot be ruled out. Indeed, when using
a more liberal significance level (p=.10, corrected), there were still edges
of reduced connectivity (see Fig. A.1, Appendix A). The hypothesis of
residual brain alterations is further supported by the elevated scores of
eating disorder pathology at the end of inpatient therapy and points to
the importance of continued treatment in an outpatient setting. Whether
the potential residuals of brain alterations represent ‘neural scars’ or
whether they are reversible with a continued treatment and a prolonged
weight stabilisation remains to be investigated.
6.5.3 Limitations
There are some limitations to the present study. There is no consensus
regarding an accepted method to find the optimal test statistic threshold
in NBS for a given data set (Zalesky, Fornito, Harding, et al., 2010).
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Thus, the set thresholds were arbitrarily chosen and the results are
not independent of the distinct primary threshold. However, as the
core of initial network remained intact over threshold changes of ± 0.5,
we are confident that the chosen threshold did not selectively shape
the composition of the identified network (for results see Fig. A.3,
Appendix A).
Studies have shown that the degree of brain parcellation used to
calculate the connectivity matrices influences the identified networks
(Lord et al., 2016; Zalesky, Fornito, Harding, et al., 2010). The current
results thus might be contingent on the implemented parcellation scheme.
However, the anatomical atlas was chosen because of its wide usage in
the field (e.g. Bomba et al., 2015; Friederich et al., 2012; Zalesky, Fornito,
Harding, et al., 2010) to enable comparisons with other studies and
variability between different parcellation schemes is rather small with
respect to the subcortical structures such as the putamen and the caudate
nucleus, important nodes in the present study.
The longitudinal design of the current study led to a relatively small
number of patients being eligible for participation due to insufficient
weight gain. Although our results are highly significant and fit the
established literature, future studies using data-driven approaches should
replicate the findings with larger sample sizes to further investigate
group differences after weight restoration and to gain further insight into
subsequent neurobiological damage after weight recovery.
6.5.4 Conclusion
This is the first longitudinal study to demonstrate the functional
connectivity reduction in a fronto-basal ganglia/limbic network and its
recovery in adult patients with severe AN who gained weight during
treatment. Interdisciplinary multimodal inpatient treatment has the po-
tential to elicit normalisation processes in a distinct network of weakened
connectivity that are accompanied by improvements of eating disorder
symptoms. These findings support the reversibility of disrupted functional
connectivity during weight restoration therapy.
90 Chapter 6 Empirical Work - Study II
6.6 Acknowledgements
We thank all patients and controls for participating and all members
of the research team for their assistance, notably A. Koller, S. Seele, and
C. Sob for their help with data acquisition. We thank H. Baetschmann
for providing MATLAB scripts supporting the network-based statistic
(NBS) tool. Further, we gratefully acknowledge the financial support
of this work from the Swiss Anorexia Nervosa Foundation (project no.
19-12), the Gottfried and Julia Bangerter-Rhyner-Foundation, and the
Parrotia Foundation.
CHAPTER 7
Empirical Work - Study III: Fornix under water? Ventricular
enlargement biases forniceal diffusion MRI indices in anorexia
nervosa
Lisa-Katrin Kaufmann1,2,3,S, Volker Baur1,S, Jürgen Hänggi2, Lutz Jäncke2,4,5,
Marco Piccirelli6, Spyros Kollias6, Ulrich Schnyder1, Ofer Pasternak7,
Chantal Martin-Soelch3, Gabriella Milos1
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
doi:10.1016/j.bpsc.2017.03.014
S equal author contribution
1 Department of Psychiatry and Psychotherapy, University Hospital Zurich,
Zurich, Switzerland
2 Division of Neuropsychology, Department of Psychology, University of Zurich,
Zurich, Switzerland
3 Unit of Clinical and Health Psychology, Department of Psychology, Univer-
sity of Fribourg, Fribourg, Switzerland
4 International Normal Aging and Plasticity Imaging Center (INAPIC), Uni-
versity of Zurich, Zurich, Switzerland
5 University Research Priority Program (URPP), Dynamic of Healthy Aging,
University of Zurich, Zurich, Switzerland
6 Department of Neuroradiology, University Hospital Zurich, Switzerland
7 Departments of Psychiatry and Radiology, Brigham and Women’s Hospital
Department of Psychiatry, Harvard Medical School, Boston, MA, USA
91
92 Chapter 7 Empirical Work - Study III
7.1 Abstract
Background: Acute anorexia nervosa (AN) is characterized by re-
duced brain mass and corresponding increased sulcal and ventricular
cerebrospinal fluid (CSF). Recent studies of white matter (WM) using
diffusion tensor imaging (DTI) consistently identified alterations in the
fornix, such as reduced fractional anisotropy (FA). However, because the
fornix penetrates the ventricles, it is prone to CSF-induced partial volume
effects that interfere with a valid assessment of FA. Here, we investigated
the hypothesis that in the acute stage of AN, FA of the fornix is markedly
affected by ventricular volumes.
Methods: First, using DTI data we established the inverse associations
between forniceal FA and volumes of the third and lateral ventricles in
a pre-study with 32 healthy subjects to demonstrate the strength of
ventricular influence on forniceal FA independent of AN. Second, we
investigated a sample of 25 acute AN patients and 25 healthy controls.
Results: Using ventricular volumes as covariates markedly reduced
the group effect of forniceal FA, even with tract-based spatial statistics
focusing only on the centre of the fornix. Further, after correcting for
free-water on voxel-level, the group differences in forniceal FA between
AN patients and controls disappeared completely.
Conclusion: It is unlikely that microstructural changes affecting FA
occurred in the fornix of AN patients. Previously identified alterations
in acute AN may have been biased by partial volume effects and the
proposed central role of this structure in the pathophysiology may need
to be reconsidered. Future studies on WM alterations in AN should
carefully deal with partial volume effects.
7.2 Introduction 93
7.2 Introduction
Anorexia nervosa (AN) is a serious and potentially life-threatening
mental illness, often with poor long-term outcomes (Berkman, Lohr, &
Bulik, 2007; Papadopoulos et al., 2009). Despite various efforts to identify
the underlying causes and pathomechanisms of AN (Polivy & Herman,
2002), the current understanding of this condition remains unsatisfactory.
Acute AN is characterized by reduced brain mass and corresponding
increased cerebrospinal fluid (CSF) in the sulci and ventricles (Seitz et al.,
2014; Titova et al., 2013). Recent neuroimaging studies have investigated
regional white matter (WM) alterations in AN using diffusion-tensor
imaging (DTI) (Moseley et al., 1990). The most common DTI derived
measure is fractional anisotropy (FA) (Chenevert, Brunberg, & Pipe,
1990), which measures the directionality of water diffusion, and is thought
to be affected by WM structural properties such as axonal integrity
and fibre coherence. Five DTI studies on acute AN were published to
date, all of which have reported alterations of diffusion parameters in
the fornix, both in adult (Hayes et al., 2015; Kazlouski et al., 2011;
Nagahara et al., 2014; Via et al., 2014) and adolescent patients with AN
(Frank, Shott, Hagman, & Yang, 2013). In a recent review (Frank, 2015),
fornix alterations have thus been suggested to play a central role in the
pathophysiology of AN and, because of comparable alterations in bulimia
nervosa, in eating disorders in general.
The fornix is part of the limbic system connecting the mammillary
bodies with the hippocampi in two C-shaped bundles of WM fibres.
Joined in the middle, its body runs above the third ventricle, parting into
the fornix crus in its posterior segment where it is enclosed by the lateral
ventricles (Fig. 7.1). Due to its position between the CSF-filled ventricles,
the diffusion indices of the fornix are severely susceptible to bias by partial
volume effects (PVE) (Concha, Livy, Beaulieu, Wheatley, & Gross, 2010;
Jones & Cercignani, 2010; Pasternak, Sochen, Gur, Intrator, & Assaf,
2009). PVE occur when voxels contain heterogeneous tissue types, which
in the case of the fornix are WM tissue and CSF. A larger amount of
CSF within a voxel means greater liberty for molecules to move in all
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directions, hence lesser anisotropy. Subsequently, PVE will result in an
underestimation of FA (Alexander, Hasan, Lazar, Tsuruda, & Parker,
2001).
A                                                P
Figure 7.1. Location of the fornix (red) surrounded by lateral ventricles
(dark blue) and third ventricle (light blue) in sagittal view. A=anterior,
P=posterior.
Given (i) the proneness of forniceal diffusion indices for PVE and (ii)
the increased volume of CSF-filled ventricles in acute AN (Seitz et al.,
2014; Titova et al., 2013), the consistently reported fornix alterations in
acute AN warrant further investigation. It is of note that studies with
recovered AN patients (Frieling et al., 2012; Yau et al., 2013), where CSF
volumes largely returns to normal values, did not indicate alterations in
forniceal diffusivity metrics (Wagner et al., 2006). Furthermore, studies
investigating samples with ventricular volume increase due to other factors
like ageing processes (Metzler-Baddeley, O’Sullivan, Bells, Pasternak, &
Jones, 2012) demonstrated an increase of CSF contamination in forniceal
diffusivity measures. This underlines the importance of considering biases
in PVE-prone samples such as patients with acute AN.
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Tissue volume and shape can modulate PVE (Vos, Jones, Viergever,
& Leemans, 2011). Modern neuroimaging data analysis pipelines like
FreeSurfer (surfer.nmr.mgh.harvard.edu) allow volumetric assessment
of CSF-filled spaces with a high regional specificity, which thus could
facilitate a proxy measure of the extent to which ventricular volumes
influence adjacent WM. However, the relation between ventricular volumes
and fornix FA has not been established so far. To support the hypothesis
that increased volumes of the third and lateral ventricles are influencing
PVE in the fornix, we first examined the association between these
volumes and forniceal FA in an independent sample of healthy subjects.
This was followed by the main analysis of acute AN patients and age-
matched healthy controls. Here we first considered ventricular volumes
as covariates to control for the increased CSF in AN patients. However,
the relationship between ventricular volumes and PVE might not be
captured best in a linear relationship (Metzler-Baddeley et al., 2012).
To account for a possibly irregular association and to acknowledge the
potential co-occurrence of increased ventricular volume and decreased
WM integrity we further removed PVE in a second step by employing a
free-water elimination approach (Pasternak et al., 2009), modelling and
removing the amount of PVE from the diffusion tensor at voxel level. We
hypothesized that a putative group difference (i.e., aberrant forniceal FA
in AN) depends on ventricular volumes, so that previously found effects
in the fornix might be, to some extent, biased by PVE and do not entirely
represent a "true" group difference.
7.3 Methods and materials
7.3.1 Participants (pre-study)
To examine the influence of PVE independent of AN, we first examined
the relationship between ventricular volumes and forniceal FA in a pre-
study with healthy subjects of similar age as the samples of the main
study. Thirty-four healthy subjects free of neurological and psychiatric
disorders were recruited. Two subjects had to be excluded due to aberrant
volumes of the third and lateral ventricles (> 3× interquartile range),
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so the final sample consisted of n=32 subjects (17 females, 15 males;
mean ± standard deviation, (SD) age: 25.06 ± 4.56 years). Details of
subjects’ recruitment have been reported elsewhere (Baur, Hänggi, &
Jäncke, 2012).
7.3.2 Participants (main-study)
Twenty-six women diagnosed with AN were recruited from the inpa-
tient unit of the Center for Eating Disorders, Department of Psychiatry
and Psychotherapy, University Hospital Zurich, Switzerland. Inclusion
criteria were a minimum duration of illness of one year and a body-
mass-index (BMI) ≤ 15.5. To avoid effects of acute malnutrition and
dehydration, patients were recruited after a hospitalisation time of 2
weeks with a fixed meal plan and extensive somatic checks. A trained
neurologist checked the anatomical images for possible anomalies. One
patient had to be excluded due to temporal lobe abnormalities (arachnoid
cyst) and atrophy beyond the normal range. Thus, the final sample
consisted of n=25 patients with AN, eleven of which (40.74 %) were
taking psychotropic medication (serotonergic and/or noradrenergic anti-
depressants: 5, atypical antipsychotics: 3, both: 3). Separately from the
pre-study sample, healthy control women (HC; n=25) were recruited via
notice boards and mailing lists. None of the controls had current or past
psychiatric disorders.
Additional exclusion criteria for both groups were: current or past
neurological disorders, substance abuse or addiction, as well as con-
traindications to MRI. To evaluate general and eating disorder-specific
psychopathology, all participants were assessed using the German versions
of the Structured Clinical Interview for DSM-IV (SCID; Wittchen et al.,
1997) and the eating disorder inventory (EDI-2; Paul & Thiel, 2005).
Fluid IQ was measured using the Vienesse Matrices Test, verbal IQ was
assessed with the Multiple Choice Vocabulary Test (WST; Schmidt &
Metzler, 1992). Groups were matched for age and IQ (see Table 7.1).
All participants were right handed, except for one AN and one HC sub-
ject who were left handed, as measured with the Edinburgh Handedness
Inventory short form (Veale, 2014). Further group characteristics are
7.3 Methods and materials 97
summarized in Table 7.1. The study was approved by the ethics commit-
tee of the Canton of Zurich, Switzerland. Written informed consent was
obtained from all participants prior to study enrolment.
Table 7.1
Group characteristics of main study sample
Group
AN HC
n = 25 n = 25
M SD M SD t p
Age 22.84 4.75 23.36 3.35 −1.0 .66
Age of illness onset 16.04 2.63
Duration of illness 6.8 4.92
BMI 13.83 1.33 21.07 1.93 −15.35 <.001
Heart rate 56.59 9.03 64.63 10.14 −2.96 .005
EDI-2 total 224.52 44.53 147.46 34.36 6.66 <.001
WMT 122.75 20.22 126.12 15.57 −0.66 .52
WST 102.79 10.16 105.72 11.53 −0.94 .35
Notes. Groups were compared with two-tailed t-tests. Age, age of illness onset,
and duration in years; BMI = body mass index; Heart rate recorded during
DTI sequence (beats per minute); EDI-2 = Eating Disorder Inventory-2; WMT
= Viennese Matrices Test; WST = Multiple Choice Vocabulary Test.
7.3.3 MRI data acquisition and pre-processing (pre-study)
For data acquisition, a 3 Tesla whole-body magnetic resonance ima-
ging (MRI) system (Ingenia, Philips, Best, The Netherlands) was used,
equipped with a 15-channel head coil. One high-resolution T1-weighted
scan (voxel size: 0.94 x 0.94 x 1 mm3) and one diffusion-weighted (DTI)
data set (voxel size: 2 x 2 x 2 mm3, 64 diffusion-weighted gradients with
a b-value of 1000 s/mm2, one non-diffusion-weighted b0 reference volume)
per subject were obtained. Preprocessing was performed with FMRIB
Software Library (FSL) Version 4.1.8 (www.fmrib.ox.ac.uk/fsl). Further
details have been described elsewhere (Baur et al., 2012).
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7.3.4 MRI data acquisition and pre-processing (main study)
For data acquisition, a 3 Tesla whole-body magnetic resonance ima-
ging (MRI) system (Ingenia, Philips, Best, The Netherlands) was used,
equipped with a 32-channel head coil. One high-resolution 3D T1-
weighted scan (voxel size: 1 x 1 x 1 mm3) and one DTI data set (voxel
size: 2 x 2 x 2 mm3, 64 diffusion-weighted gradients with a b-value of
1000 s/mm2, one non-diffusion-weighted b0 reference volume, echo time
(TE): 90 ms, repetition time (TR): 9.8 s, SENSE factor 2 (Pruessmann
et al., 1999), EPI factor 55 (Mansfield, 1977)) per subject were obtained.
In addition, a T1-weighted fast-field echo sequence was used to map the
B0 field in order to correct the DTI data for echo planar imaging related
geometrical distortions (Jones & Cercignani, 2010, ; see Appendix B for
further details). During DTI acquisition, the heart rate was concurrently
recorded at 500 Hz using an MRI compatible electrocardiograph (InVivo
International, Best, The Netherlands). The scanner software automatic-
ally detected the maximum of the cardiac signal (R-peak) and registered
their occurrences in a logfile.
T1-weighted images were processed with the FreeSurfer software suite
version 5.3 (surfer.nmr.mgh.harvard.edu). FreeSurfer offers an automated
analysis procedure which has been used widely and its processing steps
have been described in detail elsewhere (e.g. Dale et al., 1999). In
brief, FreeSurfer segments the individual raw T1-weighted image into
different tissue classes, based on intensity values of each voxel and a priori
information of anatomical atlases in stereotactic space. Data quality
and processed images were checked using the FreeSurfer QA tools 1.1
(surfer.nmr.mgh.harvard.edu/fswiki/QATools). For the present study,
volumes of interest from the FreeSurfer “aseg” analysis stream (Fischl et
al., 2002) were: total GM, total WM, total CSF, total intra-cranial (ICV),
third ventricle, and left and right lateral ventricle volume. Volumes of the
inferior lateral ventricles were left out, since these are anatomically too
distant to influence forniceal diffusion measures. Furthermore, volumes of
the lateral ventricles were summed up to obtain a single value, as we did
not expect hemispheric differences. At the individual level, ventricular
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volumes were normalized by dividing by total ICV. DTI volumes were
(pre-)processed with scripts and tools of the FMRIB Software Library
5.0 (FSL; fsl.fmrib.ox.ac.uk/fsl/fslwiki; Jenkinson, Beckmann, Behrens,
Woolrich, & Smith, 2012). This comprised brain extraction (Jenkinson,
Pechaud, & Smith, 2005), eddy current (eddy_correct) and head move-
ment correction, implicit adjustment of diffusion directions according
to the head movement correction parameters using FMRIB’s Diffusion
Toolbox (FDT; Behrens et al., 2003), unwarping geometrical distortions
due to magnetic field inhomogeneities using the B0 map and FSL’s fugue
tool (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/fugue), and voxel-wise fitting
of diffusion tensors along with the computation of FA using FDT.
To explicitly model the potential influence of head movement onto
diffusion parameters, we separately ran the image quality assessment
step of the TRACULA (TRActs Constrained by UnderLying Anatomy)
stream embedded into FreeSurfer (Yendiki, 2011). TRACULA is a tool for
automated probabilistic reconstruction of major white-matter pathways
from DTI images, whose processing stream allows the extraction of motion
parameters (i.e. translation, rotation, proportion of slices with drop-out,
drop-out score) (Yendiki, Koldewyn, Kakunoori, Kanwisher, & Fischl,
2014). There were no group differences in movement during DTI as
indicated by the four motion parameters (all p >.13).
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7.3.5 Free-water correction, spatial normalisation / skeletonisation of
diffusivity maps and of fornix a priori masks (pre- and main study)
To compute the free-water corrected FA maps, a bi-tensor model was
fitted to the diffusion data as described in Pasternak et al. (2009). In
brief, the attenuated signal is modelled by two compartments on a voxel-
level: a tissue compartment and an isotropic free-water compartment,
incorporating the diffusivity of water at body temperature (3 x 10-3
mm2/s). The free-water compartment accounts for any contribution of
CSF. The tissue compartment is then used for further analysis, allowing
for a PVE free evaluation of diffusivity measures. This model-based
approach overcomes the drawbacks of acquisition based PVE elimination
techniques, such as low signal-to-noise ratio and prolonged acquisition
time in fluid-attenuated inversion recovery (Cheng, Chung, Chen, &
Chou, 2011; Papadakis et al., 2002). It has been used previously to
improve the sensitivity of the resulted DTI measures in a number of
studies (Bergamino, Pasternak, Farmer, Shenton, & Paul Hamilton,
2016; Metzler-Baddeley, Baddeley, Jones, Aggleton, & O’Sullivan, 2013;
Metzler-Baddeley et al., 2012; Steventon, Trueman, Rosser, & Jones,
2016). The uncorrected FA maps were estimated following an identical
preprocssing pipeline as the free-water corrected FA maps, with tensors
estimated using the least squares method. Both, uncorrected and free-
water corrected FA maps were further processed with FSL scripts for
tract-based spatial statistics (TBSS) (Smith et al., 2006). This comprised:
1) optimisation of image quality (tbss_1_preproc) and visual inspection of
images, 2) non-linear registration onto the FMRIB58_FA high-resolution
(1 x 1 x 1 mm3) template in standard-space (MNI), 3) creation of mean
FA image across all subjects, and creation of skeletonised FA maps of
uncorrected maps, 4) representing the centres of WM tracts, including
only those voxels with FA > 0.2 (Smith et al., 2006).
The a priori mask of the fornix was derived from the probabil-
ity map of the Juelich histological atlas embedded into FSL viewer
(fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases) (Eickhoff et al., 2005). A threshold
of 20 % probability of belonging to the fornix was applied to each voxel,
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before creating the final binarised mask (denoted “fornixbroad”). Ad-
ditionally, for the analysis of WM centres the binary fornix mask was
multiplied (logical AND) with the binary skeleton mask image derived
from TBSS (see above), resulting in a new mask image covering a small
section of the skeleton within the fornix (denoted “fornixcentre”). For
fornixbroad the same mask was used for the participants of both studies,
whereas the fornixcentre mask was adapted to the study specific skeletons,
thus, different masks were used for pre- and main-study. To ensure proper
alignment of the masks with the fornix location, visual inspection was
performed and revealed a good fit of the masks for all participants.
7.3.6 Statistical analysis (pre-study)
Mask-based mean values of FA maps (both for fornixbroad and
fornixcentre) were extracted per subject using fslstats as part of FSL.
To examine associations with ventricular volumes, these FA values were
subjected to partial correlation analyses, using age and sex as covariates
of no interest (SPSS® version 23, IBM® SPSS Statistics Inc., Armonk,
NY).
7.3.7 Statistical analysis (main study)
To assess group differences in global brain anatomical measures and
ventricular volumes, we applied five analyses of covariance (ANCOVA)
with age as covariate of no interest, correcting for multiple comparisons
using a false discovery rate correction (Benjamini & Hochberg, 1995;
Yekutieli & Benjamini, 1999). Next, we focused according to our hypo-
thesis on the fornix and extracted mask-based forniceal mean FA values
per subject (for fornixbroad as well as for fornixcentre) per subject using
fslstats within FSL. To gain deeper insight into between-group differences
with respect to diffusivity measures and to statistically control for covari-
ates, these values were subjected to ANCOVAs. For mean FA values of
fornixbroad and fornixcentre two separate analyses were performed, with
age, mean heart rate, and the four head motion parameters as covariates
of no interest (Yendiki et al., 2014). Similar analyses were done with
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regard to radial and axial diffusivity (results shown in Supplementary
material). Lastly, the enlarged ventricles of AN patients were considered.
First, to determine whether ventricular size can be used to sufficiently
account for the impact of increased CSF in AN, volumes of third and
lateral ventricles were added as additional covariates to the group compar-
isons. Second, the ANCOVAs described above were conducted without
ventricular volumes as covariates, using free-water corrected values of
fornixbroad and fornixcentre. All group comparisons were calculated using
SPSS® (version 23, IBM® SPSS Statistics Inc., Armonk, NY).
7.4 Results
7.4.1 Pre-study
The volume of the third ventricle and the volume of the lateral vent-
ricles negatively correlated with uncorrected mean FA of fornixbroad, as
well as fornixcentre (Fig. 7.2). These results establish a direct quantitat-
ive link between ventricular volumes and fornix FA independent of AN.
Forniceal FA means and standard deviations of the pre-study sample are
presented in Appendix B.
7.4.2 Main study
7.4.2.1 Volumetric and heart rate group differences
Table 7.2 summarizes the values of heart rate, ventricular and whole-
brain tissue volumes, including group comparisons. As expected, patients
with AN showed significantly enlarged ventricles compared to HC, along
with increased CSF and reduced GM.
7.4.2.2 Group comparison of FA
Reproducing previously reported differences in forniceal FA, AN-
COVAs with uncorrected values of fornixbroad confirmed the significant
reduction in AN patients (Table 7.3). To gain new insight, the main
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Figure 7.2. Pearson correlations between Z-scores of (A) lateral and
(B) third ventricle volumes with Z-scores of fractional anisotropy (FA)
of the fornix in an independent healthy sample (n=32), controlled for
sex and age. Strong negative correlations with ventricular volumes can
be observed for both fornixbroad and fornixcentre.
goal of the current study was to consider the effect of increased ventricu-
lar CSF of AN patients on the analysis. We thus added volumes of
the third and the lateral ventricles as covariates to the group comparis-
ons. Incorporating ventricular CSF reduced the variance explained by
group (FAbroad, F [1, 40]=4.67, p=.04, 𝜂p2=0.11; FAcentre, F [1, 40]=4.37,
p=.04, 𝜂p2=0.10) , indicating a strong influence of ventricular volumes
on FA values. Nevertheless, the group differences remained statistically
significant.
As ventricular volume might be an incomplete measure of PVE, we
further sought to control for the influence of CSF by correcting for free-
water (Pasternak et al., 2009) to prevent residual confounding. Using
the free-water corrected FA values, group comparisons no longer showed
differences between patients and controls (Table 7.3), pointing out the
strong bias of PVE in the uncorrected results reported above (Fig. 7.3).
Additional group comparisons for radial and axial diffusivity are reported
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Table 7.2
Comparison of ventricular and whole-brain tissue volumes between
patients with anorexia nervosa (AN) and controls (HC)
Group
AN HC
n = 25 n = 25
M SD M SD F p
Third ventricle 1.21 0.31 0.8 0.14 33.29 <.001
Lateral ventricles 19.54 9.54 10.73 3.94 21.96 <.001
Grey matter 582.05 50.64 640.82 38.70 6.74 .016
White matter 435.35 55.53 453.31 55.71 0.03 .861
CSF total 24.48 10.05 14.76 4.26 24.72 <.001
Note. Means represent absolute volumes (cm3); statistics were calculated
correcting for intracranial volume, controlling for age. F is the F-statistic and
p the associated probability, false discovery rate corrected.
Table 7.3
Comparison of forniceal FA between patients with anorexia nervosa
(AN) and controls (HC)
Group
AN HC
n = 25 n = 25
Mask Measure M SD M SD F 𝜂p2 p
fornixbroad FA uncorrected .24 .024 .28 .020 43.25 .53 <.0001
FA corrected .35 .018 .36 .018 0.82 .02 .37
fornixcentre FA uncorrected .31 .033 .37 .031 31.35 .45 <.0001
FA corrected .44 .041 .43 .026 1.64 .04 .21
Note. Group comparisons were calculated correcting for age, mean heart rate,
and the four head motion parameters. Fornixbroad: values were derived using
a traditional approach comprising the fornix in its natural shape; fornixcentre:
values were derived from the tract centre.
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in the Appendix B (Table B.2).
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Figure 7.3. Scatter plots of fractional anisotropy (FA) with sample
means and 95 % confidence intervals for each group, per-subject. Signi-
ficant group differences of uncorrected values of (A) fornixbroad and (B)
fornixcentre (blue dots) both disappeared after correcting for free-water
(red dots). *p <.001.
7.5 Discussion
This study investigated the influence of ventricular enlargement on
diffusion properties of the fornix in acute AN. We found that increased
volumes of the third and lateral ventricles present in AN, i.e., significantly
augmented PVE in the nearby fornix, interfere with a valid assessment of
forniceal diffusivity measures. Specifically, after appropriately correcting
FA maps for free-water (Pasternak et al., 2009), the reduction of FA in
AN patients as compared to HC was no longer observable.
PVE in the fornix, due to its anatomical position surrounded by the
third and lateral ventricles, rely on a large body of empirical evidence
(Concha, Gross, & Beaulieu, 2005; Hoy, Kecskemeti, & Alexander, 2015;
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Jones & Cercignani, 2010). In the pre-study, we found that ventricular
volumes correlated with reductions of forniceal FA in an independent
sample of 32 healthy subjects, irrespective of the participants’ age or sex.
This has, to the best of our knowledge, not been demonstrated before
and gave a basis to our analyses of data from AN patients and their HC.
In the main study, we first replicated the reduction of GM and corres-
pondingly increased CSF in acute AN. Further, we replicated reduced FA
of the fornix (Frank, Shott, Hagman, & Yang, 2013; Hayes et al., 2015;
Kazlouski et al., 2011; Nagahara et al., 2014; Via et al., 2014), which has
been suggested as anatomical representation of pathological emotional
and motivational processes in recent AN research (Frank, 2015). Next,
as the central goal of the present study, we sought to establish evidence
for PVE in AN. The strong reduction of the group effect after including
ventricular volumes as covariates supported this hypothesis. To prevent
residual confounding, we further corrected FA maps for free-water with an
established bi-tensor model (Pasternak et al., 2009), improving diffusion
tensor estimates of conventional DTI images post-hoc by accounting for
the fraction of CSF within a voxel. Remarkably, now groups no longer
differed in their forniceal FA values and substantial increases in radial and
axial diffusivity diminished to slight reductions compared to HC. This
normalisation of diffusion indices in the AN group after correcting for
free-water suggests that, contrary to previous assumptions, it is unlikely
that considerable microstructural changes occur in the fornix of AN pa-
tients. The finding of reduced radial diffusivity found here in the centre
of the fornix aligns with previously reported reduced radial diffusivity in
wide-spread WM regions in AN (albeit adolescent) (Vogel et al., 2016).
Of note, CSF influenced even the TBSS-based FA values, i.e. values
extracted only from the tract centre. TBSS is considered to achieve higher
sensitivity for real effects compared to simple approaches (Smith et al.,
2006) because of its robustness to ambiguous sites in the tract’s periphery,
where PVE-related influences should be strongest. However, for such a
slim structure like the fornix, it seems that even TBSS cannot shield from
PVE. Further, the analyses with free-water corrected FA pointed out
the constraints of using ventricular volumes to account for PVE. While
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strong correlations between CSF space and FA measures may serve as a
good indicator of PVE, using ventricular volumes as covariate does not
countervail sufficiently against the complex and potentially non-linear
distortion effects of free-water.
From a methodological perspective, AN can serve as a model for
increased probability of PVE caused by ventricular enlargement. Broad-
ening this framework, our results point out two additional aspects: First,
not only the fornix may be affected, but any site in WM located near
CSF. For example, one recent study on AN patients (Frieling et al., 2012)
identified reduced FA in the mediodorsal thalamus, positioned adjacent
to the third ventricle, and in the posterior thalamic radiation, located
near the lateral ventricles. Second, building on previous research that
established the fornix as a PVE-prone structure (Concha et al., 2005; Hoy
et al., 2015; Jones & Cercignani, 2010), the present results underline the
importance to disentangle spurious from actual alterations of the fornix;
a finding that is relevant for studies beyond AN and could apply to any
condition characterized by increased CSF space. For example, findings in
bulimic and obese patients’ (Mettler, Shott, Pryor, Yang, & Frank, 2013;
Stanek et al., 2011) may be similarly affected by PVE as these conditions
have also been associated with increased CSF (Janowitz et al., 2015; Kaye,
2008). Moreover, the fornix has been implicated in the pathophysiology
of various other disorders (Thomas, Koumellis, & Dineen, 2011) including
schizophrenia (Fitzsimmons et al., 2009), a psychiatric condition also
characterized by enlarged ventricles (Chua et al., 2007).
Alterations of forniceal fibre integrity with consideration of free-water
have been reported in samples of healthy elderly participants (Metzler-
Baddeley et al., 2012) as well as in a prodromal form of Alzheimer’s
disease (Berlot, Metzler-Baddeley, Jones, & O’Sullivan, 2014), where
age or cognitive impairment were associated with reductions of forniceal
FA. Suspected processes for this microstructural degeneration are age-
related neuronal loss and subsequent degradation of axons (Wallerian
degeneration) as well as myelin breakdown due to vascular changes (Lee
et al., 2012). These processes induce irreversible changes in WM, this
is likely not the case in AN, where no fornix alterations were observed
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in weight restored patients and even the initially increased CSF seems
to return to normal levels after a recovery period (Unsworth, Wells,
Browning, Thomas, & Kendig, 2007). This being said, the fornix should
still be in focus of research to further clarify its putative role in the
pathophysiology of eating disorders as its microstructural properties have
been validly associated with BMI (Metzler-Baddeley et al., 2013).
7.5.1 Limitations
This study should be seen in light of the following limitations. First,
as DTI is sensitive to motion, cardiac pulsation can influence diffusion
estimates (Skare & Andersson, 2001). Cardiac gating can counteract these
influences by restricting acquisition to the diastole, i.e. the quiet portion
of the cardiac cycle. Considering the prolonged acquisition time, cardiac
gating was not employed in our study and a general overestimation of
FA in both groups cannot be precluded. However, since the this study
focuses on group comparisons and the same non-gated acquisition was
used for both groups, the impact of the cardiac cycle should be negligible
(Habib, Auer, & Morgan, 2010). Furthermore, all group comparisons
were corrected for individual mean heart rates thus the reported group
differences are not attributable to cardiac changes.
Second, the sample size is only moderate. Although the successful
replication of group differences in the uncorrected FA values suggests a
sufficiently large number of participants, it is still possible that minor
differences between groups in free-water corrected values were not detected
due to a lack of power and replication of our findings with a larger study
sample is desirable.
Third, we used single-shell rather than multi-shell acquisition to
keep acquisition time to a minimum. Single-shell acquired data are
comparable to multi-shell acquisitions, however, multi-shell might have
provided results that are even more accurate (Pasternak, Shenton, &
Westin, 2012) and would have allowed for a closer examination of neurite
morphology (Zhang, Schneider, Wheeler-Kingshott, & Alexander, 2012).
Likewise, constrained spherical deconvolution, which seems to be more
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robust against CSF-induced PVE (Roine et al., 2014), was not applied in
the present study.
Fourth, despite TBSS being state of the art, there are some shortcom-
ings of this analysis method that might affect fornix alignment (Bach et
al., 2014). However, to meticulously check individual skeleton positioning
visual inspection was performed and did not reveal any misalignments.
Finally, diffusion weighted images provide an indirect measure of
potential pathological alterations of underlying structures. More direct
examinations of the fornix, such as post mortem histological studies, are
needed to confirm the present findings on a histological level.
7.5.2 Conclusion
The measurement of forniceal fibre integrity in AN by FA seems to be
considerably biased by PVE. After controlling for free-water, identified
alterations are no longer significant, suggesting a reconsideration of the
proposed central role of the fornix in the pathophysiology of eating
disorders. Future research applying DTI in disorders prone to PVE, such
as AN, should incorporate new approaches and employ strategies for CSF
correction either during acquisition (i.e., using fluid-attenuated inversion
recovery prepulses) or during analysis (i.e., free-water correction) to gain
deeper insight into structural changes independent of CSF effects.
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CHAPTER 8
Additional data exploration
8.1 Association of functional brain alterations and behavioural
measures
8.1.1 Weight gain estimation
8.1.1.1 Background
Fear of gaining weight is one of the core symptoms of AN (APA, 2013).
To establish an empirical link between pathological cognitions associated
with food and body-related beliefs (weight gain), AN patients of the
present thesis participated in an additional computer-based nutrition
estimation task which previously developed and is described in detail
elsewhere (Milos et al., 2017). A previous cross-sectional study of our
group with an independent sample of 24 AN patients and 27 HC showed
marked differences in the mean weight gain estimation of AN patients
during the stage of acute underweight. Specifically, when asked to estimate
their personal expected weight gain, AN patients overestimated their
expected weight gain by almost 10%, compared to HC (Milos et al., 2017).
Results of Study II demonstrated that recovery processes of rsFC
within the fronto-basal ganglia/limbic network were negatively associated
with changes in eating disorder symptoms, namely weight concerns, within
the first half of treatment (between TP1 and TP2; see Chapter 6). To
further explore additional relationships between changes in rsFC and
weight gain expectations in that treatment period, the association of
111
112 Chapter 8 Additional data exploration
rsFC recovery and alterations in weight gain estimations as described
above were investigated.
8.1.1.2 Methods
The computer task was conducted three times over the course of
treatment, corresponding to the three time points of the thesis project,
described in section 4.2. In brief, patients were asked to rate different
food items (snacks) on a scale from 0 to 100, indicating how much
weight they expected to gain if they personally (intent-to-eat condition)
were to eat this item additionally to their regular meals. In a second
condition, they were asked to estimate how much weight anyone (general
condition) would gain if they ate the item additionally to regular meals
(Milos et al., 2017). The four different food items were chosen based
on typical regional snacks, to ensure participants familiarity with the
food selection and avoid cultural bias (Rozin, Fischler, Imada, Sarubin,
and Wrzesniewski, 1999; Wardle et al., 2004). Pictures of food items are
displayed in Fig. 8.1. Pictures were prepared and taken at the Division of
Endocrinology, Diabetes and Clinical Nutrition of the University Hospital
Zurich, Switzerland. Each snack item was displayed in four different sizes,
with distinct nutritional values (melon: 19 kcal, 38 kcal, 76 kcal, 152
kcal; banana: 35 kcal, 65 kcal, 143 kcal, 286 kcal; bread roll: 44 kcal, 89
kcal, 178 kcal, 355 kcal; chocolate: 89 kcal, 178 kcal, 267 kcal, 623 kcal),
unknown to the participants. Each picture was presented and rated once
per condition, leading to a total of 32 trials. For the purpose of this
exploratory analysis, only the ratings of the intent-to-eat condition were
considered. To analyse the association of the individuals rsFC at TP1, as
wells as rsFC recovery between TP1-TP2 and TP2-TP3 and alterations
in weight gain estimations, correlation analyses between changes in rsFC
and changes in weight gain estimations were computed for all AN patients
of the sample described in Study II (Chapter 6).
8.1.1.3 Results
Mean values for weight gain estimation and rsFC per time point are
reported in Table 8.1. In contrast to rsFC (see results Study II, Chapter
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6), average values for weight gain estimates did not change significantly
between TP1 and TP2 (t(15) = -.085, p = .93, two-tailed), or TP2 and
TP3 (t(15) = -.338, p = .74, two-tailed). Pearson correlations between
the individual change scores of rsFC and weight gain estimation for TP1-
TP2 and TP2-TP3 yielded small to medium effects (TP1-TP2: r = -.23,
TP2-TP3: r = -.43) which were however not significant (TP1-TP2: p =
.39, TP2-TP3: p = .10; two-tailed). Furthermore, correlations between
rsFC at TP1 and weight gain estimation scores yielded a medium effect
at the trend level (r = -.47, p = .08; two-tailed).
Figure 8.1. Food stimuli presented in the weight gain estimation task
(Milos et al., 2017). Four different sizes (ascending from left to right) of
four snack types were used (top to bottom): melon (very low nutritional
value), banana (low nutrition value), bread roll (modest nutrition value),
and chocolate (high nutrition value).
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Table 8.1
Descriptive statistics of the weight gain estimation task
AN (n=16)
Descriptives WGE TP1 WGE TP2 WGE TP3 WGE TP2-1 WGE TP3-2
M 40.67 40.87 39.96 0.21 −0.91
SD 13.93 12.86 11.96 9.94 11.12
Note. WGE = Weight gain estimation score (intent-to-eat condition).
8.1.2 Body image assessment
8.1.2.1 Background
Another core symptom of AN is related to body image distortions
(APA, 2013). Body image is generally conceptualised with two compon-
ents: (1) body perception (size), and (2) attitudes towards the body
(Skrzypek, Wehmeier, & Remschmidt, 2001). Here, the first component
was explored. Some, but not all patients with AN significantly overestim-
ate their body size (Probst, Vandereycken, Van Coppenolle, & Pieters,
1998). It has been suggested, that these patients form a subgroup within
the patient group and that overestimation of body images could be a
relevant factor for treatment outcome (Skrzypek et al., 2001).
8.1.2.2 Methods
Using a computer-adapted version of the widely used Figure Rating
Scale (Stunkard, Sørensen, & Schulsinger, 1983), ideal and actual body
image perception of AN patients were assessed at all three time points
of the present thesis’ project, described in section 4.2. The original
task exists in a male and female version, consisting of nine figures with
increasing size (Stunkard et al., 1983). It has demonstrated good test-
restest reliability and is appropriate for the assessment of body image
disturbances (Thompson & Altabe, 1991). To allow for a more precise
assessment, the here used computer-adapted version provided more fine
grained stages of body weight, indexed 1 to 50. A selection of the body
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image avatars is displayed in Fig. 8.2. Patients were asked to indicate one
of the 50 different body images that best resembled their ideal and actual
body image. To evaluate associations with the fronto-basal ganglia/limbic
network of impaired rsFC, correlation analyses between scores of the
figure rating task and rsFC at TP1, as well as between changes over the
course of treatment between TP1 and TP2 were calculated for all AN
patients of the sample described in Study II.
Figure 8.2. Selection of body avatars presented in the figure rating task
(adapted after Stunkard et al., 1983). Fifty different body shapes were
presented in ascending order.
8.1.2.3 Results
Mean values for body image evaluations of ideal and actual body per
time point are reported in Table 8.2. Both ideal (t(15) = -3.44, p < .001,
two-tailed) and actual body image perception (t(15) = -4.71, p < .01)
increased significantly during the first therapy phase between TP1 and
TP2. During the second therapy phase (TP2-TP3), only patients’ actual
body image increased significantly (t(15) = -2.42, p = .03, two-tailed),
while the ideal body image stayed the same (t(15) = 0.68, p = .51, two-
tailed). Mean rsFC values per time point and group are displayed in Fig
6.2. Pearson correlations between the individual ideal body image and
rsFC, as well as the actual body image and rsFC for TP1 and change
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scores between TP1 and TP2 yielded no significant associations (ps >
.29, two-tailed).
Table 8.2
Resting-state functional connectivity of the network identified in
Study II
AN (n=16)
Descriptives rsFC TP1 rsFC TP2 rsFC TP3 rsFC TP2-1 rsFC TP3-2
M 0.082 0.160 0.165 0.078 0.004
SD 0.062 0.099 0.097 0.111 0.109
Note. rsFC = resting state functional connectivity.
Table 8.3
Descriptive statistics of the body image task
AN (n=16)
TP1 TP2 TP3
Ideal Actual Ideal Actual Ideal Acutal
Descriptives body body body body body body
M 11.69 7.69 15.50 19.25 14.94 23.19
SD 5.77 9.56 8.39 9.55 7.43 10.30
8.1.3 Conclusion
The additional tasks presented above both captured body-related
beliefs. While weight gain estimates on average stayed unchanged, body
image assessment of both ideal and actual body image increased with
treatment. These alterations might be attributable both to successful
psychotherapeutic treatment, as well as to increasing girth due to weight
gain. The improvements of rsFC observed in Study II (Chapter 6)
were not related to changes in weight gain estimation and body image
perception. These results might appear contradictory, considering the
significant correlation between rsFC and the weight concern subscale
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(EDE-Q) reported in Study II (Chapter 6). However, a closer examination
of the items constituting the EDE-Q subscale reveals a clear focus on
weight-, not shape-related cognitions (Hilbert & Tuschen-Caffier, 2006).
The two tasks examined in the exploratory analyses above both were less
targeted at weight concerns (i.e. desire to lose weight, being dissatisfied
with one’s weight) but rather captured shape-related estimates, more
closely resembled in the EDE-Q shape concern subscale (i.e. feeling
fat, fear of gaining weight, being dissatisfied with one’s body shape).
Although related, the two subscales are conceptually different which
might explain the lack of significant associations with rsFC measures.
An integrated discussion of these results can be found in the general
dicussion (see Section 9.3.1.3).
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8.2 Connection of structural and functional brain alterations
8.2.1 Background
Resting-state is a context independent quantification of brain activity
and the fMRI measure most similar to structural measures and is closely
related to the underlying anatomical connectivity, but their topography
is also gated by the history of prior task activation (Fox & Greicius, 2010;
van den Heuvel & Hulshoff Pol, 2010). In both longitudinal studies (see
Chapter 5 and 6), changes in subcortical region were observed, namely
decreased network connectivity and decreased structural volume at TP1.
The rsFC network identified at TP1 comprised the subcortical regions
displayed in Table 8.4, with a notable overlap with structural alterations
in the bilateral nucleus accumbens, caudate nucleus, hippocampus, and
putamen. Both measures demonstrated processes of recovery during
weight gain treatment.
8.2.2 Methods
To investigate potential associations between the two measures, Pear-
son correlations between rsFC and subcortical volumes were calculated
cross-sectionally for TP1, as well as longitudinally for changes between
TP1 and TP3 within the group of AN patients described in Study II
(Chapter 6). The subcortical regions were well comparable, as the parcella-
tion schemes of Study I and II were both registered to the Montreal Neuro-
logical Institute (MNI) coordinate system (http://www.bic.mni.mcgill.ca/).
Study I used the Aseg Atlas Fischl2002, based on the parcellation of the
MNI305 template (Fischl et al., 2002). Study II used the Automated
Anatomical Labelling atlas, based on the parcellation of the single subject
MNI-space template brain (Tzourio-Mazoyer et al., 2002)). MNI coordin-
ates of the subcortical regions identified in both studies are reported in
Table 8.4.
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Table 8.4
Subcortical regions of reduced tissue volume and functional con-
nectivity in AN patients with severe underweight (TP1)
Structural volume Functional connectivity
MNI coordinates a MNI coordinates a
Region x y z Region x y z
Accumbens L −10 10 −9 Accumbens L −10 12 −7
Accumbens R 10 10 −9 Accumbens R 10 12 −7
Amygdala L
Amygdala R
Caudate L −15 9 7 Caudate L −13 11 9
Caudate R 16 10 8 Caudate R 14 12 9
Hippocampus L −26 −24 −15 Hippocampus L −26 −21 −10
Hippocampus R 28 −23 −15 Hippocampus R 28 −20 −10
Pallidum L
Pallidum R
Putamen L −26 0 −2 Putamen L −25 4 2
Putamen R 27 −1 −2 Putamen R 27 5 3
Thalamus L
Thalamus R
Note. aMNI coordinates of the centre of gravity (mm).
8.2.3 Results
At TP1, cross-sectional analyses of mean connectivity of the rsFC
network and corresponding volumes of the subcortical structures of both
hemispheres were not significantly correlated (ps > .14, two-tailed). Sim-
ilarly, analyses of the longitudinal data did not reveal any significant
correlations between changes of the two measures between TP1 and TP3
(ps > .12, two-tailed), suggesting that structural and functional brain
alterations in AN patients are relatively independent of each other. These
results will be discussed in more detail in the general discussion (see
Section 9.2)).

CHAPTER 9
General discussion
The aim of the present thesis was to investigate brain alterations of AN
patients during acute underweight, as well as temporal processes of neural
and behavioural alterations induced by weight restoration treatment. The
specific results of each study have been discussed in detail in the discussion
sections of the respective studies. In the following, the hypotheses and
key findings of these studies will be summarised briefly and integrated
with respect to relationships between results. Furthermore, clinical and
therapeutic implications of these findings, methodological considerations,
and suggestions for future research will be outlined.
9.1 Summary of findings
The project of the present thesis is, to the be best of my knowledge,
the first longitudinal project investigating neural changes and processes
of reorganisation at three distinct time points during weight recovery of
adult AN patients. To identify brain alterations in the acute phase of AN,
as well as to help elucidate restorative or reorganizational mechanisms and
potentially persisting brain alterations during and after weight restoration,
structural and functional MRI measures were investigated cross-sectionally
and longitudinally using advanced brain imaging analysis techniques.
Additionally, associations with demographic and psychometric measures
were explored.
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9.1.1 Structural alterations
In accordance with previous studies (Bernardoni et al., 2016; Bomba
et al., 2015), the AN group was hypothesised to demonstrate reduced
cortical thickness and reduced subcortical brain volumes at the beginning
of treatment, compared to HC. With weight restoration, at least a partial
recovery of these expected alterations had been predicted.
Analyses of T1-weighted structural images of Study I (Chapter 5) re-
vealed globally reduced cortical thickness and reduced subcortical volumes
in AN patients at the beginning of treatment. These decreases seemed
to be reversible over the course of treatment, associated with increasing
BMI of patients. However, significant residual impairments remained
in parietal and frontal brain regions even after weight restoration. In-
terestingly, restoration of cortical thickness and residual impairments in
AN patients showed a strong negative association with age, outlining the
high plasticity of the brain at young age (Pascual-Leone et al., 2011).
The hypothesis of structural brain regeneration in adult AN patients is
therefore clearly supported by our data. These findings suggest patients’
age as a strong moderator of brain restitution, potentially indicating
decreases of brain plasticity with older age (Pascual-Leone et al., 2011).
9.1.2 Functional connectivity
Resting-state activity of the brain constitutes patterns of functional
activation associated with brain organisation (Damoiseaux et al., 2006;
Deco & Corbetta, 2011; Weissman-Fogel, Moayedi, Taylor, Pope, &
Davis, 2010) and has been shown to change with continuous task-training
(Fauvel et al., 2014; Langer, von Bastian, Wirz, Oberauer, & Jäncke, 2013;
Mackey, Miller Singley, & Bunge, 2013; Taubert, Lohmann, Margulies,
Villringer, & Ragert, 2011). Based on the existing literature (for a review
see Gaudio et al., 2016), it was hypothesized that rsFC in AN patients
would be diminished at the beginning of treatment compared to HC. Over
the course of weight restoration treatment, a reorganisation and recovery
of rsFC was expected in the AN group.
Network analyses of rsFC showed reduced functional connectivity
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in a distinct fronto-basal ganglia/limbic network of AN patients during
severe underweight, compared to HC. Connectivity within this network
significantly increased with weight restoration of patients. The observed
changes in AN patients were associated with changes in eating disorder
pathology, specifically with decreased weight concerns. No significant
network differences between AN patients and HC were observed at the
end of treatment. These findings support the hypothesis of disrupted, but
reversible rsFC in AN patients. Moreover, they indicate that recovery
processes may be related to changes in clinically relevant cognitions.
9.1.3 Methodological pitfalls of diffusion tensor imaging in anorexia nervosa
In the third study, insights from structural MRI and DTI were com-
bined to investigate previously identified alterations of diffusion indices in
the fornix, which had been implicated as a key structure in the pathomech-
anisms of AN (Frank, 2015; Frank, Shott, Hagman, & Mittal, 2013; Hayes
et al., 2015; Kazlouski et al., 2011; Nagahara et al., 2014; Via et al.,
2014). The fornix is anatomically adjacent to the ventricles of the brain
and is thus susceptible to partial volume effects (PVE) (Concha et al.,
2010; Jones & Cercignani, 2010; Pasternak et al., 2009). As Study I had
demonstrated reduced brain mass and correspondingly increased sulcal
and ventricular CSF in acute AN, it was hypothesised that previously
reported disruptions of forniceal fibre integrity in AN are affected by
ventricular volumes and thus biased by PVE. Specifically, the previously
found differences in the fornix of AN patients were expected to diminish
when appropriately controlling for the PVE.
Considering CSF as potential confounder of diffusion imaging, the
hypothesis of Study I was investigated in two independent samples. First,
the inverse associations between forniceal diffusion indices and volumes
of the third and lateral ventricles were established in a pre-study with
healthy subjects. Second, comparisons of AN patients and HC revealed
that differences in forniceal fibre integrity disappear when using advanced
analysis techniques. Hence, our data supported the postulated hypothesis:
It is unlikely that microstructural alterations occurred in the fornix of
AN patients. A valid assessment of diffusion indices of the fornix requires
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adequate control of CSF-induced PVE that otherwise interfere with
diffusion measurements and bias results.
9.2 Integrated discussion
9.2.1 Similarities and differences of structural and functional longitudinal
findings
Comparing the two longitudinal studies, several commonalities stand
out. The cross-sectional analyses at TP1 of both longitudinal studies
revealed impaired subcortical regions by either reduced volume or rsFC.
Overlapping regions included the bilateral nucleus accumbens, caudate
nucleus, hippocampus, and putamen (Table 8.3). Networks of rsFC are
known to be shaped by task-related activation as well as the underlying
structural anatomy (for a review see Damoiseaux & Greicius, 2009) and
combined plastic changes of both structural and functional modalities
have been reported in learning processes (Fauvel et al., 2014).
Additional exploratory correlation analyses between individuals’ volu-
metric and connectivity values yielded no significant association at TP1,
as well as between TP1 and TP3. The observed cross-sectional and
longitudinal alterations in Study I and II thus seem to reflect distinct
changes and recovery processes in AN, corresponding to different clinical
and demographic measures, as demonstrated by correlations with age
(Chapter 5) and eating disorder symptoms (Chapter 6). The observed
rsFC changes may represent inter-regional differences rather than local
(intra-regional) dysconnectivity. The analyses of regional homogeneity
(see Appendix A.1.1) support this hypothesis, as no differences in local
intra-nodal homogeneity were found, compared to HC.
The long-term trajectories of recovery in structural and functional
measures (see Fig. 5.1 and Fig. 6.2) demonstrated the steepest slope
throughout the first phase of treatment, indicating a faster recovery
between TP1 and TP2. This is in line with research demonstrating that
learning-induced changes of grey matter and functional connectivity were
most pronounced after an initial phase of 3 weeks of training (Taubert
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et al., 2011). However, while increases of cortical thickness continued
between TP2 and TP3, rsFC no longer advanced in the second phase
of treatment. This trajectory of rsFC was paralleled by changes in
weight concern, or lack thereof (see Table 6.1). Structural restitution
progressed independent of eating disorder severity measures, such as
weight concerns. Overall, the increase in cortical thickness was less
pronounced in the second phase of treatment but still demonstrated
a significant increase. Furthermore, changes of cortical thickness were
strongly related to patients’ age. Based on these findings, it seems
plausible that grey matter changes chiefly reflect effects of starvation and
re-alimentation, mediated by age-dependent plasticity (Pascual-Leone
et al., 2011). The changes of neural activity during resting-state on
the other hand may echo experience-dependent alterations and learning
processes due to psychotherapeutic treatment (Linden, 2006).
9.2.2 Advantage of considering multiple modalities
Recently, multimodal MRI approaches have gained growing attention
in neuroimaging research (Liu et al., 2015). Multimodal MRI offers
the advantage to investigate complex and multifarious phenomena such
as neuropathological alterations in AN from different viewpoints, thus
allowing a more complete examination of research questions and a cross-
validation of results (Cha et al., 2016; Liu et al., 2015).
The third study (Chapter 7) of the present thesis integrated measures
of structural connectivity using DTI and volumetric information gained
from structural T1-weighted data, to examine findings from previous
studies implicating the fornix as a key structure in AN and eating disorder
pathology in general. Combining these modalities drew previous findings
into question and revealed the impaired structural connectivity of the
fornix reported by unimodal diffusion-weighted studies was in fact biased
by PVE. Due to the enlarged ventricles of AN patients during the phase of
severe underweight, indices of water diffusion can be severely biased (see
section 7.4). This has important implications for neuroimaging research
in AN as it underscores the importance of combining different sources
of information to better capture and understand the complexity of the
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studied phenomena, e.g. neural alterations, which otherwise may easily
lead to erratic or premature conclusions. These results may inform future
DTI studies in the field of eating disorders and serve as a model for other
disorders with enlarged ventricles, such as schizophrenia (Chua et al.,
2007).
9.3 Clinical implications: contributions of a longitudinal multimodal
MRI project to the understanding of anorexia nervosa
This project offered a unique opportunity to study mechanisms of
brain plasticity and the gradual reorganisation of the brain during weight
gain in severe AN. With regard to clinical symptoms, the temporal
mapping of neural and behavioural changes induced by weight gain
highlighted restorative mechanisms accompanying a successful therapy.
9.3.1 Updated aetiological model of Anorexia nervosa
As outlined in the theoretical background of the present thesis (see
Chapter 2), a multitude of factors are currently being discussed as con-
tributing to the aetiology of AN. A combination of factors arising prenatal
or during childhood, including genetic predispositions, developmental fea-
tures, and personality traits, together with cultural influences likely lead
to initial eating restrictions and elicit weight loss. Subsequent neural alter-
ations possibly reinforce disordered eating behaviour to counter negative
emotionality, thus leading to additional weight loss (Herpertz-Dahlmann
et al., 2011; Kaye, 2009). The findings of this thesis have important im-
plications for the development and continued amendment of aetiological
models of AN, which build a foundation not only for further research but
also new treatment approaches. In the following, contributions of the
present work to the understanding of the individual factors constituting
the aetiological model of AN (see Fig. 2.2) will be discussed.
9.3.1.1 Sociocultural and developmental factors
The sample investigated in this work was recruited from a homogen-
eous sociocultural background. Thus, no empirically-based conclusions
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can be drawn regarding influences of different cultural factors. However,
developmental factors commonly reported to promote vulnerability, such
as the development of certain personality traits, were assessed within
the extensive questionnaire survey completed by the participants of the
studies. While the study design of this thesis inherently does not permit
any inferences regarding the causative relationship of these factors, the
assessed questionnaires did confirm heightened levels of obsessionality,
anxiety, and depression in the AN group compared to HC (see Chapter
5 and 6). Furthermore, diagnostic interviews conducted upon study
participation demonstrated depression and anxiety as the main comorbid
disorders in AN (see Table 3.1), thus supporting the concept of a close
relationship of these aspects with AN.
9.3.1.2 Genetic factors
Knowledge from genetic research on AN has provided a basis for
participant selection of this thesis project. As sex has been an important
predictor of the disease (Mohler-Kuo et al., 2016), only female AN patients
and sex-matched HC were included to achieve a homogenous sample and
reduce confounding factors. With regard to HC, findings from twin-
studies indicating a strong heritable component of AN (Yilmaz et al.,
2015) informed the selection process as potential participants with first or
second degree relatives with a history of eating disorders were excluded
from the project. Results of group comparisons in the present work thus
are likely to be reflective of genetic differences between groups. Further
studies are needed to examine the relationship of genes and neurocircuitry
in AN.
9.3.1.3 Neurobiological factors
The focus of the present thesis was on neurobiological factors as-
sociated with the pathophysiology of AN, specifically brain alterations
captured by MRI. In the following, the contributions of each study to the
understanding of AN will be discussed separately.
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Structural volumetric brain alterations The findings of Study I provide
support for the reduced grey matter and reduced subcortical volumes
observed during acute underweight of AN patients. Furthermore, no
global white matter changes were found in comparison to HC. This
may indicate that potential changes of white matter are subtler and not
detectable on a volumetric level. In fact, preliminary findings of DTI
studies in adolescent AN patients point toward alterations in a number
of white matter tracts (Travis et al., 2015; Vogel et al., 2016). The
longitudinal examination of the grey matter reductions extends prior
studies on adult AN patients by demonstrating a relatively fast but
age-dependent recovery of these impairments. On a structural level,
this brain restoration was independent of changes in eating disorder
cognitions, as measured by the EDE-Q, but was rather associated with
re-alimentation during weight restoration treatment. As discussed in
Chapter 5, the histological foundation of the observed alterations is likely
a reduction of glia cells, specifically astrocytes, which were found to
decrease tremendously in a rat model of ABA, adapted to mimic chronic
starvation in AN (Frintrop et al., 2017).
Importantly, regarding the aetiology of AN, these findings support
the notion that drastic dieting behaviour and subsequent weight loss
primarily leads to neural alterations in patients with AN. Structural
brain impairments seem to appear secondary to the initial weight loss of
patients and do not contribute to initial illness onset. However, once these
brain alterations take place, they may affect behaviour and potentially
enhance the pathology of patients. Additionally, residual alterations
may have an impact on long-term recovery. The age dependence of
the recovery process highlights the enhanced ability of younger AN
patients to achieve structural brain recovery in a faster or more complete
way. Looking at prognostic factors, these findings provide ground for a
potential mechanism behind the observation that early onset AN has a
better treatment outcome (Steinhausen, 2002). Moreover, they suggest
age as a risk factor for persisting brain impairments and a chronic illness
trajectory.
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Functional connectivity Cortico-limbic circuits have previously been
implicated in resting-state research of AN, employing mainly region-
specific approaches (Gaudio et al., 2016). Findings of Study II support and
extend these results by employing a novel approach to investigate networks
of altered connectivity. At the beginning of treatment, AN patients
showed disrupted connectivity in a fronto-basal ganglia/limbic network
(Chapter 6). The basal ganglia are known to be highly interconnected and
take an essential role in reward processing of the brain (Sesack & Grace,
2010). Furthermore, they project to frontal regions where decision making
takes place (Sesack & Grace, 2010). Additional regions of the network
comprised the anterior insular cortex and the fusiform gyrus, which are
critical for interoception (Adolfi et al., 2017) and body recognition (Peelen
& Downing, 2007). With regard to the aetiology of AN, these results
may suggest a neural basis of distorted body perception in AN. However,
within the additional exploratory analyses (Chapter 8), individual figure
ratings of current body shape (ideal and actual) were not associated
with reduced functional connectivity of the identified network, potentially
suggesting a more complex relation of body perception and functional
brain connectivity. Reduced functional connectivity of reward-related
regions could indicate an impaired response in subcortical regions to
rewarding stimuli such as food, potentially facilitating food avoidance
despite low body weight. Negative correlations of patients’ functional
connectivity at TP1 with overestimation of expected weight gain upon
food consumption (weight gain estimation task, Chapter 8), albeit at
trend level, may further indicate a complex interplay of alterations in
reward-related brain regions and behaviour.
The hypoconnected network in AN patients partially recovered with
weight normalisation during a multi-modal inpatient treatment. Of note,
the recovery processes within the network were strongest during the first
half of treatment and significantly correlated with weight-related eating
disorder cognitions (Table 6.1), emphasising the importance of the initial
phase of therapy for a successful recovery process. Changes in this first
half may be more pronounced, as the majority of new experiences likely
takes place in that phase. While the treatment programme continues to
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evolve with weight restoration, the essential elements of regular meals,
group and individual therapies remain stable throughout the inpatient
stay (Department of Psychiatry and Psychotherapy, 2016).
Exploratory analyses at the end of treatment provided evidence for
residual subthreshold hypoconnectivity of the caudate nucleus and the
putamen, regions part of the basal ganglia and key structures of reward
processing (Sesack & Grace, 2010). In this context, a recently proposed
top-down model of the persistence of AN is important (Steinglass & Walsh,
2016). The model integrates findings of abnormal connectivity in fronto-
striatal regions and postulates chronic disadvantageous decision-making
in AN may be fostered in a “top-down” manner, similar to habitual
behaviour (Steinglass & Walsh, 2016). As the authors emphasise, their
model is preliminary and much research needs to be done to confirm the
hypothesis. Nonetheless, findings from Study II support and extend this
line of theory as the regions with residual alterations are known to be
central to habit learning (Knowlton, Mangels, & Squire, 1996; Yin &
Knowlton, 2006).
Structural connectivity Study 3 investigated the role of the fornix in the
pathophysiology of AN, which had been found to be severely impaired
in adult (Hayes et al., 2015; Kazlouski et al., 2011; Nagahara et al.,
2014; Via et al., 2014) and adolescent patients with AN (Frank, Shott,
Hagman, & Mittal, 2013). Based on fornix alterations reported also in
bulimia nervosa and obese patients, the fornix had been proposed as
a main structure in eating disorder pathology in general (Frank, 2015).
Findings from Study III demonstrated that previous DTI studies on AN
were likely biased by PVE due to the enlarged ventricles of patients
in the acute phase. Regarding the aetiological model of AN, these
findings not only put the role of the fornix into perspective but also
underscore the importance of considering the complexity of the disorder
and the different facets accompanying it. The results may inform future
DTI studies in the field of eating disorders to carefully deal with PVE
when investigating structural connectivity in AN, which then will likely
provide an important contribution in the pursuit of reconciling the above
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discussed structural volumetric alterations (grey matter) with the changes
in functional connectivity.
9.3.2 Current treatment approaches
The here presented findings provide evidence for successful brain
restorative processes during weight restoration treatment in a multimodal
interdisciplinary inpatient setting. The treatment concept consisted of
several phases of structured re-nutrition with the main goal of normal-
isation and stabilisation of eating behaviour and weight. In addition,
it comprised somatic checks and treatments, individual and group psy-
chotherapy, as well as body and art therapy. The results of the present
thesis underscore the importance of refeeding as first step in modern
multimodal treatment of AN.
Particularly the results of the two longitudinal studies in Chapter 5
and 6 can be seen as encouragement for both therapists and patients: Un-
like some of the other somatic issues accompanying AN (see Section 2.1.3),
the severe impairments of brain structure and function seem to be largely
reversible through refeeding therapy. Therapists should integrate these
findings in psychoeducational elements of treatment to make patients
aware of (1) the severe damage the underweight is causing and (2) of
the possible reversibility with weight normalisation in the context of a
multimodal treatment programme. This may not only support therapy
motivation, but also facilitate the perceived control over treatment pro-
cesses in their patients (Haggard & Chambon, 2012), which seems to be
decreased specifically in AN patients (Dalgleish et al., 2001; Sassaroli,
Gallucci, & Ruggiero, 2008).
It is conceivable that the observed alterations in brain function and
structure are linked to cognitive impairments often observed during
initial treatment, such as fatigue, diminished concentration and learning
(Katzman, Christensen, Young, & Zipursky, 2001). This is important to
consider for treatment planning and should find consideration in form of
shorter treatment sessions and generous recreational time slots within an
inpatient setting.
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The remaining residual alterations in both structural and functional
brain measures make the persistence of the disorder evident (Papado-
poulos et al., 2009; Steinhausen, 2002; Zipfel et al., 2015). With regard to
therapy programmes, these residual alterations underline the importance
of outpatient aftercare upon discharge to further normalise and stabilise
weight and eating behaviour of patients with AN.
9.4 Methodological considerations
9.4.1 Sample composition
All patients of the present thesis had a primary diagnosis of AN,
as diagnosed with the SCID-I (First et al., 2002). Approximately 15%
of participants met the criteria for the binge-purge subtype of AN at
TP1, while 85% were diagnosed with restrictive AN at the beginning of
treatment. This distribution remained stable over all three time points
(see Table 3.1). Comorbid diagnoses were given to almost 50% of the
patients at TP1, diagnoses included depressive disorders, dysthymia,
anxiety disorders, and post-traumatic stress disorder. There were no
proportional differences in comorbid diagnoses between time points (see
Table 3.1), indicating that therapy completion was not predominantly
driven by comorbidity, i.e. absence of comorbid diagnoses did not predict
an overall more positive outcome. In the following, relevant factors
regarding sample composition will be summarised and discussed.
9.4.1.1 Subtypes of Anorexia nervosa
Due to the limited number of the binge-purge subtype, no separate
analyses of the two subtypes were possible for the present thesis. In
general, analysis of the influence of AN subtypes is complicated due to
the relative instability of diagnoses, as about half of the patients cross
subtypes or even change diagnoses from AN to bulimia nervosa (Eckert,
Halmi, Marchi, Grove, & Crosby, 1995; Eddy et al., 2002; Milos et al.,
2005). To date, few studies have investigated the potential neural differ-
ences of the subtypes (van Kuyck et al., 2009). Results from single-photon
emission computed tomography studies with acutely ill patients suggest
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decreased blood perfusion in the restrictive subtype at rest (Naruo et al.,
2001) and increased perfusion in the binge-purge subtype during a food
task (Naruo et al., 2000), in comparison to the opposite AN subtype and
HC. However, the two studies had small sample sizes (n=7 per subtype)
and need replication. As the binge-purge subtype has been associated
with a less positive outcome (Steinhausen, 2002; Treasure et al., 2015;
Zipfel et al., 2015), a closer investigation of potential differences between
subtypes with a larger sample could help elucidating corresponding neural
representations of the behavioural differences.
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9.4.1.2 Comorbid diagnoses
Influences of comorbid diagnoses on results of the present thesis
cannot be excluded, as subgroup analyses were not feasible due to the
small number of patients within the subgroups. However, the percentage
of comorbid diagnoses of the investigated patient group is within the
range commonly observed in adult AN patients (Hudson et al., 2007).
Furthermore, the predominant comorbid diagnoses of the current sample
are in agreement with previous studies, reporting depressive and anxiety
disorders as the largest proportion of secondary diagnoses (Hudson et al.,
2007; Kaye, Bulik, Thornton, Barbarich, & Masters, 2004; Milos et al.,
2003). Thus, the observed brain alterations and restorative processes
seem to be valid for a typical sample of AN patients with the commonly
observed comorbid diagnoses (Hudson et al., 2007; Kaye et al., 2004;
Milos et al., 2003). However, the datasets of the present work do not allow
for more detailed conclusions regarding individual comorbid disorders.
9.4.1.3 Medication of patients
To avoid disruption of current inpatient treatment, patients were
instructed to continue with their medication as normal. Due to the
variety of different medications, specific influences of different medications
could not be explored more specifically. However, measurements in the
respective studies were compared for patients taking medication and
patients without medication. Although it is possible that medications
influenced the findings, results suggested that brain measurements were
within the range of patients without medication (see Chapter 5 and 6).
Thus, group differences in comparison to HC are unlikely to be driven
solely by medication effects.
9.4.1.4 Sex
Female sex has commonly been associated with a greater prevalence
of AN, with only approximately 10% of AN patients being men (Nagl
et al., 2016; Treasure, Claudino, & Zucker, 2010). To exclude sex as a
confounding factor, the present thesis has investigated exclusively female
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patients with AN. Eating disorder pathology in male populations has been
reported to be expressed in a more diverse way, with features of muscle
dysmorphia, a specifier of the body dysmorphic disorder (APA, 2013;
Grieve, Truba, & Bowersox, 2009). Little research is being conducted on
male samples and to date there are no neuroimaging studies focussing
specifically on male populations. The results of the present work are
based on a female sample; thus, the conclusions drawn from this work
may not extend to male AN patients.
The available evidence on male AN patients points out differences
in comorbidity compared to female patients, with higher rates of sub-
stance abuse and sexual identity concerns (Carlat, Camargo, & Herzog,
1997; Sharp, Clark, Dunan, Blackwood, & Shapiro, 1994; Touyz, Kopec-
Schrader, & Beumont, 1993). In terms of illness history, a delayed
illness onset, as well as premorbid obesity seem to be more prevalent in
male AN patients (Carlat et al., 1997; Sharp et al., 1994; Touyz et al.,
1993). Whether these differences of presentation reflect differences in the
pathomechanism of the disorder remains to be investigated.
9.4.2 Study design
The present thesis project consisted of three time points over the
course of a specialised inpatient treatment, allowing for closer monitoring
of recovery dynamics over time. The first time point of the project
was defined by severe underweight of AN patients (BMI ≤ 15.5). After
initial weight gain (15.5 < BMI < 17.5) of patients, as well as at the
end of treatment (BMI ≥ 17.5), MRI scans were repeated. An aspect
to keep in mind when interpreting the residual alterations at the end of
treatment is the weight range of patients at TP3. A significant weight gain
took place during treatment between TP1 and TP3. However, eligibility
criteria for TP3 was a BMI ≥ 17.5, meaning that not all patients had
yet reached a healthy BMI of 18.5. Furthermore, the phase of weight
stabilisation at the end of treatment was comparatively short (2-4 weeks),
thus residual alterations found at TP3 might be influenced by low BMI and
recover after a longer follow-up period with further BMI increase. Future
studies should include an additional time point after a longer interval
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of weight stabilisation, to investigate post-treatment recovery processes
and long-term outcomes after inpatient treatment. More specifically, this
would allow for a closer investigation of the different types of treatment
trajectories and potentially help elucidate factors predictive for a beneficial
therapy outcome, as well as factors associated with a less positive therapy
trajectory.
Measures of neuropsychological functioning were assessed at TP1 to
ensure any differences found between groups would not be attributable to
severely impaired cognitive functioning. This strengthened the reliability
of the results of the present thesis. Future studies should examine these
measures at all time points, to allow investigation of potential relationships
between cognitive performance and recovery processes in the brain.
9.4.3 Potential nuisance factor for resting-state fMRI
The somatic complexity of AN has a strong influence on measures
of the brain as demonstrated for instance by the findings of the present
thesis. Two recent studies on respiratory functions in adolescents with
AN have drawn attention to impairments, with consequences known as
respiratory acidosis (Kerem, Averin, et al., 2012, 2012). Respiratory
acidosis describes the accumulation of carbon dioxide (CO2) in the blood,
followed by a dropping pH level of the blood and is commonly caused
by insufficient expiration (WHO, 2009). An influential study by Xu et
al. (Xu et al., 2011) has investigated the effects of increased blood CO2
(hypercapnia) on resting-state brain activity in a sample of healthy adults.
The results demonstrated a strong reduction of resting-state activity upon
inhalation of CO2, suggesting a suppressive effect on spontaneous neural
activity of the brain (Xu et al., 2011).
Regarding AN, respiratory acidosis and correspondingly increased
CO2 measures in AN patients present a potential nuisance factor which
has been neglected in resting-state research on the disorder thus far.
Studies on adult patients did not find altered blood gases (González-
Moro et al., 2003; Murciano et al., 1994; Pieters et al., 2000), thus
it can be argued that results of the present thesis are unlikely to be
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caused by elevated blood-CO2 levels. However, respiratory acidosis is a
potential nuisance factor for BOLD signal-dependent fMRI and should
be considered in future studies, especially when investigating adolescent
samples, where respiratory acidosis is more likely to occur (Kerem, Averin,
et al., 2012; Kerem, Riskin, Averin, Srugo, & Kugelman, 2012).
9.5 Challenges and future work
The current thesis investigated processes of neural reorganisation
during weight recovery. To this extend, only patients with a successful
treatment trajectory (i.e. continuous weight gain) were considered for
the longitudinal studies. Approximately half of the initially included
patients fulfilled this requirement at the end of treatment. The other half
of patients either gained some weight, but discontinued therapy before
reaching a BMI ≥ 17.5, or were not able to gain weight at all even with
therapeutic support.
The question of chronicity in AN poses one of the major challenges
in AN research (Compan et al., 2015). Future studies should explicitly
address the neural basis of the persistence of AN and investigate pre-
dictors of negative treatment trajectories by including patients with a
chronic course of AN, who fail to gain weight during treatment, in longit-
udinal studies. Additionally, of those patients with a successful course
of treatment and a discharge BMI in the desired range (> 18.5), up
to 50% relapse and return to the disastrous process of weight-loss and
emaciation within 1 year after discharge from hospital (Carter, Black-
more, Sutandar-Pinnock, & Woodside, 2004; Eckert et al., 1995; Strober,
Freeman, & Morrell, 1997). In order to obtain a better understanding,
studies with an even longer time frame are required to clarify the role of
the here identified residual brain alterations and to shed light on potential
indicators of relapses or long-term recovery, which may help inform and
improve treatment approaches.
As outlined above, small sample sizes limit possible analyses and in
turn restrict the research questions that can be answered. To overcome
the limitations of small sample sizes, multicentre studies or study consor-
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tia with harmonised processing streamlines are indispensable. First steps
in this direction were made in 2009, when the Enhancing Neuroimaging
and Genetics through Meta-Analysis (ENIGMA) Network was foun-
ded (http://enigma.usc.edu/) (Mohammadi, 2015). ENIGMA is a
network of researchers organised in different working groups invest-
igating brain changes and genetics in disease and health, as well as
specific methodological questions (Mohammadi, 2015). With regard
to AN, a newly formed working group has set out to examine struc-
tural brain alterations associated with the disease on large samples
(http://enigma.usc.edu/ongoing/enigma-anorexia/). Combined ef-
forts of research groups may validate current findings on structural
alterations and help identify consistent factors associated with a positive
treatment outcome. Together with targeted investigation of candidate
genes as done by Genome Wide Association Studies (Boraska et al., 2014;
Duncan et al., 2016; Nakabayashi et al., 2009; Wang et al., 2011), this
may even allow examination of the relationship between brain alterations
and patients’ genetics.
9.6 Conclusion
The present PhD thesis provided insight into brain alterations during
acute underweight, as well as associated longitudinal regenerative pro-
cesses throughout weight restoration treatment of adult patients with
severe AN. Taken together, the longitudinal findings demonstrate a tre-
mendous plasticity of young patients’ brains and suggest that dramatic
alterations in the structural and functional realm are largely reversible
with specific treatment and careful weight restoration. However, resid-
ual alterations in both modalities (structural / functional) remained at
the end of the weight normalisation during inpatient treatment, likely
reflecting the persistence of the disorder with high relapse rates and often
persisting psychopathology. The findings of the present work highlight the
importance of sufficiently long and well-structured treatment programmes,
including outpatient after-care to further normalise and stabilise weight
and eating behaviour, as well as to improve psychopathology.
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A.1 Supplemental results
A.1.1 Functional connectivity in the phase of severe underweight
Table A.1
Network of reduced inter-regional connectivity
Network edges
Nucleus accumbens R - Anterior insula L
Nucleus accumbens R - Anterior insula R
Caudate nucleus L - Anterior insula L
Caudate nucleus L - Putamen L
Caudate nucleus L - Putamen R
Caudate nucleus R - Putamen L
Caudate nucleus R - Putamen R
Inferior frontal gyrus, triangular R - Nucleus accumbens R
Middle fontal gyrus L - Hippocampus L
Superior frontal gyrus, medial orbital L - Hippocampus R
Hippocampus L - Nucleus accumbens R
Hippocampus L - Caudate nucleus L
Hippocampus L - Caudate nucleus R
Hippocampus L - Fusiform gyrus R
Hippocampus R - Nucleus accumbens L
Hippocampus R - Nucleus accumbens R
Hippocampus R - Caudate nucleus L
Hippocampus R - Caudate nucleus R
Putamen L - Nucleus accumbens L
Putamen R - Nucleus accumbens R
Note. Edges represent reduced functional connectivity in anorexia nervosa
patients, compared to healthy controls at TP1 (t=3.5). L = left hemisphere; R
= right hemisphere.
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A.1.2 Functional connectivity after weight recovery
Figure A.1. Network of hypoconnectivity in AN compared to HC at
the last time point, comprising nodes in the left and right caudate
nucleus, and the left putamen. Displayed is the top-view onto the brain,
from posterior (left) to anterior (right). Network-based statistics were
applied to compare functional connectivity within the network identified
at TP1 between the groups (t=2.0). The network displayed survived a
statistical threshold (p=.10), corrected for multiple comparisons using
family-wise error correction.
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A.1.3 Individual-level motion correction
Figure A.2. Network of hypoconnectivity in AN compared to HC at
TP1, after motion correction at individual-level using spike regression
(Vinet & Zhedanov, 2010; Power et al., 2014). Network-based statistics
were applied to compare whole-brain functional connectivity between the
groups (t=3.5). The network consists of 13 nodes (blue spheres) and 14
edges (grey lines) that survived a statistical threshold (p=.05), corrected
for multiple comparisons using family-wise error correction. The net-
work comprised largely the same nodes compared to motion correction
on group-level (differences: F1M instead of F1MO; F3O instead of F3T;
no fusiform gyrus). The core nodes of the network (nucleus accumbens,
nucleus caudatus, hippocampus, putamen) remained unchanged, sup-
porting the robustness of the original network. Left column (top to bot-
tom): Lateral and medial view of left hemisphere, anterior view. Middle:
Top and bottom view. Right column: Lateral and medial view of right
hemisphere, posterior view. AC=Accumbens; CAU=Caudate nucleus;
F1M=Superior frontal gyrus, medial; F1MO=Superior frontal gyrus,
medial orbital; F2=Middle frontal gyrus; F3O=Inferior frontal gyrus,
orbital; F3T=Inferior frontal gyrus, triangular; HIP=Hippocampus;
INA=Insula anterior; PUT=Putamen. Network visualised using Brain-
Net Viewer (Xia et al., 2013).
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A.1.4 Test statistic threshold
A 
 
B 
 
 
C 
 
D 
 
 
Figure A.3. Networks of hypoconnectivity in AN compared to HC at
the first time point, for varying thresholds of the primary test statistic:
(A) t=3.0; (B) t=3.3; (C) t=3.7; (D) t=4.0. Displayed is the top-view
onto the brain, from posterior (left) to anterior (right). Network-based
statistics were applied to compare whole-brain functional connectivity
between the groups. The networks displayed were the only networks
per threshold and survived a statistical threshold (p=.05), corrected
for multiple comparisons using family-wise error correction.
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A.1.5 Medication effects
0.0
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Figure A.4. Boxplots of mean network connectivity at the first time-
point (TP1). Separate plots for HC and AN patients with and without
medication. The horizontal mark signifies the median per group, edges
of the box represent the 25th and 75th percentiles, and the whiskers
correspond to the minimal / maximal data points. AN=Anorexia
nervosa group; HC=Healthy control group.
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B.1 Supplemental Methods
B.1.1 B0 field correction
The B0 magnitude and phase maps were reconstructed to a spatial
resolution of 2.0 × 2.0 × 2.0 mm3 from a multiecho multislice gradient
echo acquisition with a spatial resolution of 2.0× 4.0× 2.0 mm3. Further
imaging parameters were: acquisition matrix 128× 64 pixels, 77 slices,
FOV=256×256×154 mm3, dual echo-time (TE)=4.4 / 6.7 ms, repetition-
time (TR)=400.0 ms, flip-angle =45∘, acquisition time 1 min 46 s.
B.2 Supplemental Results (pre-study)
Table B.1
Ventricular volumes of the third and lateral ventricles [cm3] and
fornix FA within each of the two fornix masks for the pre-study
sample of n = 32 healthy subjects
M SD
Third ventricle volume 0.85 0.22
Lateral ventricle volume 11.24 5.62
FA Fornixbroad 0.30 0.02
FA Fornixcentre 0.41 0.02
Note. The means reported represent the absolute volumes (cm3) or FA; volu-
metric statistics (see Chapter 6) were calculated correcting for intracranial
volume.
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B.3 Supplemental Results (main-study)
B.3.1 Group comparisons of axial and radial diffusivity
Table B.2
Comparison of axial diffusivity (AD) and radial diffusivity (RD)
[µm2/s] of the fornix between patients with anorexia nervosa (AN)
and controls (HC)
Group
AN HC
n = 25 n = 25
Mask Measure M SD M SD F 𝜂p2 p
fornixbroad AD uncorrected 2.17 0.15 1.87 0.12 70.94 .65 <.0001
AD corrected 0.81 0.02 0.82 0.01 7.23 .16 .01
RD uncorrected 1.58 0.17 1.27 0.12 70.78 .65 <.0001
RD corrected 0.44 0.03 0.47 0.01 14.32 .27 .001
fornixcentre AD uncorrected 2.04 0.18 1.70 0.16 53.25 .58 <.0001
AD corrected 0.94 0.05 0.92 0.02 1.5 .04 .23
RD uncorrected 1.31 0.18 0.97 0.13 55.25 .59 <.0001
RD corrected 0.40 0.02 0.42 0.01 4.77 .11 .04
Note. Group comparisons were calculated correcting for age, mean heart rate,
and the four head motion parameters. Fornixbroad: values were derived using
a traditional approach comprising the fornix in its natural shape; fornixcentre:
values were derived from the tract centre.
Focusing only on the uncorrected data, the pattern of increased
axial diffusivity (AD), increased radial diffusivity (RD) (Table S2), and
decreased FA values in AN patients (see main paper) points to a substan-
tially increased free-water fraction within the fornix masks, where both
AD and RD significantly increase with decreased tissue density (Beaulieu,
2002). However, after correcting for free-water, AD and RD increases
in AN patients no longer exist. Within the broad mask, AN patients
even demonstrate a slight reduction of AD and RD compared to HCs.
Similarly, within the mask of the tract center AD values are no longer
significantly elevated after correcting for free-water and RD values even
show a minor reduction in the patient group.
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C Project documents
C.1 Patient information
Patientinnen-Information,24.03.2015; Version Amendment 3 1  
UniversitätsSpital 
Zürich u Klinik für Psychiatrie und Psychotherapie 
 
 
 
 
 
Patientinnen-Information 
24.03.2015 
 
 
“Reshaping” the Brain – Longitudinal Assessment of Changes in Structural and 
Functional Connectivity During Weight Gain in Anorexia Nervosa 
 
Die “Neuformierung” des Gehirns – Evaluierung von Veränderungen der 
strukturellen und funktionellen Konnektivität während der Gewichtszunahme bei 
Anorexia Nervosa 
 
 
Finanziert durch die Gottfried und Julia Bangerter-Rhyner-Stiftung, Hermann-Klaus-Stiftung und 
Parrotia-Stiftung  
 
 
 
Sehr geehrte Teilnehmerin 
 
 
1 Auswahl der Studienteilnehmerinnen 
 
Wir fragen Sie an, ob Sie an einer Studie teilnehmen möchten, weil Sie entweder unter akuter 
Anorexia nervosa („Magersucht“) leiden oder früher unter Anorexia nervosa gelitten haben.  
 
 
2 Ziel der Studie 
 
In dieser wissenschaftlichen Studie geht es um Veränderungen im Gehirn während der langsamen 
Gewichtszunahme im Rahmen der Therapie bei Patientinnen mit Anorexia Nervosa. Die Stärke der 
Verbindung und/oder der Kommunikation zwischen einzelnen Hirngebieten wird sowohl auf der 
Ebene der Hirn-Aktivität („funktionelle Konnektivität“) als auch der Hirn-Anatomie („strukturelle 
Konnektivität“) untersucht. 
 
 
3 Allgemeine Informationen zur klinischen Studie 
 
 Durch diese Studie soll eine Verbesserung des Verständnisses derjenigen biologischen 
Mechanismen erlangt werden, die zur Anorexia nervosa führen und die durch eine 
therapeutische Intervention angestossen werden.  
 Jede Patientin mit akuter Anorexia nervosa wird im Längsschnitt über drei Messzeitpunkte 
innerhalb von sechs Monaten untersucht. Personen, die früher an Anorexia nervosa litten, 
werden nur einmal untersucht. Die Studie dauert insgesamt ca. zwei Jahre exkl. Daten-
Auswertung und -Publikation. Es werden insgesamt 100 Teilnehmerinnen rekrutiert (50 
Patientinnen mit akuter Anorexia nervosa, 25  geheilte Patientinnen, die früher Magersucht 
hatten und nun in einem stabilen Zustand sind, und 25 gesunde Vergleichspersonen).  
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 Diese Studie wird in Übereinstimmung mit der schweizerischen Gesetzgebung und nach 
international anerkannten Richtlinien durchgeführt. Sie wurde von der zuständigen, 
unabhängigen Ethikkommission des Kantons genehmigt. 
 Magnetresonanztomographie (magnetic resonance imaging, MRI): Das MRI ist ein 
bildgebendes Verfahren zur Darstellung der Struktur und Funktion des Gehirns. Dabei können 
sowohl hochauflösende Bilder des Gehirns als auch die neuronale Aktivität des Gehirns 
aufgenommen werden. Das MRI beruht auf einem starken Magnetfeld, d.h. die Untersuchung 
ist frei von Röntgenstrahlen und gilt daher als ungefährlich. Sie ist ausserdem schmerzlos und 
nebenwirkungsfrei. Dennoch werden Schwangere von der Studie ausgeschlossen.  
 Zufallsbefunde: Da es sich um bildgebende Untersuchungen des Gehirns handelt, könnten 
sich  so genannte neurologische „Zufallsbefunde“ aufdrängen. Im Zusammenhang mit MRI-
Aufnahmen könnten sich Missbildungen oder andere Auffälligkeiten in den Aufnahmen zeigen. 
Im Rahmen Ihrer Einverständniserklärung werden Sie die Möglichkeit haben zu entscheiden ob 
Sie über einen neurologischen Zufallsbefund 1) direkt informiert werden möchten, 2) nicht 
informiert werden möchten oder 3) die Entscheidung einem Arzt überlassen. 
 
 
4 Freiwilligkeit der Teilnahme 
 
Ihre Teilnahme an dieser Studie ist freiwillig. Wenn Sie nicht an dieser Studie teilnehmen wollen, 
haben Sie keine Nachteile für Ihre medizinische Betreuung zu erwarten. Das gleiche gilt, wenn Sie 
Ihre einmal gegebene Einwilligung zu einem späteren Zeitpunkt widerrufen. Diese Möglichkeit 
haben Sie jederzeit. Einen allfälligen Widerruf Ihrer Einwilligung bzw. den Rücktritt von der Studie 
müssen Sie nicht begründen. Im Fall eines Widerrufs werden die bis zu diesem Zeitpunkt 
erhobenen Daten weiter verwendet und die gelagerten Blut- und Stuhlproben werden für 
Forschungszwecke nicht mehr weiter verwendet. 
 
 
5 Studienablauf 
 
 Nachdem Sie die Einverständniserklärung unterschrieben haben, vereinbaren wir einen Termin 
mit Ihnen für die Voruntersuchung. Diese beinhaltet eine kurze Abklärung Ihres 
Gesundheitszustands und das Ausfüllen einiger Fragebögen zu Ihrem Gemütszustand. Sie 
dauert ca. 45 min.  
 Ihre weitere Teilnahme an der Studie besteht aus drei MRI-Untersuchungen und drei 
Computer-Aufgaben innerhalb von ca. sechs Monaten. MRI-Untersuchung und Computer-
Aufgaben müssen jeweils zeitnah (d.h. nicht länger als ca. 7 Tage) aufeinander folgen; die 
Termine sollen daher im Voraus (gemeinsam mit der Versuchsleitung) entsprechend 
abgestimmt werden. Der jeweilige Zeitpunkt dieser Untersuchungen ist abhängig von der 
Zunahme Ihres Gewichtes (BMI, body-mass index) im Laufe der Therapie. Jede MRI-
Untersuchung dauert ca. 1,5 h, die Computer-Aufgaben dauern jeweils ca. 75 min. Ort der 
Untersuchungen ist das UniversitätsSpital Zürich. Bei jedem MRI-Termin werden Sie 
ausserdem gebeten einige Fragebögen auszufüllen (unten schematisch dargestellt). Zudem 
findet eine Blutentnahme statt, die es uns ermöglicht, hormonelle Parameter zu erfassen und 
genetische Analysen durchzuführen. Es werden dabei spezifische Gene analysiert, die mit der 
Entwicklung einer Essstörung in Verbindung gebracht wurden. Hormonelle und genetische 
Analysen wiederum werden mit der aus dem MRI gewonnenen Datenmenge in Verbindung 
gebracht. Da sich die Bakterienzusammensetzung im Darm durch eine Umstellung der 
Ernährung im Rahmen Ihrer Therapie verändern kann, werden sie gebeten, um den jeweiligen 
Messzeitpunkt herum (höchstens zwei Tage früher oder später als der MRI-Termin) eine 
Stuhlprobe abzugeben. Sie erhalten dazu ein Röhrchen; die Gewinnung ist einfach und erfolgt 
diskret auf der Toilette. 
 Vor Beginn der Studie wird ein Schwangerschaftstest durchgeführt. 
 
Im Folgenden ist der Ablauf einer MRI-Untersuchung schematisch dargestellt: 
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Während des MRI werden Ihre Herz- und Atemfrequenz aufgezeichnet. Dazu werden Ihnen vor der 
MRI-Untersuchung am Rippenbereich Elektroden angeklebt und es wird ein Atemgurt um den 
Bauch herum angebracht. 
 
Instruktionen für die Teilnehmerinnen während des MRI: 
• In der Ruhe-Messung bitten wir Sie, ihre Augen geschlossen zu halten und sich nicht zu 
bewegen. Sie können sich entspannen und Ihren Gedanken freien Lauf lassen. Sie sollten 
während der Ruhe-Messung nicht einschlafen. 
• Im ersten Teil der Ereignis-Messung bekommen Sie verschiedene Bilder zu sehen, auf denen 
entweder Speisen/Nahrungsmittel oder Nicht-Nahrungsmittel (Gegenstände/Tiere/Pflanzen) 
abgebildet sind. Bei den Speisen sollen Sie sich vorstellen, davon zu essen. Bei den Nicht-
Nahrungsmitteln sollen Sie sich vorstellen, sie zu verwenden bzw. zu berühren. Die 
Präsentation erfolgt in Blöcken (20 s) mit wechselnden Bildern (2 s pro Bild). Zwischen den 
Blöcken sehen Sie ein Fixationskreuz (ebenfalls 20 s), das Sie bitte mit Ihren Augen fixieren. 
• Im zweiten Teil der Ereignis-Messung werden Ihnen in zufälliger Reihenfolge Bilder mit 
entweder nahrungsbezogenem oder nicht-nahrungsbezogenem Inhalt gezeigt. Ihre Aufgabe 
wird es sein, bei den nicht-nahrungsbezogenen Bildern so schnell wie möglich eine Taste zu 
drücken, während Sie diese Reaktion bei den nahrungsbezogenen Bildern unterdrücken sollten. 
Der Teil wird dann mit der umgekehrten Instruktion wiederholt. 
• Im dritten Teil der Ereignis-Messung sehen Sie Bilder mit Szenarien bestimmter Kategorien: Die 
Szenarios können entweder neutralen, positiven oder negativen emotionalen Gehalt 
repräsentieren. Der Ablauf ist wie beim ersten Teil der Ereignis-Messung. Es gibt keine spezielle 
Aufgabe für Sie; nehmen Sie die Bilder einfach wahr und lassen Sie sie auf sich wirken. 
• Bei den weiteren Messungen des MRI können Sie sich entspannen und – sofern Sie möchten 
und können – schlafen. 
• Die Qualität der Daten und damit der wissenschaftliche Wert hängt massgeblich davon 
ab, wie ruhig Sie während des MRI (ca. 50 min) liegen. Wir bitten Sie daher, sich 
währenddessen nicht zu bewegen (insbesondere Kopf und Schultern).  
• Nach dem MRI werden Sie gebeten, zu einigen der im Ereignis-Teil gesehenen Bildern eine 
persönliche Bewertung abzugeben. 
 
Beschreibung der Computer-Aufgaben 
Die Computer-Aufgaben werden unabhängig von den MRI-Untersuchungen im 
psychophysiologischen Labor des UniversitätsSpitals Zürich stattfinden. Beide Aufgaben zusammen 
inkl. Voraufgaben dauern ca. 75 min. 
Voraufgaben: Hier lösen Sie visuell-räumliche sowie verbale Aufgaben. 
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Aufgabe 1: Hier geht es um das räumliche Erinnerungsvermögen. Für richtige Antworten können 
Sie dabei zusätzlich Geld verdienen (max. 26,40 CHF).  
Aufgabe 2: Hier werden Ihnen verschiedene Portionen von Mahlzeiten gezeigt, deren Grösse Sie 
bewerten sollen. 
 
Ausserdem bitten wir Sie,  
• am Tag der Untersuchung vor der Untersuchung keinen Kaffee und keinen Alkohol zu trinken 
sowie keine anderen auf die Psyche wirkende Substanzen (z. B. Cannabis) zu sich zu nehmen 
und  
• am Tag vor der Untersuchung keinen Alkohol und keine anderen auf die Psyche wirkende 
Substanzen einzunehmen. Vielen Dank. 
 
 
6 Pflichten der Studienteilnehmerin  
 
Als Studienteilnehmerin sind Sie verpflichtet,  
 den medizinischen Anweisungen Ihres Studienarztes zu folgen und sich an den Studienplan zu 
halten, 
 Ihren Studienarzt über den Verlauf der Erkrankung zu informieren und neue Symptome, neue 
Beschwerden und Änderungen im Befinden melden,  
 Ihren Studienarzt über die gleichzeitige Behandlung bei einem anderen Arzt und über die 
Einnahme von Medikamenten zu informieren. Zu den Medikamenten gehören auch alle 
selbstgekauften, ohne ärztliches Rezept erhältlichen und/oder alternativmedizinischen 
Präparate. 
 
 
7 Andere Behandlungsmethoden 
 
Diese Studie beinhaltet kein Testen etwaiger Behandlungsmethoden (keine Medikamenten-
Studie). 
 
 
8 Nutzen für die Teilnehmer 
 
Ihre Teilnahme an dieser klinischen Studie kann zur Verbesserung des Verständnisses und der 
Behandlung der Magersucht beitragen, ist für Sie jedoch nicht mit einem direkten Nutzen 
verbunden 
 
 
9 Risiken und Unannehmlichkeiten 
 
 Unannehmlichkeiten könnten beim MRI durch die längere Liegezeit (ca. 50 min) und durch 
etwaige Beklemmungsgefühle auftreten. Stark unruhige Personen und Personen mit 
ausgeprägter Platzangst sollten daher nicht teilnehmen. 
 Da das MRI mit einem hohen Lautstärkepegel einhergeht, bekommen Sie Ohrstöpsel und 
einen Kopfhörer zum Schutz Ihres Gehörs. Wir bitten Sie, sich die Ohrstöpsel gewissenhaft 
einzusetzen. 
 Bei evtl. plötzlich auftretenden Unannehmlichkeiten während des MRI können Sie jederzeit 
durch Drücken eines Knopfes Kontakt mit dem Versuchsleiter herstellen und die Untersuchung 
auf eigenen Wunsch abbrechen. 
 Kurze Unannehmlichkeiten oder leichte Hautirritationen könnten beim Entfernen der auf die 
Haut geklebten Elektroden auftreten. 
 Die Blutentnahme kann einen kurzen Schmerz und/oder einen leichten Bluterguss 
verursachen.  
 Neu auftretende Symptome und Beschwerden sind dem Studienarzt zu melden.  
 Der Stuhl kann am einfachsten auf der Toilette gesammelt werden, Sie werden hierzu von uns 
einen Plastikbecher zum Auffangen des Stuhles sowie ein Röhrchen zur eigentlichen 
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Aufbewahrung erhalten. Die Entnahme der Stuhlproben ist mit keinerlei Aufwand, Schmerzen 
oder Gefahr für Sie verbunden. Die Stuhlröhrchen mit einer Flüssigkeit zum Konservieren der 
Bakterien enthalten am Deckel einen Plastiklöffel, mit dem problemlos eine kleine Stuhlmenge 
in die Flüssigkeit gegeben werden kann.  
 
 
Schwangerschaft 
Teilnehmerinnen, die während der Studie schwanger werden, müssen ihren Studienarzt 
umgehend informieren und dürfen nicht weiter an der Studie teilnehmen). Der Studienarzt wird mit 
Ihnen das weitere Vorgehen besprechen. In diesem Fall werden Sie gebeten, Angaben über den 
Verlauf und den Ausgang der Schwangerschaft zu machen.  
 
 
10 Neue Erkenntnisse 
 
Der Studienarzt wird Sie während der Studie über alle neuen Erkenntnisse informieren, die den 
Nutzen der Studie oder ihre Sicherheit und somit Ihre Einwilligung zur Teilnahme an der Studie 
beeinflussen können. Sie werden die Information mündlich und schriftlich erhalten. 
Bei Zufallsbefunden (z.B. vom MRI, genetische Analysen), die bei Ihnen zur Verhinderung, 
Feststellung und Behandlung bestehender oder künftig zu erwartender Krankheiten beitragen 
können, haben Sie die Wahl: a) Sie möchten über diese Befunde direkt informiert werden, b) Sie 
möchten nicht informiert werden, oder c) Sie überlassen die Entscheidung Ihrem behandelnden 
Arzt (s. Einverständniserklärung). 
Die Ergebnisse genetischer Analysen haben für den einzelnen Teilnehmer keine Aussagekraft. Sie 
gelten lediglich für das untersuchte Kollektiv. Sie werden deshalb grundsätzlich nicht aktiv über 
diese Ergebnisse informiert, dürfen aber Einsicht in Ihre Daten haben.  
 
 
11 Vertraulichkeit der Daten 
 
In dieser Studie werden persönliche und medizinische Daten von Ihnen erfasst. Diese Daten 
werden verschlüsselt, d.h. mit einem Code versehen. Nur Mitglieder des Forschungsteams haben 
Zugang zu den Daten. Spezielle Fachleute des Sponsors (oder deren Beauftragte) können im 
Rahmen von Qualitätskontrollen die Durchführung der Studie überprüfen. Diese, sowie im Rahmen 
von Inspektionen auch die Mitglieder der zuständigen Behörden und Ethikkommissionen können 
über Ihren Studienarzt Einsicht in Ihre nicht codierte Krankengeschichten nehmen. Im Schadenfall 
erhalten Vertreter der Versicherung ebenfalls über Ihren Studienarzt Einsicht in Ihre medizinischen 
Daten, jedoch nur soweit dies zur Erledigung des Schadenfalles notwendig ist. Während der 
ganzen Studie und bei den erwähnten Kontrollen wird die Vertraulichkeit strikt gewahrt. Ihr Name 
wird in keiner Weise in Rapporten oder Publikationen, die aus der Studie hervorgehen, 
veröffentlicht.  
Im Rahmen dieser Studie werden auch Blut- und Stuhlproben erhoben, welche am Institut für 
Medizinische Genetik, Universität Zürich bzw. an der Klinik für Gastroenterologie, 
UniversitätsSpital Zürich für den Zeitraum nach Daten-Erhebung bis kurz nach Daten-Analyse 
aufbewahrt werden. Die Proben werden mit einem Code, der Ihre vollste Anonymität gewährleistet 
(keine Rückschlüsse auf Ihre persönlichen Daten wie Namen und Geburtsdatum), versehen und 
aufbewahrt. Die Proben werden für die Erforschung der Anorexia Nervosa verwendet. Sie haben 
das Recht auf Einsicht in die Daten wie auch auf die Vernichtung der Proben. Die Proben werden 
nach der Analyse vernichtet. 
 
 
12 Kosten 
 
Die in dieser Teilnehmerinformation erwähnten studienspezifischen Untersuchungen bzw. 
Studienmedikamente sind kostenlos. Weder Ihnen noch Ihrer Krankenkasse entstehen im 
Zusammenhang mit Ihrer Teilnahme zusätzliche Kosten. Medikamente und Therapien, die Sie 
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unabhängig von der Studie einnehmen oder verwenden, werden nicht vom Sponsor dieser Studie 
übernommen.  
 
 
 
 
13 Entschädigung für die Studienteilnehmenden  
 
Für die Teilnahme an dieser klinischen Studie erhalten Sie folgende Entschädigung: CHF 100.—
pro MRI-Termin. Auf Wunsch erhalten Sie auch ein Abbild Ihres eigenen Gehirns einige Tage nach 
der MRI-Messung auf CD ausgehändigt.  
Zusätzlich kann bei Computer-Aufgabe 1 durch richtige Antworten Geld verdient werden.  
 
 
14 Unfreiwilliger Studienabbruch 
 
Ihre Teilnahme kann durch den Studienarzt oder den Studiensponsor abgebrochen werden. 
Folgende Gründe können dazu führen:  
• Auftreten eines in den Ausschlusskriterien benannten Zustandes 
• neue Erkenntnisse über potenziell schädliche Vorgänge in den angewandten Methoden (MRI, 
Blutentnahme) 
 
 
15 Deckung von Schäden 
 
Treten während oder nach dem klinischen Versuch gesundheitliche Störungen oder irgendwelche 
Schäden auf, so wenden Sie sich bitte an die verantwortliche Studienärztin Dr. Gabriella Milos. Sie 
wird für Sie die notwendigen Schritte einleiten. Das UniversitätsSpital Zürich ersetzt Ihnen 
Schäden, die Sie gegebenenfalls im Rahmen des klinischen Versuchs erleiden. Zu diesem Zweck 
hat das UniversitätsSpital Zürich zu Ihren Gunsten eine Versicherung bei der Zürich 
Versicherungsgesellschaft AG (Global Corporate Switzerland, Postfach, 8085 Zürich) 
abgeschlossen. 
 
 
16 Kontaktperson(en) 
 
Bei Unklarheiten, Notfällen, unerwarteten oder unerwünschten Ereignissen, die während der 
Studie oder nach deren Abschluss auftreten, können Sie sich jederzeit  an die untenstehende 
Kontaktperson wenden:  
 
Verantwortliche Studienärztin: 
Prof. Dr. med. Gabriella Milos 
Zentrum für Ess-Störungen, Klinik für Psychiatrie und Psychotherapie, UniversitätsSpital Zürich 
Culmannstr. 8, 8091 Zürich 
Tel.: 044 255 5160 
gabriella.milos@usz.ch 
 
 
Wir bedanken uns für Ihr Interesse und würden uns über Ihre Teilnahme an der Studie sehr freuen! 
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“Reshaping” the Brain – Longitudinal Assessment of Changes in Structural and 
Functional Connectivity During Weight Gain in Anorexia Nervosa 
 
Die “Neuformierung” des Gehirns – Evaluierung von Veränderungen der 
strukturellen und funktionellen Konnektivität während der Gewichtszunahme bei 
Anorexia Nervosa 
 
 
Finanziert durch die Gottfried und Julia Bangerter-Rhyner-Stiftung, Hermann-Klaus-Stiftung und 
Parrotia-Stiftung  
 
 
 
Sehr geehrte Teilnehmerin 
 
 
1 Auswahl der Studienteilnehmerinnen 
 
Wir fragen Sie an, ob Sie an einer Studie teilnehmen möchten, weil Sie in guter Gesundheit sind 
und nicht unter einer Ess-Störung leiden oder gelitten haben.  
 
 
2 Ziel der Studie 
 
In dieser wissenschaftlichen Studie geht es um Veränderungen im Gehirn während der langsamen 
Gewichtszunahme im Rahmen der Therapie bei Patientinnen mit Anorexia nervosa („Magersucht“). 
Die Stärke der Verbindung und/oder der Kommunikation zwischen einzelnen Hirngebieten wird 
sowohl auf der Ebene der Hirn-Aktivität („funktionelle Konnektivität“) als auch der Hirn-Anatomie 
(„strukturelle Konnektivität“) untersucht. 
 
 
3 Allgemeine Informationen zur klinischen Studie 
 
 Durch diese Studie soll eine Verbesserung des Verständnisses derjenigen biologischen 
Mechanismen erlangt werden, die zur Anorexia nervosa führen und die durch eine 
therapeutische Intervention angestossen werden.  
 Jede Probandin dient als Vergleichsperson zu einer Patientin mit Anorexia nervosa und wird im 
Längsschnitt über zwei Messzeitpunkte innerhalb von sechs Monaten untersucht. Die Studie 
dauert insgesamt ca. zwei Jahre exkl. Daten-Auswertung und -Publikation. Es werden 
insgesamt 100 Teilnehmerinnen rekrutiert (50 Patientinnen mit akuter Anorexia nervosa, 25  
geheilte Patientinnen, die früher Magersucht hatten und nun in einem stabilen Zustand sind, 
und 25 gesunde Vergleichspersonen).  
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 Diese Studie wird in Übereinstimmung mit der schweizerischen Gesetzgebung und nach 
international anerkannten Richtlinien durchgeführt. Sie wurde von der zuständigen, 
unabhängigen Ethikkommission des Kantons genehmigt. 
 Magnetresonanztomographie (magnetic resonance imaging, MRI): Das MRI ist ein 
bildgebendes Verfahren zur Darstellung der Struktur und Funktion des Gehirns. Dabei können 
sowohl hochauflösende Bilder des Gehirns als auch die neuronale Aktivität des Gehirns 
aufgenommen werden. Das MRI beruht auf einem starken Magnetfeld, d.h. die Untersuchung 
ist frei von Röntgenstrahlen und gilt daher als ungefährlich. Sie ist ausserdem schmerzlos und 
nebenwirkungsfrei. Dennoch werden Schwangere von der Studie ausgeschlossen.  
 Zufallsbefunde: Da es sich um bildgebende Untersuchungen des Gehirns handelt, könnten 
sich so genannte neurologische „Zufallsbefunde“ aufdrängen. Im Zusammenhang mit MRI-
Aufnahmen könnten sich Missbildungen oder andere Auffälligkeiten in den Aufnahmen zeigen. 
Im Rahmen Ihrer Einverständniserklärung werden Sie die Möglichkeit haben zu entscheiden ob 
Sie über einen neurologischen Zufallsbefund 1) direkt informiert werden möchten, 2) nicht 
informiert werden möchten oder 3) die Entscheidung einem Arzt überlassen. 
 
 
4 Freiwilligkeit der Teilnahme 
 
Ihre Teilnahme an dieser Studie ist freiwillig und Sie können Ihre einmal gegebene Einwilligung zu 
einem späteren Zeitpunkt widerrufen. Diese Möglichkeit haben Sie jederzeit. Einen allfälligen 
Widerruf Ihrer Einwilligung bzw. den Rücktritt von der Studie müssen Sie nicht begründen. Im Fall 
eines Widerrufs werden die bis zu diesem Zeitpunkt erhobenen Daten weiter verwendet und die 
gelagerten Blutproben werden für Forschungszwecke nicht mehr weiter verwendet. 
 
 
5 Studienablauf 
 
 Nachdem Sie die Einverständniserklärung unterschrieben haben, vereinbaren wir einen Termin 
mit Ihnen für die Voruntersuchung. Diese beinhaltet eine kurze Abklärung Ihres 
Gesundheitszustands und das Ausfüllen einiger Fragebögen zu Ihrem Gemütszustand. Sie 
dauert ca. 45 min.  
 Ihre weitere Teilnahme an der Studie besteht aus zwei MRI-Untersuchungen und zwei 
Computer-Aufgaben innerhalb von ca. sechs Monaten. Jede MRI-Untersuchung dauert ca. 1,5 
h; die Computer-Aufgaben dauern jeweils ca. 75 min. Ort der Untersuchungen ist das 
UniversitätsSpital Zürich. Bei jedem MRI-Termin werden Sie ausserdem gebeten einige 
Fragebögen auszufüllen (unten schematisch dargestellt). Zudem findet eine Blutentnahme 
statt, die es uns ermöglicht, hormonelle Parameter zu erfassen und genetische Analysen 
durchzuführen. Es werden dabei spezifische Gene analysiert, die mit der Entwicklung einer 
Essstörung in Verbindung gebracht wurden. Hormonelle und genetische Analysen wiederum 
werden mit der aus dem MRI gewonnenen Datenmenge in Verbindung gebracht. 
 Vor jedem der beiden MRI-Untersuchungen wird ein Schwangerschaftstest durchgeführt. 
 
Im Folgenden ist der Ablauf einer MRI-Untersuchung schematisch dargestellt: 
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Während des MRI werden Ihre Herz- und Atemfrequenz aufgezeichnet. Dazu werden Ihnen vor der 
MRI-Untersuchung am Rippenbereich Elektroden angeklebt und es wird ein Atemgurt um den 
Bauch herum angebracht. 
 
Instruktionen für die Teilnehmerinnen während des MRI: 
• In der Ruhe-Messung bitten wir Sie, ihre Augen geschlossen zu halten und sich nicht zu 
bewegen. Sie können sich entspannen und Ihren Gedanken freien Lauf lassen. Sie sollten 
während der Ruhe-Messung nicht einschlafen. 
• Im ersten Teil der Ereignis-Messung bekommen Sie verschiedene Bilder zu sehen, auf denen 
entweder Speisen/Nahrungsmittel oder Nicht-Nahrungsmittel (Gegenstände/Tiere/Pflanzen)  
abgebildet sind. Bei den Speisen sollen Sie sich vorstellen, davon zu essen. Bei den Nicht-
Nahrungsmitteln sollen Sie sich vorstellen, sie zu verwenden bzw. zu berühren. Die 
Präsentation erfolgt in Blöcken (20 s) mit wechselnden Bildern (2 s pro Bild). Zwischen den 
Blöcken sehen Sie ein Fixationskreuz (ebenfalls 20 s), das Sie bitte mit Ihren Augen fixieren. 
• Im zweiten Teil der Ereignis-Messung werden Ihnen in zufälliger Reihenfolge Bilder mit 
entweder nahrungsbezogenem oder nicht-nahrungsbezogenem Inhalt gezeigt. Ihre Aufgabe 
wird es sein, bei den nicht-nahrungsbezogenen Bildern so schnell wie möglich eine Taste zu 
drücken, während Sie diese Reaktion bei den nahrungsbezogenen Bildern unterdrücken sollten. 
Der Teil wird dann mit der umgekehrten Instruktion wiederholt. 
• Im dritten Teil der Ereignis-Messung sehen Sie Bilder mit Szenarien bestimmter Kategorien: Die 
Szenarios können entweder neutralen, positiven oder negativen emotionalen Gehalt 
repräsentieren. Der Ablauf ist wie beim ersten Teil der Ereignis-Messung. Es gibt keine spezielle 
Aufgabe für Sie; nehmen Sie die Bilder einfach wahr und lassen Sie sie auf sich wirken. 
• Bei den weiteren Messungen des MRI können Sie sich entspannen und – sofern Sie möchten 
und können – schlafen. 
• Die Qualität der Daten und damit der wissenschaftliche Wert hängt massgeblich davon 
ab, wie ruhig Sie während des MRI (ca. 50 min) liegen. Wir bitten Sie daher, sich 
währenddessen nicht zu bewegen (insbesondere Kopf und Schultern).  
• Nach dem MRI werden Sie gebeten, zu einigen der im Ereignis-Teil gesehenen Bildern eine 
persönliche Bewertung abzugeben. 
 
Beschreibung der Computer-Aufgaben 
Die Computer-Aufgaben werden unabhängig von den MRI-Untersuchungen im 
psychophysiologischen Labor des UniversitätsSpitals Zürich stattfinden. Beide Aufgaben zusammen 
inkl. Voraufgaben dauern ca. 75 min. 
Voraufgaben: Hier lösen Sie visuell-räumliche sowie verbale Aufgaben. 
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Aufgabe 1: Hier geht es um das räumliche Erinnerungsvermögen. Für richtige Antworten können 
Sie dabei zusätzlich Geld verdienen (max. 26,40 CHF). 
Aufgabe 2: Hier werden Ihnen verschiedene Portionen von Mahlzeiten gezeigt, deren Grösse Sie 
bewerten sollen. 
 
Ausserdem bitten wir Sie,  
• am Tag der Untersuchung vor der Untersuchung keinen Kaffee und keinen Alkohol zu trinken 
sowie keine anderen auf die Psyche wirkende Substanzen (z. B. Cannabis) zu sich zu nehmen 
und  
• am Tag vor der Untersuchung keinen Alkohol und keine anderen auf die Psyche wirkende 
Substanzen einzunehmen. Vielen Dank. 
 
 
6 Pflichten der Studienteilnehmerin  
 
Als Studienteilnehmerin sind Sie verpflichtet, den Anweisungen Ihres Studienarztes zu folgen. 
 
 
7 Andere Behandlungsmethoden 
 
Diese Studie beinhaltet kein Testen etwaiger Behandlungsmethoden (keine Medikamenten-
Studie). 
 
 
8 Nutzen für die Teilnehmer 
 
Ihre Teilnahme an dieser klinischen Studie kann zur Verbesserung des Verständnisses und der 
Behandlung der Magersucht beitragen, ist für Sie jedoch nicht mit einem direkten Nutzen 
verbunden. 
 
 
9 Risiken und Unannehmlichkeiten 
 
 Unannehmlichkeiten könnten beim MRI durch die längere Liegezeit (ca. 50 min) und durch 
etwaige Beklemmungsgefühle auftreten. Stark unruhige Personen und Personen mit 
ausgeprägter Platzangst sollten daher nicht teilnehmen. 
 Da das MRI mit einem hohen Lautstärkepegel einhergeht, bekommen Sie Ohrstöpsel und 
einen Kopfhörer zum Schutz Ihres Gehörs. Wir bitten Sie, sich die Ohrstöpsel gewissenhaft 
einzusetzen. 
 Bei evtl. plötzlich auftretenden Unannehmlichkeiten während des MRI können Sie jederzeit 
durch Drücken eines Knopfes Kontakt mit dem Versuchsleiter herstellen und die Untersuchung 
auf eigenen Wunsch abbrechen. 
 Kurze Unannehmlichkeiten oder leichte Hautirritationen könnten beim Entfernen der auf die 
Haut geklebten Elektroden auftreten. 
 Die Blutentnahme kann einen kurzen Schmerz und/oder einen leichten Bluterguss 
verursachen.  
 Neu auftretende Symptome und Beschwerden sind dem Studienarzt zu melden.  
 
Schwangerschaft 
Teilnehmerinnen, die während der Studie schwanger werden, müssen ihren Studienarzt 
umgehend informieren und dürfen nicht weiter an der Studie teilnehmen). Der Studienarzt wird mit 
Ihnen das weitere Vorgehen besprechen. In diesem Fall werden Sie gebeten, Angaben über den 
Verlauf und den Ausgang der Schwangerschaft zu machen.  
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10 Neue Erkenntnisse 
 
Der Studienarzt wird Sie während der Studie über alle neuen Erkenntnisse informieren, die den 
Nutzen der Studie oder ihre Sicherheit und somit Ihre Einwilligung zur Teilnahme an der Studie 
beeinflussen können. Sie werden die Information mündlich und schriftlich erhalten. 
Bei Zufallsbefunden (z.B. vom MRI, genetische Analysen), die bei Ihnen zur Verhinderung, 
Feststellung und Behandlung bestehender oder künftig zu erwartender Krankheiten beitragen 
können, haben Sie die Wahl: a) Sie möchten über diese Befunde direkt informiert werden, b) Sie 
möchten nicht informiert werden, oder c) Sie überlassen die Entscheidung Ihrem behandelnden 
Arzt (s. Einverständniserklärung). 
Die Ergebnisse genetischer Analysen haben für den einzelnen Teilnehmer keine Aussagekraft. Sie 
gelten lediglich für das untersuchte Kollektiv. Sie werden deshalb grundsätzlich nicht aktiv über 
diese Ergebnisse informiert, dürfen aber Einsicht in Ihre Daten haben.  
 
 
11 Vertraulichkeit der Daten 
 
In dieser Studie werden persönliche und medizinische Daten von Ihnen erfasst. Diese Daten 
werden verschlüsselt, d.h. mit einem Code versehen. Nur Mitglieder des Forschungsteams haben 
Zugang zu den Daten. Spezielle Fachleute des Sponsors (oder deren Beauftragte) können im 
Rahmen von Qualitätskontrollen die Durchführung der Studie überprüfen. Diese, sowie im Rahmen 
von Inspektionen auch die Mitglieder der zuständigen Behörden und Ethikkommissionen können 
über Ihren Studienarzt Einsicht in Ihre nicht codierte Krankengeschichten nehmen. Im Schadenfall 
erhalten Vertreter der Versicherung ebenfalls über Ihren Studienarzt Einsicht in Ihre medizinischen 
Daten, jedoch nur soweit dies zur Erledigung des Schadenfalles notwendig ist. Während der 
ganzen Studie und bei den erwähnten Kontrollen wird die Vertraulichkeit strikt gewahrt. Ihr Name 
wird in keiner Weise in Rapporten oder Publikationen, die aus der Studie hervorgehen, 
veröffentlicht.  
Im Rahmen dieser Studie werden auch Blutproben erhoben, welche am Institut für Medizinische 
Genetik, Universität Zürich für den Zeitraum nach Daten-Erhebung bis kurz nach Daten-Analyse 
aufbewahrt werden. Die Proben werden mit einem Code, der Ihre vollste Anonymität gewährleistet 
(keine Rückschlüsse auf Ihre persönlichen Daten wie Namen und Geburtsdatum), versehen und 
aufbewahrt. Die Proben werden für die Erforschung der Anorexia nervosa verwendet. Sie haben 
das Recht auf Einsicht in die Daten wie auch auf die Vernichtung der Proben. Die Proben werden 
nach der Analyse vernichtet. 
 
 
12 Kosten 
 
Die in dieser Teilnehmerinformation erwähnten studienspezifischen Untersuchungen bzw. 
Studienmedikamente sind kostenlos. Weder Ihnen noch Ihrer Krankenkasse entstehen im 
Zusammenhang mit Ihrer Teilnahme zusätzliche Kosten. Medikamente und Therapien, die Sie 
unabhängig von der Studie einnehmen oder verwenden, werden nicht vom Sponsor dieser Studie 
übernommen.  
 
 
13 Entschädigung für die Studienteilnehmenden  
 
Für die Teilnahme an dieser klinischen Studie erhalten Sie folgende Entschädigung: CHF 100.—
pro MRI-Termin. Auf Wunsch erhalten Sie auch ein Abbild Ihres eigenen Gehirns einige Tage nach 
der MRI-Messung auf CD ausgehändigt. 
Zusätzlich kann bei Computer-Aufgabe 1 durch richtige Antworten Geld verdient werden.  
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14 Unfreiwilliger Studienabbruch 
 
Ihre Teilnahme kann durch den Studienarzt oder den Studiensponsor abgebrochen werden. 
Folgende Gründe können dazu führen:  
• Auftreten eines in den Ausschlusskriterien benannten Zustandes 
• neue Erkenntnisse über potenziell schädliche Vorgänge in den angewandten Methoden (MRI, 
Blutentnahme) 
 
 
15 Deckung von Schäden 
 
Treten während oder nach dem klinischen Versuch gesundheitliche Störungen oder irgendwelche 
Schäden auf, so wenden Sie sich bitte an die verantwortliche Studienärztin Dr. Gabriella Milos. Sie 
wird für Sie die notwendigen Schritte einleiten. Das UniversitätsSpital Zürich ersetzt Ihnen 
Schäden, die Sie gegebenenfalls im Rahmen des klinischen Versuchs erleiden. Zu diesem Zweck 
hat das UniversitätsSpital Zürich zu Ihren Gunsten eine Versicherung bei der Zürich 
Versicherungsgesellschaft AG (Global Corporate Switzerland, Postfach, 8085 Zürich) 
abgeschlossen. 
 
 
16 Kontaktperson(en) 
 
Bei Unklarheiten, Notfällen, unerwarteten oder unerwünschten Ereignissen, die während der 
Studie oder nach deren Abschluss auftreten, können Sie sich jederzeit  an die untenstehende 
Kontaktperson wenden:  
 
Verantwortliche Studienärztin: 
Prof. Dr. med. Gabriella Milos 
Zentrum für Ess-Störungen, Klinik für Psychiatrie und Psychotherapie, UniversitätsSpital Zürich 
Culmannstr. 8, 8091 Zürich 
Tel.: 044 255 5160 
gabriella.milos@usz.ch 
 
 
Wir bedanken uns für Ihr Interesse und würden uns über Ihre Teilnahme an der Studie sehr freuen! 
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UniversitätsSpital 
Zürich u Klinik für Psychiatrie  und Psychotherapie 
 
MRI-Sicherheitsfragebogen für ProbandInnen und PatientInnen 
 
Zentrum für Essstörungen 
 
Dieser Fragebogen dient Ihrer Sicherheit im MR‐Gerät. Wir bitten 
Sie daher, die Fragen gewissenhaft zu beantworten. Wenn Sie sich 
nicht sicher sind oder eine Frage nicht verstehen, wenden Sie sich 
bitte an den Untersucher/die Untersucherin. 
 
Projektnummer 
FCA010413 
Ethiknummer 
2013‐0273 
Probandencode 
 
Name Vorname Geburtsdatum (TT.MM.JJJJ) 
Strasse, Hausnummer PLZ, Wohnort Gewicht (kg) 
 
 
 
 
 
 
Wurden Sie jemals am Kopf, Herz oder Gefässsystem operiert? 
 
 
 
Ja 
 
 
 
Nein 
 
Haben Sie einen Herzschrittmacher? 
 
 
 
Ja 
 
 
 
Nein 
 
Haben Sie einen Nervenstimulator? 
 
 
 
Ja 
 
 
 
Nein 
 
Haben Sie eine Insulinpumpe oder eine Schmerzpumpe? 
 
 
 
Ja 
 
 
 
Nein 
 
Haben Sie irgendwelche Implantate (z.B. Cochleaimplantat, Marknägel)? 
 
 
 
Ja 
 
 
 
Nein 
Haben Sie irgendwelche metallische Prothesen (z.B. Herzklappenprothese, 
Hüftprothese, Knieprothese)? 
 
 
 
Ja 
 
 
 
Nein 
Tragen Sie ein Medikamentenpflaster (z.B. Nitro‐Pflaster, Schmerzpflaster, 
Nikotinpflaster, Hormonpflaster, Reisepflaster)? 
 
 
 
Ja 
 
 
 
Nein 
Haben Sie sonstige Metallteile oder ‐splitter im Körper? (z.B. Metall‐ 
splitterverletzungen, Schusswunden, Clips nach Operationen) 
 
 
 
Ja 
 
 
 
Nein 
Hatten Sie jemals beruflich oder privat mit der Verarbeitung von Metallen 
zu tun (z.B. Schleifen, Fräsen)? 
 
 
 
Ja 
 
 
 
Nein 
 
Tragen Sie ein Hörgerät? 
 
 
 
Ja 
 
 
 
Nein 
 
Tragen Sie Kontaktlinsen? 
 
 
 
Ja 
 
 
 
Nein 
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Tragen Sie eine Zahnspange oder eine Zahnprothese? 
 
 
 
Ja 
 
 
 
Nein 
Haben Sie eine Tätowierung (egal wie gross)? 
Wenn ja, wo?                                                            
 
 
 
Ja 
 
 
 
Nein 
 
Tragen Sie Permanent‐Make‐Up? 
 
 
 
Ja 
 
 
 
Nein 
 
Tragen Sie Körperschmuck (ein Piercing)? 
 
 
 
Ja 
 
 
 
Nein 
 
Haben Sie Angst vor geschlossenen oder engen Räumen (Klaustrophobie)? 
 
 
 
Ja 
 
 
 
Nein 
 
Sind Sie lärmempfindlich oder schwerhörig? 
 
 
 
Ja 
 
 
 
Nein 
 
Nehmen Sie zurzeit irgendwelche Medikamente ein? 
 
 
 
Ja 
 
 
 
Nein 
 
Nehmen Sie zurzeit Aspirin oder andere Schmerzmittel ein? 
 
 
 
Ja 
 
 
 
Nein 
 
  
 
Besteht die Möglichkeit, dass Sie schwanger sind? 
 Falls ja: Bitte Schwangerschaftstest durchführen. 
 
 
 
Ja 
 
 
 
Nein 
 
 Schwangerschaftstest durchgeführt am               _   .   __  .20_____       
 
 
 
Pos. 
 
 
 
Neg. 
 
Tragen Sie eine Kupferspirale? 
 
 
 
Ja 
 
 
 
Nein 
 
 
 
 
Ich bin über die Risiken der bevorstehenden MR‐Untersuchung aufgeklärt worden 
und stimme der Durchführung zu. 
 
 
 
 
 
  _____________________  _________________________ 
  Ort und Datum                        Unterschrift 
 (ProbandIn)  
 
 
 
  _____________________  ________________________ 
  Ort und Datum                        Unterschrift 
 (UntersucherIn) 
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